Reviewer #1 (Public Review):

Summary:

The manuscript of Zhao et al. aimed at investigating the relationships between type 2 diabetes, bone mineral density (BMD) and fracture risk using Mendelian Randomization (MR) approach.<br /> The authors found that genetically predicted T2D was associated with higher BMD and lower risk of fracture, and suggested a mediated effect of RSPO3 level. Moreover, when stratified by the risk factors secondary to T2D, they observed that the effect of T2D on the risk of fracture decreased when the number of risk factors secondary to T2D decreased.

Strengths:

- Important question<br /> - Manuscript is overall clear and well-written<br /> - MR analyses have been conducted properly, which include the usage of various MR methods and sensitivity analyses, and likely meet the criteria of the MR-strobe checklist to report MR results.

Weaknesses:

- Interpretation of MR findings should be more nuanced given the modest (almost neutral) relationship between T2D and fracture risk in MR

Reviewer #2 (Public Review):

The authors employed the Mendelian Randomization method to analyze the association between type 2 diabetes (T2D) and fracture using the UK Biobank data. They found that "genetically predicted T2D was associated with higher BMD and lower risk of fracture". Additionally, they identified 10 loci that were associated with both T2D and fracture risk, with the SNP rs4580892 showing the highest signal. While the negative relationship between T2D and fracture has been previously observed, the discovery of these 10 loci adds an intriguing dimension to the findings, although the clinical implications remain uncertain.

Many thanks for your response which has clarified my understanding of your paper. And, thank you for the additional analyses. I still find the paper challenging to understand due to two different analyses that yielded conflicting results: (a) in the observational analysis, the authors found that type 2 diabetes was associated with both higher BMD and a higher risk of fracture (ie a paradox); but (b) in the Mendelian randomization analysis, 'genetically predicted type 2 diabetes' was associated with greater BMD and a lower risk of fracture. I consider that your conclusion is not consistent with the data you presented.

Reviewer #1 (Public Review):

Hu et al. performed sc-RNA-seq analyses of kidney cells with or without virus infection, vaccines, and vaccines+virus infections from pooled adult zebrafish. They compared within these experimental groups as well as kidney vs spleen. Their analyses identified expected populations but also revealed new hematopoietic stem/progenitor cell (HSPC), even in spleen. Their analyses show that HSPCs in kidney can respond to virus infection differentially and can be trained to recognize the same infection and argue that zebrafish kidney can serve as a secondary immune organ. The findings are important and interesting. The manuscript is well written and a pleasure to read.

Reviewer #2 (Public Review):

Summary:

In this manuscript, the authors have meticulously constructed a comprehensive atlas delineating hematopoietic stem/progenitor cell (HSPC) and immune-cell types within the zebrafish kidney, employing single-cell transcriptome profiling analysis. Notably, these cell populations exhibited distinctive responses to viral infection. Intriguingly, the investigation revealed that HSPCs manifest positive reactivities to viral infection, indicating the effective induction of trained immunity in select HSPCs. Furthermore, the study unveiled the capacity for the generation of antigen-stimulated adaptive immunity within the kidney, suggesting a role for the zebrafish kidney as a secondary lymphoid organ. This research elucidates the distinctive features of the fish immune system and underscores the multifaceted biology of the kidney in ancient vertebrates.

Strengths:

This study, encompassing 13 figures along with supplementary material, distinguishes itself as one of the most comprehensive investigations on this subject to date.

Reviewer #1 (Public Review):

Summary:

In this study, the authors used both the commonly used neonatal hyperoxia model as well as cell-type-specific genetic inactivation of Tgfbr2 models to study the basis of BPD. The bulk of the analyses focus on the mesenchymal cells. Results indicate impaired myofibroblast proliferation, resulting in decreased cell number. InactzXivation of Etc2 in Pdgfra-lineaged cells, preventing cytokinesis of myofibroblasts, led to alveolar simplification. Together, the findings demonstrate that disrupted myofibroblast proliferation is a key contributor to BPD pathogenesis.

Strengths:

Overall, this comprehensive study of BPD models advances our understanding of the disease. The data are of high quality.

Weaknesses:

The critiques are mostly minor and can be addressed without extensive experimentation.

Reviewer #2 (Public Review):

Summary:

In this study, the authors systematically explore the mechanism(s) of impaired postnatal lung development with relevance to BPD (bronchopulmonary dysplasia) in two murine models of 'alveolar simplification', namely hyperoxia and epithelial loss of TGFb signaling. The work presented here is of great importance, given the limited treatment options for a clinical entity frequently encountered in newborns with high morbidity and mortality that is still poorly understood, and the unclear role of TGFb signaling, its signaling levels, and its cellular effects during secondary alveolar septum formation, a lung structure generating event heavily impacted by BPD. The authors show that hyperoxia and epithelial TGFb signaling loss have similar detrimental effects on lung structure and mechanical properties (emphysema-like phenotype) and are associated with significantly decreased numbers of PDGFRa-expressing cells, the major cell pool responsible for generation of postnatal myofibroblasts. They then use a single-cell transcriptomic approach combined with pathway enrichment analysis for both models to elucidate common factors that affect alveologenesis. Using cell communication analysis (NicheNet) between epithelial and myofibroblasts they confirm increased projected TGFb-TGFbR interactions and decreased projected interactions for PDGFA-PDGFRA, and other key pathways, such as SHH and WNT. Based on these results they go on to uncover in a sequela of experiments that surprisingly, increased TGFb appears reactive to postnatal lung injury and rather protective/homeostatic in nature, and the authors establish the requirement for alpha V integrins, but not the subtype alphaVbeta6, a known activator of TGFb signaling and implied in adult lung fibrosis. The authors then go beyond the TGFb axis evaluation to show that mere inhibition of proliferation by conditional KO of Ect2 in Pdgfra lineage results in alveolar simplification, pointing out the pivotal role of PDGFRa-expressing myofibroblasts for normal postnatal lung development.

Strengths:

(1) The approach including both pharmacologic and mechanistically-relevant transgenic interventions both of which produced consistent results provides robustness of the results presented here.

(2) Further adding to this robustness is the use of moderate levels of hyperoxia at 75% FiO2, which is less extreme than 100% FiO2 frequently used by others in the field, and therefore favors the null hypothesis.

(3) The prudent use of advanced single-cell analysis tools, such as NicheNet to establish cell interactions through the pathways they tested and the validation of their scRNA-seq results by analysis of two external datasets. Delineation of the complexity of signals between different cell types during normal and perturbed lung development, such as attempted successfully in this study, will yield further insights into the underlying mechanism(s).

(4) The combined readout of lung morphometric (MLI) and lung physiologic parameters generates a clinically meaningful readout of lung structure and function.

(5) The systematic evaluation of TGFb signaling better determines the role in normal and postnatally-injured lungs.

Weaknesses:

(1) While the study convincingly establishes the effect of lung injury on the proliferation of PDGFRa-expressing cells, differentiation is equally important. Characterization of PDGFRa expressing cells and tracking the changes in the injury models in the scRNA analysis, a key feature of this study, would benefit from expansion in this regard. PDGFRa lineage gives rise to several key fibroblast populations, including myofibroblasts, lipofibroblasts, and matrix-type fibroblasts (Collagen13a1, Collagen14a1). Lipofibroblasts constitute a significant fraction of PDGFRa+ cells, and expand in response to hyperoxic injury, as shown by others. Collagen13a1-expressing fibroblasts expand significantly under both conditions (Figure 3), and appear to contain a significant number of PDGFRa-expressing cells (Suppl Fig.1). Effects of the applied injuries on known differentiation markers for these populations should be documented. Another important aspect would be to evaluate whether the protective/homeostatic effect of TGFb signaling is supporting the differentiation of myofibroblasts. Postnatal Gli1 lineage gains expression of PDGFRa and differentiation markers, such as Acta2 (SMA) and Eln (Tropoelastin). Loss of PDGFRa expression was shown to alter Elastin and TGFb pathway-related genes. TGFb signaling is tightly linked to the ECM via LTBPs, Fibrillins, and Fibulins. An additional analysis in the aforementioned regard has great potential to more specifically identify the cell type(s) affected by the loss of TGFb signaling and allow analysis of their specific transcriptomic changes in response and underlying mechanism(s) to postnatal injury.

(2) Of the three major lung abnormalities encountered in BPD, the authors focus on alveolarization impairment in great detail, to a very limited extent on inflammation, and not on vascularization impairment. However, this would be important not only to better capture the established pathohistologic abnormalities of BPD, but also it is needed since the authors alter TGFb signaling, and inflammatory and vascular phenotypes with developmental loss of TGFb signaling and its activators have been described. Since the authors make the point about the absence of inflammation in their BPD model, it will be important to show the evidence.

(3) Conceptually it would be important that in the discussion the authors reconcile their findings in the experimental BPD models in light of human BPD and the potential implications it might have on new ways to target key pathways and cell types for treatment. This allows the scientific community to formulate the next set of questions in a disease-relevant manner.

Reviewer #3 (Public Review):

Summary:

This paper seeks to understand the role of alveolar myofibroblasts in abnormal lung development after saccular stage injury.

Strengths:

Multiple models of neonatal injury are used, including hyperoxia and transgenic models that target alveolar myofibroblasts.

Weaknesses:

There are several weaknesses that leave the conclusions significantly undersupported by the data as presented:

(1) There is no validation of the decreased number of myofibroblasts suggested by flow cytometry/scRNAseq at the level of the tissue. Given that multiple groups have reported increased myofibroblasts (aSMA+ fibroblasts) in humans with BPD and in mouse models, demonstrating a departure from prior findings with tissue validation in the mouse models is essential. There are many reasons for decreased numbers of a subpopulation by flow cytometry, most notably that injured cells may be less likely to survive the cell sorting process.

(2) The hallmark genes used to define the subpopulations are not given in single-cell data. As the definition of fibroblast subtypes remains an area of unsettled discussion in the field, it is possible that the decreased number by classification and not a true difference. Tissue validation and more transparency in the methods used for single-cell sequencing would be critical here.

(3) There is an oversimplification of neonatal hyperoxia as a "BPD model" used here without a reference to detailed prior work demonstrating that the degree and duration of hyperoxia dramatically change the phenotype. For example, Morty et al have shown that hyperoxia of 85% or more x 14 days is required to demonstrate the septal thickening observed in severe human BPD. Other than one metric of lung morphometry (MLI), which is missing units on the y-axis and flexivent data, the authors have not fully characterized this model. Prior work comparing 75% O2 exposure for 5, 8, or 14 days shows that in the 8-day exposed group (similar to the model used here), much of the injury was reversible. What evidence do the authors have that hyperoxia alone is an accurate model of the permanent structural injury seen in human BPD?

(4) Thibeault et al published a single-cell analysis of neoantal hyperoxia in 2021, with seemingly contrasting findings. How does this dataset compare in context?

Reviewer #1 (Public Review):

Summary:

In this study, Xie and colleagues aimed to explore the function and potential mechanisms of the gut microbiota in a hamster model of severe leptospirosis. The results demonstrated that Leptospira infection was able to cause intestine damage and inflammation. Leptospira infection promoted an expansion of Proteobacteria, increased gut barrier permeability, and elevated LPS levels in the serum. Thus, they proposed an LPS-neutralization therapy which improved the survival rate of moribund hamsters combined with antibody therapy or antibiotic therapy.

Strengths:

The work is well-designed and the story is interesting to me. The gut microbiota is essential for immunity and systemic health. Many life-threatening pathogens, such as SARS-CoV-2 and other gut-damaged infection, have the potential to disrupt the gut microbiota in the later stages of infection, causing some harmful gut microbiota-derived substances to enter the bloodstream. It is emphasized that in addition to exogenous pathogenic pathogens, harmful substances of intestinal origin should also be considered in critically ill patients.

Weaknesses:

(1) There are many serotypes of Leptospira, it is suggested to test another pathogenic serotype of Leptospira to validate the proposed therapy.

(2) Authors should explain why the infective doses of leptospires was not consistent in different study.

(3) In the discussion section, it is better to supplement the discussion of the potential link between the natural route of infection and leptospirosis.

(4) Line 231, what is the solvent of thioglycolate?

(5) Lines 962-964, there are some mistakes which are not matched to Figure 7.

Reviewer #2 (Public Review):

Severe leptospirosis in humans and some mammals often meet death in the endpoint. In this article, authors explored the role of the gut microbiota in severe leptospirosis. They found that Leptospira infection promoted a dysbiotic gut microbiota with an expansion of Proteobacteria and LPS neutralization therapy synergized with antileptospiral therapy significantly improved the survival rates in severe leptospirosis. This study is well-organized and has potentially important clinical implications not only for severe leptospirosis but also for other gut-damaged infections.

Reviewer #3 (Public Review):

Summary:

This is a well-prepared manuscript that presented interesting research results. The only defect is that the authors should further revise the English language.

Strengths:

The omics method produced unbiased results.

Weaknesses:

LPS neutralization is not a new method for treating leptospiral infection.

Reviewer #1 (Public Review):

Summary:<br /> The manuscript by Rowell et al aims to identify differences in TCR recombination and selection between foetal and adult thymus in mice. Authors sequenced the unpaired bulk TCR repertoire in foetal and adult mice thymi and studied both TCRB and TCRa characteristics in the double positive (DP, CD4+CD8+) and single positive (SP4 CD4+CD8-CD3+ and SP8 CD4-CD8+CD3+) populations. They identified age-related differences in TCRa and TCRB segment usage, including a preferential bias toward 3'TRAV and 5' TRAJ rearrangements in foetal cells compared to adults who had a larger perveance for 5'TRAV segments. By depleting the thymocyte population in adult thymi using hydrocortisone, the authors demonstrated that the repertoire became more foetal like, they therefore argue that the preferential 5'TRAV rearrangements in adults may be resulting from prolonged/progressive TCRa rearrangements in the adult thymocytes. In line with previous studies, Authors demonstrate that the foetal TCR repertoire was less diverse, less evenly distributed and had fewer non-template insertions while containing more clonal expansions. In addition, the authors claim that changes in V-J usage and CDR1 and CDR2 in the DP vs SP repertoires indicated that positive selection of foetal thymocytes are less dependent on interactions with the MHC.

Strengths:<br /> Overall, the manuscript provides an extensive analysis of the foetal and adult TCR repertoire in the thymus, resulting in new insights in T cell development in foetal and adult thymi.

Weaknesses:<br /> Three major concerns arise: 1) the authors have analysed TCR repertoires of only 4 foetal and 4 adult mice, considering the high spread the study may have been underpowered. 2) Gating strategies are missing and 3) the manuscript is very technical and clearly aimed for a highly specialised audience with expertise in both thymocyte development and TCR analysis. Authors are recommended to provide schematics of the TCR rearrangements/their findings and include a summary conclusions/implications of their findings at the end of each results section rather than waiting till the discussion. This will help the reader to interpret their findings while reading the results.

Reviewer #2 (Public Review):

Summary:<br /> The authors comprehensively assess differences in the TCRB and TCRA repertoires in the fetal and adult mouse thymus by deep sequencing of sorted cell populations. For TCRB and TCRA they observed biased gene segment usage and less diversity in fetal thymocytes. The TCRB repertoire was less evenly distributed and displayed more evidence of clonal expansions and repertoire sharing among individuals in fetal thymocytes. In both fetal and adult thymocytes they show skewing of V segment (CDR1-2) repertoires in CD4 and CD8 as compared to DP thymocytes, which they attribute to MHC-I vs MHC-II restriction during positive selection. However the authors assess these effects to be weaker in fetal thymocytes, suggesting weaker MHC-restriction. They conclude that in multiple respects fetal repertoires are distinct from and more innate-like than adult.

Strengths:<br /> The analyses of the F18.5 and adult thymic repertoires are comprehensive with respect to the cell populations analyzed and the diversity of approaches used to characterize the repertoires. Because repertoires were analyzed in pre- and post-selection thymocyte subsets, the data offer the potential to assess repertoire selection at different developmental stages. The analysis of repertoire selection in fetal thymocytes may be unique.

Weaknesses:<br /> (1) Problematic experimental design and some lack of familiarity with prior work have resulted in highly problematic interpretations of the data, particularly for TCRA repertoire development.<br /> The authors note fetal but not adult thymocytes to be biased towards usage of 3' V segments and 5'J segments. It should be noted that these basic observations were made 20 years ago using PCR approaches (Pasqual et al., J.Exp.Med. 196:1163 (2002)), and even earlier by others. The authors also note that in fetal thymus this bias persists after positive selection, and it can be reproduced in adults during recovery from hydrocortisone treatment. The authors conclude that there are fewer rounds of sequential TCRA rearrangements in the fetal thymus, perhaps due to less time spent in the DP compartment in fetus versus adult. However, the repertoire difference noted by the authors does not require such an explanation. What the authors are analyzing in the fetus is the leading edge of a synchronous wave of TCRA rearrangements, whereas what they are analyzing in adults is the unsynchronized steady state distribution. It is certainly true, as has been shown previously, that the earliest TCRA rearrangements use 3' TRAV and 5'TRAJ segments. But analysis of adult thymocytes has shown that the progression from use of 3' TRAV and 5' TRAJ to use of 5' TRAV and 3' TRAJ takes several days (Carico et al., Cell Rep. 19:2157 (2017)). The same kinetics, imposed on fetal development, would put development of a more complete TCRA repertoire at or shortly after birth. In fact, Pasqual showed exactly this type of progression from F18 through D1 after birth, and could reproduce the progression by placing F16 thymic lobes in FTOC. It is not appropriate to compare a single snapshot of a synchronized process in early fetal thymocytes to the unsynchronized steady state situation in adults. In fact, the authors' own data support this contention, because when they synchronize adult thymocytes by using hydroxycortisone, they can replicate the fetal distribution. Along these lines, the fact that positive selection of fetal thymocytes using 3' TRAV and 5' TRAJ segments occurs within 2 days of thymocyte entry into the DP compartment does not mean that DP development in the fetus is intrinsically rapid and restricted to 2 days. It simply means that thymocytes bearing an early rearranging TCR can be positively selected shortly after TCR expression. The expectation would be that those DP thymocytes that had not undergone early positive selection using a 3' TRAV and a 5' TRAJ would remain longer in the DP compartment and continue the progression of TCRA rearrangements, with the potential for selection several days later using more 5'TRAV and 3'TRAJ.<br /> (2) The authors note 3' V and 5'J biases for TCRB in fetal thymocytes. The previously outlined concerns about interpreting TCRA repertoire development do not directly apply here. But it would be appropriate to note that by deep sequencing, Sethna (PNAS 114:2253 (2017)) identified skewed usage of some of the same TRBV gene segments in fetal versus adult. It should also be noted that Sethna did not detect significantly skewed usage of TRBJ segments. Regardless, one might question whether the skewed usage of TRBJ segments detected here should be characterized as relating to chromosomal location. There are two logical ways one can think about chromosomal location of TRBJ segments - one being TRBJ1 cluster vs TRBJ2 cluster, the other being 5' to 3' within each cluster. The variation reported here does not obviously fit either pattern. Is there a statistically significant difference in aggregate use of the two clusters? There is certainly no clear pattern of use 5' to 3' across each cluster.<br /> (3) The authors show that biases in TCRA and TCRB V and J gene usage between fetal and adult thymocytes are mostly conserved between pre- and post-selection thymocytes (Fig 2). In striking contrast, TCRA and TCRB combinatorial repertoires show strong biases pre-selection that are largely erased in post-selection thymocytes (Fig 3). This apparent discrepancy is not addressed, but interpretation is challenging.<br /> (4) The observation that there is a higher proportion of nonproductive TCRB rearrangements in fetal thymus compared to adult is challenging to interpret, given that the results are based upon RNA sequencing so are unlikely to reflect the ratio in genomic DNA due to processes like NMD.<br /> (5) An intriguing and paradoxical finding is that fetal DP, CD4 and CD8 thymocytes all display greater sharing of TCRB CDR3 sequences among individuals than do adults (Fig 5DE), whereas DP and CD8 thymocytes are shown to display greater CDR3 amino acid triplet motif sharing in adults (with a similar trend in CD4). The authors attribute high amino acid triplet sharing to the result of selection of recurrent motifs by contact with pMHC during positive selection. But this interpretation seems highly problematic because the difference between fetal and adult thymocytes is dramatic even in unfractionated DP thymocytes, the vast majority of which have not yet undergone positive selection. How then to explain the differences in CDR3 sharing visualized by the different approaches?<br /> (6) The authors conclude that there is less MHC restriction in fetal thymocytes, based on measures of repertoire divergence from DP to CD4 and CD8 populations (Fig. 6). But the authors point to no evidence of this in analysis of TRBV usage, either by PC or heatmap analyses (A,B,D). The argument seems to rest on PC analysis of TRAV usage (Fig S6), despite the fact that dramatic differences in the SP4 and SP8 repertoires are readily apparent in the fetal thymocyte heatmaps. The data do not appear to be robust enough to provide strong support for the authors' conclusion.

Reviewer #3 (Public Review):

Summary:<br /> This study provides a comparison of TCR gene segment usage between foetal and adult thymus.

Strengths:<br /> Interesting computational analyses was performed to find interesting differences in TCR gene usage within unpaired TCRa and TCRb chains between foetal and adult thymus.

Weaknesses:<br /> This study was significantly lacking insight and interpretation into what the data analysed actually means for the biology. The dataset discussed in the paper is from only two experiments. One comparing foetal and adult thymi from 4 mice per group and another which involved hydrocortisone treatment. The paper uses TCR sequencing methodology that sequences each TCR alpha and beta chains in an unpaired way, meaning that the true identity of the TCR heterodimer is lost. This also has the added problem of overestimating clonality, and underestimating diversity.<br /> Limited detail in the methods sections also limits the ability for readers to properly interpret the dataset. What sex of mice were used? Are there any sex differences? What were the animal ethics approvals for the study?

Reviewer #1 (Public Review):

The author's goal was to determine the role of O-GlcNAc modification in associate learning in Drosophila using an odor discriminatory task. In particular, they sought to determine the population of O-GlcNAc modified proteins in a region of the brain critical for memory, the mushroom body. They provide compelling evidence that there are brain-region-specific populations of O-GlcNAc modified proteins and that in the mushroom body, proteins involved in translation represent a sizable, and larger fraction than elsewhere in the central nervous system. Using expression of a bacterial protein that cleaves O-GlcNAc in the mushroom body, they show both reductions in the levels of this modification and effects on associative learning. Further exploration of new protein synthesis in situ supports the hypothesis that O-GlcNAc modification affects the activity of the translational machinery and could provide the basis for learning deficits when O-GlcNAc levels are compromised. Rescue of deficits resulting from reductions in O-GlcNAc was achieved by over-expression of dMyc, a known regulator of ribosome biogenesis and translation. While the critical role of protein synthesis in learning is long established, and that O-GlcNAc modification regulates protein synthesis, this work connects O-GlcNAc modification in a specialized region of the brain to translation regulation and associative learning. The authors also provide a method for identification of O-GlcNAc modified proteins using a tissue-specific and inducible proximity-labelling method. This will provide a useful tool for further functional studies of O-GlcNAc modification.

Reviewer #2 (Public Review):

In this report Yu et al. try to demonstrate how O-GlcNAcylation of ribosomal proteins in the mushroom body (MB) is required for protein synthesis and olfactory learning. The authors develop a new method combining the O-GlcNAc binding activity of an OGlcNAcase (OGN) and TurboID for efficient isolation. This novel method is a useful tool for the identification of O-GlcNAc modified proteins and closely interacting partners. Transgenic expression of this binder allows the authors to perform a profiling that can be time and tissue/region/cell specific. This novel tool is thoroughly tested to show it works in cultured cells, whole Drosophila and in a tissue specific manner expressing it pan-neuronally or specific regions of the brain.

The authors had previously shown that reduced O-GlcNAcylation through transgenic expression of a highly active OGN affected olfactory learning. In this work the same approach is used to reduce O-GlcNAcylation in different brain regions to show that specific reduction in the adult MB reduced olfactory learning performance. As control OGN expression in the ellipsoid body has no effect on olfactory learning. Optic and antennal lobes could not be tested as OGN expression affected olfactory acuity. The most critical part of this finding is time specific expression of OGN in the adult in a tissue specific manner given the developmental defects it induces with earlier expression. The MB has a widely reported role in associative learning, therefore this finding while not unexpected it is satisfying.

Yu et al. use their TurboID-OGA to identify O-GlcNAcylated proteomes in different brain regions. The authors focus on the MB given its role in associative learning and the effect of reduced O-GlcNAcylation in this region. Among other substrates several ribosomal proteins are found to be specifically O-GlcNAcylated to a greater extent in the MB compared to other brain regions.

To demonstrate the role of MB O-GlcNAcylated ribosomes in protein synthesis an ex vivo OPP fluorescent assay is used in brains of flies expressing OGN or a mutant form lacking its catalytic and binding activities. The experiment shows reduced protein synthesis in the MB. In addition, the authors can increase protein synthesis inducing ribosomal biogenesis through the expression of dMyc. Flies expressing of dMyc and OGN together do not present the learning deficits of flies carrying only OGN. Protein synthesis in MB has been previously reported to be required for associative learning (for example Wu et al.2017 or Lin et al. 2022) and the present results bring further support. A link between ribosomal O-GlcNAcylation and protein synthesis could be a really interesting finding but, unfortunately the experiments presented in this work are still too preliminary.

The experiments presented just focus on ribosomal proteins while these are just some of the O-GlcNAcylation substrates in the MB. While a correlation between ribosomal modification and protein synthesis is shown, a demonstration is not provided. Many other mechanisms and O-GlcNAcylation of other substrates could account for the same observations. For example, O-GlcNAcylation has been reported to have a role in protein synthesis affecting different translation initiation factors (Li et al 2018, Shu et al 2022). In vitro experiments where specific O-GlcNAcylation ribosomal components could be targeted are required. In addition, O-GlcNAcylation is also known to modify ribosomal-associated mRNAs. Experiments where specific mutations preventing O-GlcNAcylation in ribosomes could demonstrate a direct link of such ribosomal modifications in olfactory learning.

Reviewer #1 (Public Review):

Analysis of a sizable number of matched primary AML samples from diagnosis and relapse was done with ATAC-seq and showed that epigenetic changes are seen at relapse. Meta-analysis of multiple studies showed that relapse is not associated generally with changes in mutational burden. The authors also performed clonal tracking with mitochondrial clones and show that heterogeneity in clonal expansions is seen in various cases. Overall, these are novel findings with translational relevance.

Reviewer #2 (Public Review):

In the manuscript entitled, "Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia", Majeti and colleagues describe patterns of chromatin accessibility alterations at relapse in AML. Through an analysis of publicly available datasets as well as their samples, they show that a subset of AML cases show significant changes in chromatin accessibility despite showing little to no change in clonal composition. Evaluation of predicted changes in gene expression based on chromatin accessibility identifies common differentially expressed pathways at relapse and indicates that blasts are more immature at relapse. Using mitochondrial single-cell ATAC-seq, the authors identify "mitoclones' and observe that mitochondrially-defined clones exhibit more similar chromatin accessibility at relapse relative to diagnosis. Based on these data, the authors conclude that epigenetic evolution is a feature of relapsed AML and that convergent epigenetic evolution can occur following induction chemotherapy.

The strengths of this study are its novelty in AML and its rigorous use of single-cell ATAC-seq and mitochondrial single-cell ATAC-seq to identify chromatin accessibility patterns in AML blasts at diagnosis and relapse, including in clonally related blasts determined by mitochondrial DNA sequencing. That epigenetic changes contribute to relapse and therapy resistance, or that blasts at relapse are less differentiated are not new ideas, but these studies rigorously demonstrate these concepts in AML patient samples. These insights are important since they have the potential to identify novel targets that can be targeted in combination with induction chemotherapy.

While these findings advance our understanding of potential mechanisms or disease relapse/therapy resistance in AML, some of the conclusions are less supported due to the lack of more information on clonally unstable cases. Given that 60-70% of AML cases are not clonally stable following chemotherapy, this raises questions regarding the broad applicability of the authors' proposed model. Indeed, it remains unclear why only a subset of AML cases shows stable clonal patterns.

Reviewer #3 (Public Review):

This manuscript reports a detailed genetic and epigenomic analysis of diagnostic and relapsed AML. The study is mostly correlative and some of the initial findings, such as the stability of mutations in epigenetic regulators at diagnosis and relapse and in signaling pathway modulators such as FLT3 and NRAS being lost - not novel.

The authors show that in a large fraction (approximately half) of the relapsed AMLs they study, there are no alterations in the AML driver mutations. The authors conclude that this indicates that these patients show non-genetic mechanisms of relapse, for which the authors embark on a series of epigenomic experiments to try and pin down the correlative or causative epigenetic mechanisms. In 9 (out of 25) patient samples with stable driver mutations ( i.e. no change in clonality or novel AML driver mutation accumulation) the study shows that there is high epigenetic variability as measured by chromatin accessibility changes and that these changes resemble less differentiated state in the relapsed compared to the diagnostic sample. The manuscript makes some key observations: 1) non-genetic mechanisms are likely to account for relapse in a substantial proportion of patients. 2) some of the clones that emerge following relapse are likely present in prior diagnosis samples indicating that chemotherapy selects for them, 3) Of note, the authors also look at the LSC and non-LSC compartments and show that the LSC compartment is more rigid in terms of epigenetic evolution towards relapse than the non-LSC cells. 4) Using a small number of patients (but justifiable since the assays used are rigorous and demanding) - the authors present the most interesting finding of the study - that epigenetic evolution of relapse in several different AML patients seems to be convergent.<br /> This is based on the epigenetic similarities in clones (as defined by mitochondrial Atac-seq) between different epigenetic relapsed clones, even though they were distinct at diagnosis. Thus, this study has several important observations. Some of these observations are incremental - it has been shown that epigenetic mechanisms drive relapse in AML but several are not. I think this study - although descriptive and not showing causal relationships - is an important study for advancing our understanding of AML relapse.

Reviewer #1 (Public Review):

Summary:

The paper combines phenotypic and genomic analyses of the "sheltered load" (i.e. the accumulation of deleterious mutations linked to S-Loci that are hidden from selection in the homozygous state) in Arabidopsis. The authors compare results to previous theoretical predictions concerning the extent of the load in dominant vs recessive S-alleles, and further develop exciting theory to reconcile differences between previous theory and observed results.

Strengths:

This is a very nice combination of theory and data to address a classical question in the field.

Weaknesses:

The "genetic load" is a poorly defined concept in general, and its quantification via the number of putatively deleterious mutations is quite difficult. Furthermore counting up the number of derived mutations at fully constrained nucleotides may not be a great estimate of the load, and certainly does not allow for evaluation of recessivity -- a concept critical to ideas concerning the sheltered load. Alternative approaches - including estimating the severity of mutations - could be helpful as well. This imperfection in available approaches to test theory must be acknowledged more strongly by the authors.

Reviewer #2 (Public Review):

Summary:

This study looks into the complex dominance patterns of S-allele incompatibilities in Brassicaceae, through which it attempts to learn more about the sheltering of deleterious load. I found several weak points in the analyses that diminished my excitement about the results. In particular, the way in which deleterious mutations were classified lacked the ability to distinguish the severity of the mutations and thus their expected associated dominance. Furthermore, the simulation approach could have provided this exact sort of insight but was not designed to do so, making this comparison to the empirical data also less than exciting for me.

Major and minor comments:

I think the introduction (or somewhere before we dive into it in the results) of the dominance hierarchy for the S-alleles needs a more in-depth explanation. Not being familiar with this beforehand really made this paper inaccessible to me until I then went to find out more before continuing. I would expect this paper to be broad enough that self-contained information makes it accessible to all readers. For example, lines 110-115 could be in the Introduction.

Along with my above comment, perhaps it is not my place to comment, but I find the paper not of a broad enough scope to be of interest to a broad readership. This S-allele dominance system is more than simple balancing selection, it is a very complex and specific form of dominance between several haplotypes, and the mechanism of dominance does not seem to be genetic. I am not sure that it thus extrapolates to broad comments on general dominance and balancing selection, e.g. it would not be the same as considering inversions and this form of balancing selection where we also expect recessive deleterious mutations to accumulate.

It would have been particularly interesting, or a nice addition, to see deleterious mutations classed by something like SNPeff or GERP where you can have different classes of moderate to severe deleterious variants, which we would expect also to be more recessive the more deleterious they are. In line with my next comment on the simulations, I think relative differences between mutations expected to be more or less dominant may be even more insightful into the process of sheltering which may or may not be going on here.

In the simulations, h=0 and s=0.01 (as in Figure 5) for all deleterious mutations seems overly simplistic, and at the convenient end for realistic dominance. I think besides recessive lethals which we expect to be close to h=0 would have a much larger selection coefficient, and other deleterious mutations would only be partially recessive at such an s value. I expect this would change some of the simulation results seen, though to what degree I am not certain. It would be nice to at least check the same exact results for h=0.3 or 0.2 (or additionally also for recessive lethals, e.g. h=0 and s=-0.9). I would also disagree with the statement in line 677, many studies have shown, particularly those on balancing selection, that partially recessive deleterious mutations are not eliminated by natural selection and do play a role in population genetic dynamics. I am also not surprised that extinction was found for higher s values when the mutation rate for such mutations was very high and the distribution of s values was constant. An influx of such highly deleterious mutations is unlikely to ever let a population survive, yet that does NOT mean that in nature, the rare influx of such mutations does lead to them being sheltered. I find overall that the simulation results contribute very little, to none, to this paper, as without something more realistic, like a simultaneous distribution of s and h values, you cannot say which, if any class of these mutations are the ones expected to accumulate because of S-allele dominance. Rather they only show the disappointing or less exciting result that fully recessive, weakly deleterious mutations (which I again think do not even exist in nature as I said above) have minor, to no effect across the classes of S-allele dominance. They provide no insight into whether any type of recessive deleterious mutation can accumulate under the S-allele dominance hierarchy, and that is the interesting question at hand. I would either remove these simulations or redo them in another approach. The authors never mention what simulation approach was used, so I can only assume this is custom, in-house code. Yet I do not find that code provided on the github page. I do not know if the lack of a distribution for h and s values is then a choice or a programming limitation, but I see it as one that should be overcome if these simulations are meant to be meaningful to the results of the study.

Reviewer #1 (Public Review):

Summary:

Based on a "dichoptic-background-movie" paradigm that modulates ocular dominance, the present study combines fMRI and TMS to examine the role of the frontoparietal attentional network in ocular dominance shifts. The authors claimed a causal role of FEF in generating the attention-induced ocular dominance shift.

Strengths:

A combination of fMRI, TMS, and "dichoptic-background-movie" paradigm techniques is used to reveal the causal role of the frontoparietal attentional network in ocular dominance shifts. The conclusions of this paper are well supported by data.

Weaknesses:

My previous concerns have been addressed.

Reviewer #2 (Public Review):

Summary

Song et al investigate the role of the frontal eye field (FEF) and the intraparietal sulcus (IPS) in mediating the shift in ocular dominance (OD) observed after a period of dichoptic stimulation during which attention is selectively directed to one eye. This manipulation has been previously found to transiently shift OD in favor of the unattended eye, similar to the effect of short-term monocular deprivation. To this aim, the authors combine psychophysics, fMRI, and transcranial magnetic stimulation (TMS). In the first experiment, the authors determine the regions of interest (ROIs) based on the responses recorded by fMRI during either dichoptic or binocular stimulation, showing selective recruitment of the right FEF and IPS during the dichoptic condition, in line with the involvement of eye-based attention. In a second experiment, the authors investigate the causal role of these two ROIs in mediating the OD shift observed after a period of dichoptic stimulation by selectively inhibiting with TMS (using continuous theta burst stimulation, cTBS), before the adaptation period (50 min exposure to dichoptic stimulation). They show that, when cTBS is delivered on the FEF, but not the IPS or the vertex, the shift in OD induced by dichoptic stimulation is reduced, indicating a causal involvement of the FEF in mediating this form of short-term plasticity. A third control experiment rules out the possibility that TMS interferes with the OD task (binocular rivalry), rather than with the plasticity mechanisms. From this evidence, the authors conclude that the FEF is one of the areas mediating the OD shift induced by eye-selective attention.

The authors have addressed the issues that I raised during the first round of review.<br /> While the results of the new experiment (Experiment 4), leave some unresolved isssues (addressed in the discussion section), they provide a very important replication of the main result, showing that even if the observed effect is small, it is robust.

Reviewer #3 (Public Review):

Summary:

This study studied the neural mechanisms underlying the shift of ocular dominance induced by "dichoptic-backward-movie" adaptation. The study is self-consistent.

Strengths:

The experimental design is solid and progressive (relationship among three studies), and all of the raised research questions were well answered.<br /> The logic behind the neural mechanisms is solid.<br /> The findings regarding the cTMS (especially the position/site can be useful for future medical implications).<br /> The updated Exp4 eliminates some concerns and thus makes the results even more solid.

Reviewer #2 (Public Review):

Summary:

The authors are interested in large-scale cell flow during gastrulation and in particular in the polonaise movement. This movement corresponds to a bilateral vortex-like counter-rotating cell flow and transport the mesendodermal cells allowing ingression of cells through the primitive streak and ultimately the formation of the mesoderm and endoderm. The authors specifically wanted to investigate the coupling of the polonaise movement and primitive streak to understand whether the polonaise movement is a consequence of the formation of the primitive streak or the other way around. They propose a model where the primitive streak elongation is not required for the cell flow but rather for its maintenance and that robust cell flow is not required for primitive streak extension.

Strengths:

Overall, the manuscript is well written with clear experimental designs. The authors have used live imaging and cell flow analysis in different conditions, where either the formation of the primitive streak or the cell flow was perturbed.<br /> Their live imaging and PIV-based analyses convincingly support their conclusions that primitive streak deformation or mitotic arrest do not impact the initiation of the polonaise movement but rather the location or maintenance of these rotations. They additionally showed that disruption of the polonaise movement in the authentic primitive streak by elegant addition of an ectopic primitive streak does not impact the original primitive streak elongation.

Weaknesses:

- Since myosin cables have been shown to be instrumental for the polonaise movement, it would be interesting to better investigate how the manipulations by the delta-DEP-GFP construct, or Vg1/Cos affect the myosin cables (as shown in preliminary form for the aphidicolin-treated embryos).

Thank you for indicating that this will be a focus of future studies.

Reviewer #1 (Public Review):

In chicken embryos, the counter-rotating migration of epiblast cells on both sides of the forming primitive streak (PS), a process referred to as polonaise movements, has attracted longstanding interest as a paradigm of morphogenetic cell movements. However, the association between these cell movements and PS development is still controversial. This study investigated PS development and polonaise movements separately at their initial stage, showing that both could be uncoupled (at least at the initial phase), being activated via Vg1 signaling.

Strengths of this study

Polonaise movements, i.e., the circular cell migration of epiblast cells on both sides of the forming PS in avian embryos, have been the subject of research through live imaging and promoted the development of new tools to analyze quantitatively such movements. However, conclusions from previous studies remain controversial, at least partly due to the nature of perturbations to PS development and polonaise movements.

This study performed the challenging technique of electroporation to successfully mark and manipulate Wnt/PCP pathways in unincubated chicken embryo cells at the initiation phase of these two processes. In addition, the authors separately altered PS development and polonaise movements: PS development was perturbed by inhibiting either the Wnt/PCP pathway or DNA synthesis using aphidicolin, while polonaise movements were modified by the development of a second PS after engrafting Vg1-expressing COS cells located at the opposite end of the blastoderm. The study concluded that Vg1 elicits both PS development and polonaise movements, which occur in a parallel and are not inter-dependent.

To support these conclusions, particle image velocimetry (PIV) of cell trajectories captured by live imaging was performed. These tools delineated visually appealing cell movements and gave rise to vorticity profiles, adding more value to this study.

Weaknesses of this study

Engrafted Vg1-expressing COS cells located at the anterior end of the blastoderm elicited both the development of a second PS and marked bilateral polonaise movements while perturbing these movements along the original PS. How do polonaise movements along the second PS dominate over those along the normal PS? The authors suggested a model in which Vg1 acts in a graded or dose-dependent manner since engrafted COS cells over-expressed Vg1. This model can be tested by reducing the mass of engrafted COS cells. Although the authors propose performing this analysis in further investigations, it would be preferable to incorporate into this study for better consistency.

Thank you for indicating that this will be a focus of future studies.

Reviewer #3 (Public Review):

Summary:<br /> In the manuscript by Valenzisi et al., the authors report on the role of WRNIP1 to prevent R-loop and TRC-associated DNA damage. The authors claim WRNIP1 localizes to TRCs in response to replication stress and prevents R-loop accumulation, TRC formation, replication fork stalling, and subsequent DNA damage. While the findings are of potential significance to the field, the strength of evidence in support of the conclusions is lacking.

In the revised submission by Velenzisi et al., the manuscript is still missing the controls that were requested in the original review. One cannot conclude the D37A mutant is unable to rescue DNA damage unless it is shown in the same experiment that the WT is able to rescue it. This is also true for the fork speed, stalled forks, and restarting forks experiments. Below is a list of Figures missing key controls.

Figure 1B -missing the shWRNIP1WT control<br /> Figure 1C - missing the MRC5SV control<br /> Figure 1D - missing the shWRNIP1WT control<br /> Figure 3C - missing the shWRNIP1WT control<br /> Figure 5A - missing the shWRNIP1WT control<br /> Figure 5B - missing the shWRNIP1WT control<br /> Figure 5C - missing the shWRNIP1WT control<br /> Figure 5D - missing the shWRNIP1WT control<br /> Figure 6C - missing the shWRNIP1WT control

Also, the authors did not explain the result showing shWRNIP1 decreases DNA damage compared to MRC5SV in Figure 1D (compare lanes 4 and 8). Again, this suggests WRNIP1 actually increases DNA damage in response to Aph and DRB. This concern was raised in the original peer review, and it remains unaddressed in the revised manuscript.

The use of RNaseHIII increases the specificity of the S9.6 antibody and improves confidence in the DNA-RNA hybrid data throughout the manuscript.

Reviewer #1 (Public Review):

This paper describes the role of WRNIP1 AAA+ ATPase, particularly its UBZ domain for ubiquitin-binding, but not ATPase, to prevent the formation of the R-loop when DNA replication is mildly perturbated. By combining cytological analysis for DNA damage, R-loop and chromosome aberration with the proximity ligation assay for colocalization of various proteins involved in DNA replication and transcription, the authors provide solid evidence to support the claim. The authors also revealed a distinct role of WRNIP1 in the prevention of R-loop-induced DNA damage from FANCD2, which is inconsistent with the known relationship between WRNIP1 and FANCD2 in the repair of crosslinks.

Reviewer #2 (Public Review):

This paper aims at establishing the role of WRN-interacting protein 1 (WRNIP1) and its UBZ domain (an N-terminal ubiquitin-binding zinc finger domain) on genome instability caused by mild inhibition of DNA synthesis by aphidicolin. The authors used human MRC5 fibroblasts investigated with standard methods in the field. The results clearly showed that WRNIP1 silencing and UBZ-mutation (D37A) increased DNA damage, chromosome aberrations, and transcription-replication conflicts caused by aphidicolin.

The conclusions of the paper are overall well supported by results, however, aspects of some data analyses would need to be clarified and/or extended.

(1) The methods (immunofluorescence microscopy and dot-blots) to determine R-loop levels can lack sensitivity and specificity. In particular, since the S9.6 antibody can bind to other structures besides heteroduplex, dot-blot analyses only grossly assess R-loop levels in cellular samples of purified nucleic acids, which are constituted by many different types of DNA/RNA structures.

(2) Experimental plan has analyzed the impact of WRNIP1 lack or mutations at steady-state conditions. Thus, the possible role of WRNIP1 at an early step of the mechanism would require some sort of kinetics analysis of the molecular process, therefore not at steady-state conditions. The findings of a co-localization of R-loops and WRNIP1 have been obtained with the S9.6 antibody, which recognizes DNA-RNA heteroduplexes. Since WRNIP1 is known to be recruited at stalled forks and DNA cleavage sites, it is not surprising that WRNIP1 is very close to heteroduplexes, abundant structures at replication forks and cleavage sites. Similar interpretations may also be valid for Rad51/S9.6 co-localization findings.

(3) Determination of DNA damage, chromosome aberration, and co-localization data are reported as means of measurements with appropriate statistics. However, the fold-change values relative to corresponding untreated samples are not reported. In some instances, it seems that WRNIP1 silencing or mutations actually reduce or do not affect aphidicolin effects. That leaves open the interpretation of specific results.

Joint Public Review:

This study is concerned with the general question as to how pools of synaptic vesicles are organized in presynaptic terminals to support different types of transmitter release, such as fast synchronous and asynchronous release. To address this issue, the authors employed the classical method of loading synaptic vesicle membranes with FM-styryl dyes and assessing dye destaining during repetitive synapse stimulation by live imaging as a readout of the mobilization of vesicles for fusion. Among other findings, the authors provide evidence indicating that there are multiple reserve vesicle pools, that quickly and slowly mobilized reserves do not mix, and that vesicle fusion does not follow a mono-exponential time course, leading to the notion that two separate reserve pools of vesicles - slowly vs. rapidly mobilizing - feed two distinct releasable pools - reluctantly vs. rapidly releasing. These findings are valuable to the field of synapse biology, where the organization of synaptic vesicle pools that support synaptic transmission in different temporal and stimulation regimes has been a focus of intense experimentation and discussion for more than two decades.

On the other hand, the present study has limitations, so that the authors' key conclusions remain incompletely supported by the data, and alternative interpretations of the data remain possible. The approach of using bulk FM-styryl dye destaining as a readout of precise vesicle arrangements and pools in a population of functionally very diverse synapses bears problems. In essence, the approach is 'blind' to many additional processes and confounding factors that operate in the background, from other forms of release to inter-synaptic vesicle exchange. Further, averaging signals over many - functionally very diverse - synapses makes it difficult to distinguish the dynamics of separate vesicle pools within single synapses from a scenario where different kinetics of release originate from different types of synapses with different release probabilities.

The reviewers commented on the revised version of your paper, in essence reiterating the limitations of the approach of bulk imaging of FM de-staining:

(1) The authors sincerely addressed many of the previous concerns, mainly by clarification. The data are consistent with the authors' hypothesis. The pool concept is somewhat similar to that of Richards et al (2000) and Rey et al (2015). The authors further propose that two reserve pools feed vesicles to two readily-releasable pools independently. Unfortunately, the heterogeneity among individual synapses remains a concern as shown in (some of) the raw data (Fig. 3 and supplements). Bulk imaging of FM de-staining does not really measure the fraction of non-stained vesicles, which changes dynamically during stimulation, so that the situation calls for an independent readout of stained and non-stained vesicles. Moreover, direct correspondence between two specific stimulation frequencies (with long stimulation) and vesicle pools is not straightforward. These issues make the experimentally measured pools not well-defined.

(2) The authors' latest round of responses did not alleviate most of my major previous concerns. The additional data now shown in Fig 3 rely on conceptually the same type of bulk measurements and thus suffer from the same limitations as outlined in the earlier review. Moreover, the image of neuronal cultures shown in Fig. 3 might be problematic. It shows very bright staining with large round lumps, which may be indicative of unhealthy cultures.

Reviewer #1 (Public Review):

Summary:

This study presents fundamental new insights into vesicular monoamine transport and the binding pose of the clinical drug tetrabenazine (TBZ) to the mammalian VMAT2 transporter. Specifically, this study reports the first structure for the mammalian VMAT (SLC18) family of vesicular monoamine transporters. It provides insights into the mechanism by which this inhibitor traps VMAT2 into a 'dead-end' conformation. The structure also provides some evidence for a novel gating mechanism within VMAT2, which may have wider implications for understanding the mechanism of transport in the wider SLC18 family.

Strengths:

The structure is high quality, and the method used to determine the structure via fusing mVenus and the anti-GFP nanobody to the amino and carboxyl termini is novel. The binding and transport data are convincing and provide new insights into the role of conserved side chains within the SLC18 members. The binding position of TBZ is of high value, given its role in treating Huntington's chorea and for being a 'dead-end' inhibitor for VMAT2.

Reviewer #2 (Public Review):

As a report of the first structure of VMAT2, indeed the first structure of any vesicular monoamine transporter, this manuscript represents an important milestone in the field of neurotransmitter transport. VMAT2 belongs to a large family (the major facilitator superfamily, MFS) containing transporters from all living species. There is a wealth of information relating to the way that MFS transporters bind substrates, undergo conformational changes to transport them across the membrane and couple these events to the transmembrane movement of ions. VMAT2 couples the movement of protons out of synaptic vesicles to the vesicular uptake of biogenic amines (serotonin, dopamine and norepinephrine) from the cytoplasm. The new structure presented in this manuscript can be expected to contribute to an understanding of this proton/amine antiport process.

The structure contains a molecule of the inhibitor TBZ bound in a central cavity, with no access to either luminal or cytoplasmic compartments. The authors carefully analyze which residues interact with bound TBZ and measure TBZ binding to VMAT2 mutated at some of those residues. These measurements allow well-reasoned conclusions about the differences in inhibitor selectivity between VMAT1 and VMAT2 and differences in affinity between TBZ derivatives.

The structure also reveals polar networks within the protein and hydrophobic residues in positions that may allow them to open and close pathways between the central binding site and the cytoplasm or the vesicle lumen. The authors propose involvement of these networks and hydrophobic residues in coupling of transport to proton translocation and conformational changes.

Reviewer #3 (Public Review):

Summary:

The vesicular monoamine transporter is a key component in neuronal signaling and is implicated in diseases such as Parkinson's. Understanding of monoamine processing and our ability to target that process therapeutically has been to date provided by structural modeling and extensive biochemical studies. However, structural data is required to establish these findings more firmly.

Strengths:

Dalton et al resolved a structure of VMAT2 in the presence of an important inhibitor, tetrabenazine, with the protein in detergent micelles, using cryo-EM and with the aid of protein domains fused to its N- and C-terminal ends, including one fluorescent protein that facilitated protein screening and purification. The resolution of the maps allows clear assignment of the amino acids in the core of the protein. The structure is in good agreement with a wealth of experimental and structural prediction data, and provides important insights into the binding site for tetrabenazine and selectivity relative to analogous compounds. The authors provide additional biochemical analyses that further support their findings. The comparison with AlphaFold models is enlightening.

Reviewer #3 (Public Review):

Neuronal migration is one of the key processes for appropriate neuronal development. Defects in neuronal migration are associated with different brain disorders often accompanied by intellectual disabilities. Therefore, the study of the mechanisms involved in neuronal migration helps to understand the pathogenesis of some brain malformations and psychiatric disorders.

FMRP is an RNA-binding protein implicated in RNA metabolism regulation and mRNA local translation. FMRP loss of function causes fragile X syndrome (FXS), the most common form of inherited intellectual disability. Previous studies have shown the role of FMRP in the multipolar to bipolar transition during the radial migration in the cortex and its possible relation with periventricular heterotopia and altered synaptic communication in humans with FXS. However, the role of FMRP in neuronal tangential migration is largely unknown. In this manuscript, the authors aim to decipher the role of FMRP in the tangential migration of neuroblasts along the rostral migratory stream (RMS) in the postnatal brain. By extensive live-imaging analysis of migrating neuroblasts along the RMS, they demonstrate the requirement of FMRP for neuroblast migration and centrosomal movement. These migratory defects are cell-autonomous and mediated by the microtubule-associated protein Map1b.

Overall, the manuscript highlights the importance of FMRP in neuronal tangential migration. They performed an analysis of different aspects of migration such as nucleokinesis and cytokinesis in migrating neuroblasts from live-imaging videos. The authors have reinforced the results that associate defects in microtubule organization in Fmrp1 KO neurons and this rescue with the microtubule-associated protein Map1b. Overall, results concerning the role of Fmr1 in the tangential migration of neuroblasts are solid and convincing.

However, the work is still quite incomplete. My main concern is still what are the functional consequences of delay in neuroblast migration in the integration and function of OB interneurons and this relation with FXS pathophysiology. An anatomical examination of the RMS in the Fmr1KO mice is still missing.

Reviewer #1 (Public Review):

This study investigated Fragile X Messenger Ribonucleoprotein (FMRP) protein impact on neuroblast tangential migration in the postnatal rostral migratory stream (RMS). Authors conducted a series of live-imaging on organotypic brain slices from Fmr1-null mice. They continued their analysis silencing Fmr1 exclusively from migrating neuroblasts using electroporation-mediated RNA interference method (MiRFmr1 KD). These impressive approaches show that neuroblasts tangential migration is impaired in Fmr1-null mice RMS and these defects are mostly recapitulated in the MiRFmr1neuroblasts. This nicely supports the idea that FMRP have a cell autonomous function in tangentially migrating neuroblasts. Authors also confirm that FMRP mRNA target Microtubule Associated Protein 1B (MAP1B) is overexpressed in the Fmr1-null mice RMS. They successfully use electroporation-mediated RNA interference method to silence Map1b in the Fmr1-null mice neuroblasts. This discreet and elaborate experiment rescues most of the migratory defects observed both in Fmr1-null and MiRFmr1neuroblasts. Altogether, these results strongly suggest that FMRP-MAP1B axis has an important role in regulation of the neuroblasts tangential migration in the RMS. Neurons move forward in cyclic saltatory manner which includes repeated steps of leading process extension, migration of the cell organelles and nuclear translocation. Authors reveal by analyzing the live-imaging data that FMRP-MAP1B axis is affecting movement of centrosome and nucleus during saltatory migration. An important part of the centrosome and nucleus movement is forces mediated by microtubule dynamics. Authors propose that FMRP regulate tangential migration via microtubule dynamics regulator MAP1B. This work provides valuable new information on regulation of the neuroblasts tangential saltatory migration. These findings also increase and improve our understanding of the issues involved in Fragile X Syndrome (FXS) disorders. The conclusions of this work are supported by the presented data.

The current version of the study has improved substantially. Authors have enhanced the material and methods section including a more detailed section on the neuronal migration analysis. This amendment is a very valuable addition and strengthens the interpretation of the results, analysis and conclusions. Authors also have strengthened and clarified their results providing a more profound analysis of the migration directionality between controls, Fmr1-null, MiRFmr1 KD and MiRMap1b KD neuroblasts. They have incorporated new results in the study which elaborate FMRP and MAP1B participation in microtubule organization during tangential migration. Authors show that FMRP-MAP1B axis act on microtubule cage surrounding the nucleus. Microtubule cage participate on proper nuclear movement during neuron migration. These results emphasize more the interplay between FMRP, MAP1B, and the microtubule cytoskeleton. The authors have successfully expanded both the introduction and discussion sections of the manuscript.

Reviewer #3 (Public Review):

Summary:

This manuscript describes a study of the olfactory tubercle in the context of reward representation in the brain. The authors do so by studying the responses of OT neurons to odors with various reward contingencies and compare systematically to the ventral pallidum. Through careful tracing, they present convincing anatomical evidence that the projection from the olfactory tubercle is restricted to the lateral portion of the ventral pallidum.

Using a clever behavioral paradigm, the authors then investigate how D1 receptor- vs. D2 receptor-expressing neurons of the OT respond to odors as mice learn different contingencies. The authors find that, while the D1-expressing OT neurons are modulated marginally more by the rewarded odor than the D2-expressing OT neurons as mice learn the contingencies, this modulation is significantly less than is observed for the ventral pallidum. In addition, neither of the OT neuron classes shows conspicuous amount of modulation by the reward itself. In contrast, the OT neurons contained information that could distinguish odor identities. These observations have led the authors to conclude that the primary feature represented in the OT may not be reward.

Strengths:

The highly localized projection pattern from olfactory tubercle to ventral pallidum is a valuable finding and suggests that studying this connection may give unique insights into the transformation of odor by reward association.

Comparison of olfactory tubervle vs. ventral pallidum is a good strategy to further clarify the olfactory tubercle's position in value representation in the brain.

Weaknesses:

The study comes to a different conclusion about the olfactory tubercle regarding reward representations from several other prior works. Whether this stems from a difference in the experimental configurations such as behavioral paradigms used or indeed points to a conceptually different role for the olfactory tubercle remains to be seen.

Reviewer #1 (Public Review):

In this manuscript, Lee et al. compared encoding of odor identity and value by calcium signaling from neurons in the ventral pallidum (VP) in comparison to D1 and D2 neurons in the olfactory tubercle (OT).

Strengths:

They utilize a strong comparative approach, which allows the comparison of signals in two directly connected regions. First, they demonstrate that both D1 and D2 OT neurons project strongly to the VP, but not the VTA or other examined regions, in contrast to accumbal D1 neurons which project strongly to the VTA as well as the VP. They examine single unit calcium activity in a robust olfactory cue conditioning paradigm that allows them to differentiate encoding of olfactory identity versus value, by incorporating two different sucrose, neutral and air puff cues with different chemical characteristics. They then use multiple analytical approaches to demonstrate strong, low-dimensional encoding of cue value in the VP, and more robust, high-dimensional encoding of odor identity by both D1 and D2 OT neurons, though D1 OT neurons are still somewhat modulated by reward contingency/value. Finally, they utilize a modified conditioning paradigm that dissociates reward probability and lick vigor to demonstrate that VP encoding of cue value is not dependent on encoding of lick vigor during sucrose cues, and that separable populations of VP neuros encode cue value/sucrose probability and lick vigor. Direct comparisons of single unit responses between the two regions now utilize linear mixed effects models with random effects for subject,

Weaknesses:

The manuscript still includes mention of differences in effect size or differing "levels" of significance between VP and OT D1 neurons without reports of a direct comparisons between the two populations. This is somewhat mitigated by the comprehensive statistical reporting in the supplemental information, but interpretation of some of these results is clouded by the inclusion of OT D2 neurons in these analyses, and the limited description or contextualization in the main text.

Reviewer #2 (Public Review):

We appreciate the authors revision of this manuscript and toning down some of the statements regarding "contradictory" results. We still have some concerns about the major claims of this paper which lead us to suggest this paper undergo more revision as follows since, in its present form, we fear this paper is misleading for the field in two areas. here is a brief outline:

(1) Despite acknowledging that the injections only occurred in the anteromedial aspect of the tubercle, the authors still assert broad conclusions regarding where the tubercle projects and what the tubercle does. for instance, even the abstract states "both D1 and D2 neurons of the OT project primarily to the VP and minimally elsewhere" without mention that this is the "anteromedial OT". Every conclusion needs to specify this is stemming from evidence in just the anteromedial tubercle, as the authors do in some parts of the the discussion.

(2) The authors now frame the 2P imaging data that D1 neuron activity reflects "increased contrast of identity or an intermediate and multiplexed encoding of valence and identity". I struggle to understand what the authors are actually concluding here. Later in discussion, the authors state that they saw that OT D1 and D2 neurons "encode odor valence" (line 510). We appreciate the authors note that there is "poor standardization" when it comes to defining valence (line 521). We are ok with the authors speculating and think this revision is more forthcoming regarding the results and better caveats the conclusions. I suggest in abstract the authors adjust line 14/15 to conclude that, "While D1 OT neurons showed larger responses to rewarded odors, in line with prior work, we propose this might be interpreted as identity encoding with enhanced contrast." [eliminating "rather than valence encoding" since that is a speculation best reserved for discussion as the authors nicely do.

The above items stated, one issue comes to mind, and that is, why of all reasons would the authors find that the anteromedial aspect of the tubercle is not greatly reflecting valence. the anteromedial aspect of the tubercle, over all other aspects of the tubercle, is thought my many to more greatly partake in valence and other hedonic-driven behaviors given its dense reception of VTA DAergic fibers (as shown by Ikemoto, Kelsch, Zhang, and others). So this finding is paradoxical in contrast to if the authors would had studied the anterolateral tubercle or posterior lateral tubercle which gets less DA input.

Reviewer #1 (Public Review):

The propagation of electrical signals within neuronal circuits is tightly regulated by the physical and molecular properties of neurons. Since neurons vary in size across species, the question arises whether propagation speed also varies to compensate for it. The present article compares numerous speed-related properties in human and rat neurons. They found that the larger size of human neurons seems to be compensated by a faster propagation within dendrites but not the axons of these neurons. The faster dendritic signal propagation was found to arise from wider dendritic diameters and greater conductance load in human neurons. In addition, the article provides a careful characterization of human dendrites and axons, as the field has only recently begun to characterize post-operative human cells. There are only a few studies reporting dendritic properties and these are not all consistent, hence there is the added value of reporting these findings, particularly given that the characterization is condensed in a compartmental model.

Strengths:<br /> The study was performed with great care using standard techniques in slice electrophysiology (pharmacological manipulation with somatic patch-clamp) as well as some challenging ones (axonal and dendritic patch-clamp). Modeling was used to parse out the role of different features in regulating dendritic propagation speed. The finding that propagation speed varies across species is novel as previous studies did not find a large change in membrane time constant or axonal diameters (a significant parameter affecting speed). A number of possible, yet less likely factors were carefully tested (Ih, membrane capacitance). The main features outlined here are well-known to regulate speed in neuronal processes. The modeling was also carefully done to verify that the magnitude of the effects is consistent with the difference in biophysical properties. Hence, the findings appear very solid to me.

Weaknesses:<br /> The role of diameter in regulating propagation speed is well-known in the axon literature.

Reviewer #2 (Public Review):

Summary:<br /> In this paper, Oláh and colleagues introduce new research data on the cellular and biophysical elements involved in transmission within the pyramidal circuits of the human neocortex. They gathered a comprehensive set of patch-clamp recordings from human and rat pyramidal neurons to compare how the temporal aspect of neuronal processing is maintained in the larger human neocortex. A broad range of experimental, theoretical, and computational methods are used, including two-photon guided dual whole-cell recordings, electron microscopy, and computational simulations of reconstructed neurons.

Recordings from synaptically connected pyramidal neurons revealed longer intercellular path lengths within the human neocortex. Further, by using dual whole-cell recordings from soma-dendrite and soma-axon locations, they found that short latencies from soma to soma can be partly attributed to an increased propagation speed for synaptic potentials, but not for the propagation of action potentials along the axon.

Next, in a series of extensive computational modeling studies focusing on the synaptic potentials, the authors observe that the short-latency within large human pyramidal neural circuits may have a passive origin. For a wide array of local synaptic input sites, the authors show that the conductance load of the dendrites, electrically coupled to a large diameter apical dendrite, affects the cable properties. The result is a relatively faster propagation of EPSPs in the human neuron.

The manuscript is well-written and the physiological experiments and biophysical arguments are very well explained. I appreciated the in-depth theoretical steps for the simulations. That passive cable properties of the dendrites are causing a higher velocity in human dendrites is interesting but there is a disconnect between the experimental findings and the model simulations. Based on the present data the contribution of active membrane properties cannot be dismissed and deserves further experiments.

Strengths:<br /> The authors present state-of-the-art 2P-guided dual whole-cell recordings in human neurons. In combination with detailed reconstructions, these approaches represent the next steps in unravelling the information processing in human circuits.

The computational modeling based on cable theory and experimentally constrained simulations provides an excellent integrated view of the passive membrane properties.

Weaknesses:<br /> There are smaller and larger issues with the statistical analyses of the experimental data which muddles the interim conclusions.

That the cable properties alone are the main explanation for speeding the electrical signaling in human pyramidal neurons appears inconsistent with the experimental data.

Some of the electrophysiological experiments require further control experiments to make robust conclusions.

Reviewer #3 (Public Review):

Summary:<br /> This study indicates that connections across human cortical pyramidal cells have identical latencies despite a larger mean dendritic and axonal length between somas in the human cortex. A precise demonstration combining detailed electrophysiology and modeling indicates that this property is due to faster propagation of signals in proximal human dendrites. This faster propagation is itself due to a slightly thicker dendrite, a larger capacitive load, and stronger hyperpolarizing currents. Hence, the biophysical properties of human pyramidal cells are adapted such that they do not compromise information transfer speed.

Strengths:<br /> The manuscript is clear and very detailed. The authors have experimentally verified a large number of aspects that could affect propagation speed and have pinpointed the most important one. This paper provides an excellent comparison of biophysical properties between rat and human pyramidal cells. Thanks to this approach a comprehensive description of the mechanisms underlying the acceleration of propagation in human dendrite is provided.

Weaknesses:<br /> Several aspects having an impact on propagation speed are highlighted (dendritic diameter, ionic channels, capacitive load) and there is no clear ranking of their impact on signal propagation speed. It seems that the capacitive load plays a major role, much more than dendritic diameter for which only a 10% increase is observed across species. Both aspects actually indicate that there is an increase in passive signal propagation speed with bigger cells at least close to the soma. This suggests that bigger cells are mechanically more rapid. An intuitive reason why capacitive load increases speed would also help the reader follow the demonstration.

Reviewer #2 (Public Review):

Summary:

PKA is a major signaling protein that has been long studied and is vital for synaptic plasticity. Here, the authors examine the mechanism of PKA activity and specifically focus on addressing the question of PKA dissociation as a major mode of its activation in dendritic spines. This would potentially allow us to determine the precise mechanisms of PKA activation and address how it maintains spatial and temporal signaling specificity.

Strengths:

The results convincingly show that PKA activity is governed by the subcellular localization in dendrites and spines and is mediated via subunit dissociation. The authors make use of organotypic hippocampal slice cultures, where they use pharmacology, glutamate uncaging, and electrophysiological recordings.

Overall, the experiments and data presented are well executed. The experiments all show that at least in the case of synaptic activity, the distribution of PKA-C to dendritic spines is necessary and sufficient for PKA-mediated functional and structural plasticity.

The authors were able to persuasively support their claim that PKA subunit dissociation is necessary for its function and localization in dendritic spines. This conclusion is important to better understand the mechanisms of PKA activity and its role in synaptic plasticity.

Weaknesses:

While the experiments are indeed convincing and well executed, the data presented is similar to previously published work from the Zhong lab (Tillo et al., 2017, Zhong et al 2009). This reduces the novelty of the findings in terms of re-distribution of PKA subunits, which was already established. A few alternative approaches for addressing this question: targeting localization of endogenous PKA, addressing its synaptic distribution, or even impairing within intact neuronal circuits, would highly strengthen their findings. This would allow us to further substantiate the synaptic localization and re-distribution mechanism of PKA as a critical regulator of synaptic structure, function, and plasticity.

Reviewer #1 (Public Review):

Summary:

This is a short self-contained study with a straightforward and interesting message. The paper focuses on settling whether PKA activation requires dissociation of the catalytic and regulatory subunits. This debate has been ongoing for ~ 30 years, with renewed interest in the question following a publication in Science, 2017 (Smith et al.). Here, Xiong et al demonstrate that fusing the R and C subunits together (in the same way as Smith et al) prevents the proper function of PKA in neurons. This provides further support for the dissociative activation model - it is imperative that researchers have clarity on this topic since it is so fundamental to building accurate models of localised cAMP signalling in all cell types. Furthermore, their experiments highlight that C subunit dissociation into spines is essential for structural LTP, which is an interesting finding in itself. They also show that preventing C subunit dissociation reduces basal AMPA receptor currents to the same extent as knocking down the C subunit. Overall, the paper will interest both cAMP researchers and scientists interested in fundamental mechanisms of synaptic regulation.

Strengths:

The experiments are technically challenging and well executed. Good use of control conditions e.g untransfected controls in Figure 4.

Weaknesses:

The novelty is lessened given the same team has shown dissociation of the C subunit into dendritic spines from RIIbeta subunits localised to dendritic shafts before (Tillo et al., 2017). Nevertheless, the experiments with RII-C fusion proteins are novel and an important addition.

Reviewer #3 (Public Review):

Summary:

Xiong et al. investigated the debated mechanism of PKA activation using hippocampal CA1 neurons under pharmacological and synaptic stimulations. Examining the two PKA major isoforms in these neurons, they found that a portion of PKA-C dissociates from PKA-R and translocates into dendritic spines following norepinephrine bath application. Additionally, their use of a non-dissociable form of PKC demonstrates its essential role in structural long-term potentiation (LTP) induced by two-photon glutamate uncaging, as well as in maintaining normal synaptic transmission, as verified by electrophysiology. This study presents a valuable finding on the activation-dependent re-distribution of PKA catalytic subunits in CA1 neurons, a process vital for synaptic functionality. The robust evidence provided by the authors makes this work particularly relevant for biologists seeking to understand PKA activation and its downstream effects essential for synaptic plasticity.

Strengths:

The study is methodologically robust, particularly in the application of two-photon imaging and electrophysiology. The experiments are well-designed with effective controls and a comprehensive analysis. The credibility of the data is further enhanced by the research team's previous works in related experiments. The conclusions of this paper are mostly well supported by data. The research fills a significant gap in our understanding of PKA activation mechanisms in synaptic functioning, presenting valuable insights backed by empirical evidence.

Weaknesses:

The physiological relevance of the findings regarding PKA dissociation is somewhat weakened by the use of norepinephrine (10 µM) in bath applications, which might not accurately reflect physiological conditions. Furthermore, the study does not address the impact of glutamate uncaging, a well-characterized physiologically relevant stimulation, on the redistribution of PKA catalytic subunits, leaving some questions unanswered.

Reviewer #1 (Public Review):

In this manuscript, Lebedeva et al. report the input/output wiring diagram of a population of previously identified giant excitatory neurons (abbreviated as ExNr) in the CA1 region of the rat hippocampus. Overall, Lebedeva et al. report that 1) ExNr are driven by Schaffer collaterals; 2) ExNr do not contact CA1Pyrs; 3) ExNr innervate PV interneurons; 4) ExNr received inhibition from bistratified cells, but not basket cells; and 5) ExNr -> PV synapse is strong enough to massively inhibit CA1Pyrs. Some of the findings reported here appear interesting. However, my appreciation of this manuscript was dampened by the limited scientific novelty, strong statements that are sometimes not supported by data, and vague, imprecise, and oversimplified narratives used throughout.

(1) The identity of ExNr reported here is unclear. It is unclear how ExNr are identified, and how robust the identification criteria are. A single anatomical reconstruction is provided together with depolarization-induced firing. However, whether all cells are consistent with the examples provided is unclear. Giant radiatum cells (previously known as RGCs, here abbreviated as ExNr) were previously identified by Maccaferri (1996) and Gulyas (1998). Based on anatomical criteria alone, it was suggested that these cells could take 4 different forms. The current manuscript mostly ignores this past finding. Given the topic of this paper, a careful anatomical and electrophysiological examination of ExNr is required.

(2) The identity of recorded interneurons is unclear. A major and potentially interesting finding reported here is the differential connectivity of ExNr to basket and bistratified neurons. However, it seems like basket and bistratified cells were mostly identified on the basis of electrophysiological criteria, and that 'only 5 neurons of each group were filed with biocytin, and the identity of interneurons was confirmed by axonal arborization pattern.' First, this significantly departs from the general current practices in the field where interneurons are identified based on combined anatomical and electrophysiological properties. This is because multiple examples in the literature support the extreme heterogeneity of interneurons, and that a combination of criteria is usually required for their appropriate identification. Second, the reconstruction of these neurons should be provided. Since the circuit wiring diagram proposed by the authors is based on these results, proper interneuron classification is necessary.

(3) Multiple conclusions are overstatements. For example, the interpretation that ExNr escapes perisomatic inhibition, as reported in the title, seems to ignore large families of cholecystokinin- or Sncg-expressing basket cells.

(4) Some of the more exciting findings appear preliminary, and the robustness of the findings is hard to evaluate. An example of that is found on Page 8, line 179: 'Thus, ExNR can operate as an amplification relay station for feed-forward inhibition of neurons in the CA area.' This conclusion appears only loosely supported by a few observations, (n = 3), as stated above. Similarly, the next section investigates the downstream effect of ExNr firing on CA1 pyramidal cells. The author reports that 'In 24% of the slices unitary APs in ExNr generated an fIPSP, delayed relative to the peak of the AP by 5.5 ms (n=6; Fig 3D-F).' In my opinion, 24% is a relatively low occurrence, even if we consider potentially cut axons (rightfully acknowledged by the authors) during the slicing procedure. Overall, this clearly doesn't fit the 'massive inhibition of downstream CA1Pyrs' proposed by the authors.

(5) The abstract and introduction are often too vague or oversimplified.

Reviewer #2 (Public Review):

Summary:

This study addresses an intriguing and little-studied population of large excitatory cells that lie in the stratum radiatum, outside the classical cell body layers in the hippocampus. Interestingly, the authors show that these "giant excitatory neurons in stratum radiatum" strongly drive both bistratified and basket interneurons. Activating a single giant cell could induce action potential firing in postsynaptic interneurons, which in turn inhibit their postsynaptic pyramidal cell targets. They appear to receive excitatory input from CA3 but not the entorhinal cortex; at a local level, they are not strongly interconnected with CA1 pyramidal cells, and receive inhibitory input from bistratified but not basket cells.

The lack of perisomatic input from basket cells is unique in comparison with the vast majority of excitatory cells in the hippocampus. It is however not surprising, given the fact that the giant excitatory neurons studied in this paper are defined by their position in a particular hippocampal layer (stratum radiatum), and the axons of inhibitory basket cells are largely restricted to another layer (stratum pyramidale). Nonetheless, the fact that this study draws attention to this unique property, and also provides data to support it, is valuable. As the authors also point out, given the importance of such perisomatic input for rhythmogenesis in the hippocampus, the lack of such input may leave these cells free to operate outside of the dominant rhythm.

In combination with the strong drive onto interneurons, which strongly control the activity of pyramidal cells, the giant excitatory cells in the stratum radiatum appear to be in a unique position to influence the hippocampal circuit. Although clearly such an alternative pathway provides the potential for more diverse functions within the hippocampal circuit, and the connectivity shown in this study will likely be of interest to anyone interested in hippocampal function, the authors do not show a concrete function for this pathway.

Strengths:

Overall, the main value of this study is to demonstrate that this small population of oft-neglected cells could have an unexpectedly large impact on hippocampal function via a uniquely strong excitatory output onto two types of interneurons. Whereas activating a "classical" pyramidal cell produces only subthreshold activity in postsynaptic interneurons, meaning that several pyramidal cells have to be co-active to drive their postsynaptic targets to fire, here the authors show that a single giant excitatory neuron in the stratum radiatum can directly drive at least a subset of its postsynaptic targets to fire.

The authors also show the effect of this output both on the membrane potential of CA1 pyramidal cells and on the extracellular field potential as measured with silicon probes. The fact that the authors identified a relatively large number of these sparse giant excitatory cells in the stratum radiatum and performed paired recordings from them is itself a strength of this study.

Another strength is the fact that the authors also investigate the inputs to these giant excitatory cells. The method of paired patch-clamp recordings in rat brain slices enables in principle to record connectivity in both directions, by stimulating one and checking for a response in the other. Recording the interconnectivity of giant excitatory cells with bistratified, basket, and pyramidal cells, as well as the connectivity between pyramidal cells and the two types of interneurons, allows insightful comparisons between "classic" CA1 pyramidal cells and the displaced giant excitatory cells. Although the lack of connectivity between the latter two cell types that the authors report is not so surprising (given the generally very low connectivity between excitatory cells in CA1), it is nonetheless important data. To also check non-local inputs the authors used optogenetics, whereby a Camk2a promoter likely limited cells expressing channelrhodopsin to mostly excitatory cells.

Weaknesses:

The main weakness of this study is perhaps the lack of a clear function for the described circuitry. Although the authors do speculate on this, it remains to be demonstrated what the role of these cells and their connections with the identified interneuron types might be for hippocampal function.

For the first experimental result, it's not fully clear from the evidence the authors present, that indeed the injections were limited to CA3 (for Figure 1c) and to EC (for Figure 1d). This is important since in theory the CA3 injection could also include e.g. CA2 or CA1 itself, which is not that unlikely given the relatively large injected volume of 1ul per side (bilateral). Similarly for the EC injection, it appears the injection may be 2 ul per side (the methods are a bit ambiguous, unfortunately), and this could lead to infection in e.g. Subiculum. Given that these potential mistargeted areas may also project to CA1, this could obviously change the conclusions one can draw from the optogenetic stimulation results the authors present. Furthermore, for the EC result, the authors assume the response they measure is not monosynaptic, which indeed is likely given the long delay, but to interpret this properly a few recordings with pharmacology would be helpful to really show monosynaptic connections (also for the CA3 inputs). One could also cut the inputs to the DG to show that the delayed EC inputs are abolished then (or instead they may be relayed via local CA1 pyramids receiving EC input). Either way, some additional line of evidence beyond simply the delay would be reassuring. A further worry for the EC result relates to the angle of slicing: can the authors give the reader some reassurance that the lack of monosynaptic inputs is not simply a result of cut connections in the slices they used? Especially since only 5 neurons were recorded with stimulation of presumed EC fibers, it is hard to rule out EC input based on the presented evidence. Related to this, one wonders why in Figures 1D and 1E there are no reported connections from EC to CA1 pyramidal cells (while the authors do include CA1 pyramidal cell recordings for the CA3 stimulation experiments); again this might suggest the connections are simply cut in the slice preparation.

For the connectivity results, the data seem to support the claims, but the conclusions would be improved if the terminology of "privileged" and "escaped" could be avoided. More importantly, the exact criteria for distinguishing between bistratified and basket cells are not fully clear; it seems that the amount of current needed to induce AP firing was the main criterion but there is no figure showing this data (only an example in S1A). The input resistance distributions are overlapping, so this was clearly not used as the main criterion. Showing some pictures of the filled cells as supplemental material would also be helpful to give the reader a bit more confidence that the classification is reliable. In the methods, it is mentioned that 10 cells were filled with biocytin, but the authors don't explicitly state (or show) that the identity was confirmed for all 10 filled cells, and what this was based on. Overall, a bit more info on the giant excitatory cells in the stratum radiatum would be helpful (e.g. soma locations, extent of dendrites relative to layers, density/nr of cells); a brief mention of this in the introduction or discussion would help the reader to place the work in context.

The number of tested pairs or cells is also a bit low (or unclear) in some cases. For instance, the relatively low number of recordings (n=30) between CA1 pyramidal cells and giant excitatory cells in the radiatum means a low connectivity rate on the order of a few percent cannot be ruled out; it has been shown that even in CA3, which is classically considered a "reciprocally connected" area, such low connectivity rates can still be functionally important (Guzman et al).

For the feedforward inhibition result, the concept of "amplification relay station" that was introduced is not so clear. It is not unexpected that when you strongly innervate BC cells and bring them to spike, as the giant cells in this study do, this activity will in turn inhibit pyramidal cells (and actually quite a lot of them, so that it is not surprising that you can measure IPSCs). Furthermore, the rationale for doing the silicon probe recordings is not well explained, and it would be helpful if the authors could discuss the significance of performing such LFP recordings in slices.

Conceptually, the presentation of perisomatic inhibition as simply silencing pyramidal and granule cells, forming a "burden" that needs to be "overcome" or "bypassed" via an alternative pathway (as in the example the authors give of having an axon coming from a dendrite instead of the presumably "blocked" soma), is not so convincing. Perisomatic inhibition is much more than that, particularly if one takes timing into account (indeed the authors point to its role in rhythmogenesis). This does not detract from the fact that the lack of perisomatic inhibition (at least from fast-spiking basket cells) is likely to have large functional implications, which the authors rightly emphasize.

Reviewer #3 (Public Review):

Summary:

This paper reexamined large excitatory neurons in the stratum radiatum with optogenetics. The findings are valuable because prior studies of the circuitry were confounded by the use of stimulating electrodes placed in different layers where multiple inputs were stimulated at one time. The strength of the evidence for the conclusions is incomplete because of several concerns with the manuscript.

Strengths:

The strength of the study is the very nice presentation of data. Also, there is a nice combination of patching, LFPs, paired recordings, and microelectrode arrays.

Weaknesses:

The limitations are in the conclusions which don't seem fully justified.

Reviewer #1 (Public Review):

Summary:<br /> Fiber photometry has become a very popular tool in recording neuronal activity in freely behaving animals. Despite the number of papers published with the method, as the authors rightly note, there are currently no standardized ways to analyze the data produced. Moreover, most of the data analyses confine to simple measurements of averaged activity and by doing so, erase valuable information encoded in the data. The authors offer an approach based on functional linear mixed modeling, where beyond changes in overall activity various functions of the data can also be analyzed. More in-depth analysis, more variables taken into account, and better statistical power all lead to higher quality science.

Strengths:<br /> The framework the authors present is solid and well-explained. By reanalyzing formerly published data, the authors also further increase the significance of the proposed tool opening new avenues for reinterpreting already collected data.

Weaknesses:<br /> However, this also leads to several questions. The normalization method employed for raw fiber photometry data is different from lab to lab. This imposes a significant challenge to applying a single tool of analysis. Does the method that the authors propose work similarly efficiently whether the data are normalized in a running average dF/F as it is described in the cited papers? For example, trace smoothing using running averages (Jeong et al. 2022) in itself may lead to pattern dilution. The same question applies if the z-score is calculated based on various responses or even baselines. How reliable the method is if the data are non-stationery and the baselines undergo major changes between separate trials?

Finally, what is the rationale for not using non-linear analysis methods? Following the paper's logic, non-linear analysis can capture more information that is diluted by linear methods.

Reviewer #2 (Public Review):

Summary:<br /> This work describes a statistical framework that combines functional linear mixed modeling with joint 95% confidence intervals, which improves statistical power and provides less conservative statistical inferences than in previous studies. As recently reviewed by Simpson et al. (2023), linear regression analysis has been used extensively to analyze time series signals from a wide range of neuroscience recording techniques, with recent studies applying them to photometry data. The novelty of this study lies in 1) the introduction of joint 95% confidence intervals for statistical testing of functional mixed models with nested random-effects, and 2) providing an open-source R package implementing this framework. This study also highlights how summary statistics as opposed to trial-by-trial analysis can obscure or even change the direction of statistical results by reanalyzing two other studies.

Strengths:<br /> The open-source package in R using a similar syntax as the lme4 package for the implementation of this framework on photometry data enhances the accessibility, and usage by other researchers. Moreover, the decreased fitting time of the model in comparison with a similar package on simulated data, has the potential to be more easily adopted.

The reanalysis of two studies using summary statistics on photometry data (Jeong et al., 2022; Coddington et al., 2023) highlights how trial-by-trial analysis at each time-point on the trial can reveal information obscured by averaging across trials. Furthermore, this work also exemplifies how session and subject variability can lead to opposite conclusions when not considered.

Weaknesses:<br /> Although this work has reanalyzed previous work that used summary statistics, it does not compare with other studies that use trial-by-trial photometry data across time-points in a trial.

As described by the authors, fitting pointwise linear mixed models and performing t-test and Benjamini-Hochberg correction as performed in Lee et al. (2019) has some caveats. Using joint confidence intervals has the potential to improve statistical robustness, however, this is not directly shown with temporal data in this work. Furthermore, it is unclear how FLMM differs from the pointwise linear mixed modeling used in this work.

In this work, FLMM usages included only one or two covariates. However, in complex behavioral experiments, where variables are correlated, more than two may be needed (see Simpson et al. (2023), Engelhard et al. (2019); Blanco-Pozo et al. (2024)). It is not clear from this work, how feasible computationally would be to fit such complex models, which would also include more complex random effects.

Reviewer #3 (Public Review):

Summary:<br /> Loewinger et al., extend a previously described framework (Cui et al., 2021) to provide new methods for statistical analysis of fiber photometry data. The methodology combines functional regression with linear mixed models, allowing inference on complex study designs that are common in photometry studies. To demonstrate its utility, they reanalyze datasets from two recent fiber photometry studies into mesolimbic dopamine. Then, through simulation, they demonstrate the superiority of their approach compared to other common methods.

Strengths:<br /> The statistical framework described provides a powerful way to analyze photometry data and potentially other similar signals. The provided package makes this methodology easy to implement and the extensively worked examples of reanalysis provide a useful guide to others on how to correctly specify models.

Modeling the entire trial (function regression) removes the need to choose appropriate summary statistics, removing the opportunity to introduce bias, for example in searching for optimal windows in which to calculate the AUC. This is demonstrated in the re-analysis of Jeong et al., 2022, in which the AUC measures presented masked important details about how the photometry signal was changing.

Meanwhile, using linear mixed methods allows for the estimation of random effects, which are an important consideration given the repeated-measures design of most photometry studies.

Weaknesses:<br /> While the availability of the software package (fastFMM), the provided code, and worked examples used in the paper are undoubtedly helpful to those wanting to use these methods, some concepts could be explained more thoroughly for a general neuroscience audience.

While the methodology is sound and the discussion of its benefits is good, the interpretation and discussion of the re-analyzed results are poor:

In section 2.3, the authors use FLMM to identify an instance of Simpson's Paradox in the analysis of Jeong et al. (2022). While this phenomenon is evident in the original authors' metrics (replotted in Figure 5A), FLMM provides a convenient method to identify these effects while illustrating the deficiencies of the original authors' approach of concatenating a different number of sessions for each animal and ignoring potential within-session effects. The discussion of this result is muddled. Having identified the paradox, there is some appropriate speculation as to what is causing these opposing effects, particularly the decrease in sessions. In the discussion and appendices, the authors identify (1) changes in satiation/habitation/motivation, (2) the predictability of the rewards (presumably by the click of a solenoid valve) and (3) photobleaching as potential explanations of the decrease within days. Having identified these effects, but without strong evidence to rule all three out, the discussion of whether RPE or ANCCR matches these results is probably moot. In particular, the hypotheses developed by Jeong et al., were for a random (unpredictable) rewards experiment, whereas the evidence points to the rewards being sometimes predictable. The learning of that predictability (e.g. over sessions) and variation in predictability (e.g. by attention level to sounds of each mouse) significantly complicate the analysis. The FLMM analysis reveals the complexity of analyzing what is apparently a straightforward task design. If this paper is not trying to arbitrate between RPE and ANCCR, as stated in the text, the post hoc reasoning of the authors of Jeong et al 2022 provided in the discussion is not germane. Arbitrating between the models likely requires new experimental designs (removing the sound of the solenoid, satiety controls) or more complex models (e.g. with session effects, measures of predictability) that address the identified issues.

Of the three potential causes of within-session decreases, the photobleaching arguments advanced in the discussion and expanded greatly in the appendices are not convincing. The data being modeled is a processed signal (ΔF/F) with smoothing and baseline correction and this does not seem to have been considered in the argument. Furthermore, the photometry readout is also a convolution of the actual concentration changes over time, influenced by the on-off kinetics of the sensor, which makes the interpretation of timing effects of photobleaching less obvious than presented here and more complex than the dyes considered in the cited reference used as a foundation for this line of reasoning.

Within this discussion of photobleaching, the characterization of the background reward experiments used in part to consider photobleaching (appendix 7.3.2) is incorrect. In this experiment (Jeong et al., 2022), background rewards were only delivered in the inter-trial-interval (i.e. not between the CS+ and predicted reward as stated in the text). Both in the authors' description and in the data, there is a 6s before cue onset where rewards are not delivered and while not described in the text, the data suggests there is a period after a predicted reward when background rewards are not delivered. This complicates the comparison of this data to the random reward experiment.

The discussion of the lack of evidence for backpropagation, taken as evidence for ANCCR over RPE, is also weak. A more useful exercise than comparing FLMM to the methods and data of Jeong et al., 2022, would be to compare against the approach of Amo et al., 2022, which identifies backpropagation (data publicly available: DOI: 10.5061/dryad.hhmgqnkjw). The replication of a positive result would be more convincing of the sensitivity of the methodology than the replication of a negative result, which could be a result of many factors in the experimental design. Given that the Amo et al. analysis relies on identifying systematic changes in the timing of a signal over time, this would be particularly useful in understanding if the smoothing steps in FLMM obscure such changes.

Reviewer #2 (Public Review):

Summary:<br /> Zhixin and collaborators have investigated if the molecular pathways present in glia play a role in the proliferation, maintenance, and differentiation of Neural Stem Cells. In this case, Drosophila Neuroblasts are used as models. The authors find that neuronal iron metabolism modulated by glial ferritin is an essential element for Neuroblast proliferation and differentiation. They show that loss of glial ferritin is sufficient to impact on the number of neuroblasts. Remarkably, the authors have identified that ferritin produced in the glia is secreted to be used as an iron source by the neurons. Therefore iron defects in glia have serious consequences in neuroblasts and likely vice versa. Interestingly, preventing iron absorption in the intestine is sufficient to reduce NB number. Furthermore, they have identified Zip13 as another regulator of the process. The evidence presented strongly indicates that loss of neuroblasts is due to premature differentiation rather than cell death.

Strengths:<br /> - Comprenhensive analysis of the impact of glial iron metabolism in neuroblast behaviour by genetic and drug-based approaches as well as using a second model (mouse) for some validations.<br /> - Using cutting-edge methods such as RNAseq as well as very elegant and clean approaches such as RNAi-resistant lines or temperature-sensitive tools<br /> - Goes beyond the state of the art highlighting iron as a key element in neuroblast formation as well as as a target in tumor treatments.

Weaknesses:<br /> Although the manuscripts have clear strengths, there are also some strong weaknesses that need to be addressed.<br /> - Some literature is missing<br /> - In general, the authors succeeded but in some cases, the authors´ claims are not fully supported by the evidence presented and additional experiments are critical to discriminate among different hypotheses.<br /> - Moreover, some potential flaws might be present in the analysis of cell death and mitochondrial iron.

Reviewer #1 (Public Review):

Summary:<br /> This study unveils a novel role for ferritin in Drosophila larval brain development. Furthermore, it pinpoints that the observed defects in larval brain development resulting from ferritin knockdown are attributed to impaired Fe-S cluster activity and ATP production. In addition, knocking down ferritin genes suppressed the formation of brain tumors induced by brat or numb RNAi in Drosophila larval brains. Similarly, iron deficiency suppressed glioma in the mice model. Overall, this is a well-conducted and novel study.

Strengths:<br /> Thorough analyses with the elucidation of molecular mechanisms.

Weaknesses:<br /> Some of the conclusions are not well supported by the results presented.

Reviewer #3 (Public Review):

In this manuscript, Ma et al seek to identify stem cell niche factors. They perform an RNAi screen in glial cells and screen for candidates that support and maintain neuroblasts (NBs) in the developing fly brain. Through this, they identify two subunits of ferritin, which is a conserved protein that can store iron in cells in a non-toxic form and release it in a controlled manner when and where required. They present data to support the conclusion that ferritin produced in glia is released and taken up by NBs where it is utilised by enzymes in the Krebs cycle as well as in the electron transport chain. In its absence from glia, NBs are unable to generate sufficient energy for division and therefore prematurely differentiate via nuclear prospero resulting in small brains. The work will be of interest to those interested in neural stem cells and their non-cell autonomous control by niches.

The past decade has seen a growing appreciation of how glial cells support and maintain NBs during development. The authors' discovery of glial-derived ferritin providing essential iron atoms for energy production is interesting and important. They have employed a variety of genetic tools and assays to uncover how ferritin in glia might support NBs. This is particularly challenging because there are no direct ways of assaying for iron or energy consumption in a cell-specific manner.

There are however instances where conclusions are drawn to support the story being developed without considering the equally plausible alternative explanations that should ideally be addressed.

For example, the data supporting the transfer of ferritin from glia to NBs was weak given the misexpression system used; the Shi[ts] experiment was also not convincing (perhaps they have more representative images?).

The iron manipulation experiments are in the whole animal and it is likely that this affects general feeding behaviour, which is known to affect NB exit from quiescence and proliferative capacity. The loss of ferritin in the gut and iron chelators enhancing the NB phenotype are used as evidence that glia provide iron to NB to support their number and proliferation. Since the loss of NB is a phenotype that could result from many possible underlying causes (including low nutrition), this specific conclusion is one of many possibilities.

Similarly, knockdown of the FeS protein assembly components phenocopy glial ferritin knock down. Since iron is so important for the TCA and the ETC, this is not surprising, but the similarities in the two phenotypes seem insufficient to say that it's glial ferritin that's causing the lack of iron in the NB and therefore resulting in loss of NBs.

Pros RNAi will certainly result in an increase in NB numbers because the loss of pros results in an inability of NB progeny to differentiate. This (despite the slight increase in nuclear pros) is not sufficient to infer that glial ferritin knockdown results in premature differentiation of NBs via nuclear pros.

I recognise these are challenging to prove irrefutably, however, the frequency of such expansive interpretations of data is of concern.

Reviewer #2 (Public Review):

Summary:

In this work Ibtisam and Kisselev explore the role of DDI2 in the proteasome function recovery after a clinically relevant pulse dosing using different proteasome inhibitors and their corresponding PK properties. The authors report that despite lack of NRF1 activation by DDI2 there was no difference in recovery from pulsed proteasome inhibition observed in DDI2 KO cells as compared to WT controls suggesting DDI2 is not required for recovery in this system. They further show that transcription of the proteasome subunits is initiated only after partial recovery of proteasome activity is already observed suggesting that non-transcriptional mechanisms might be also involved. The authors further show that translation inhibition blocked the recovery from proteasome inhibitors.

Strengths:

Overall, it is very important and informative to use a pulse treatment type approach (mimicking the PK properties of the drugs) to explore the biology of PIs as used in this study. The authors also provide convincing data that DDI2 is not required for proteasome activity recovery post-PI pulse treatment in the systems they explored.

Weaknesses:

The authors show that the recovery of one specific catalytic activity of the proteasome post-PI treatment is transcription independent. However, in this work they do not explore the other catalytic activities of the proteasome, the protein levels of the individual subunits and most importantly the level of the different assembled proteasome complexes and how they change over time. Without this data the proposed mechanism is still speculative, in particular the conclusion on the role of translation, and ignores other findings in the field that suggest that alternative mechanisms (such as proteasome complex assembly regulation for instance) might be just as plausible.

Reviewer #1 (Public Review):

Summary:

There has been substantial prior work trying to understand the transcriptional control of proteasome expression as an adaptive response to proteasome inhibition. This field has been mired by fierce debates over the role of the protease Ddi2 in activating the transcription factor Nrf1/NFE2L1. As the authors of this manuscript point out, most of the previous research centers on the continuous treatment of cells with proteasome inhibitors rather than a brief pulse of inhibition that better models the situation when these drugs are used clinically. The authors find that the initial recovery of proteasome activity is independent of Ddi2 and involves a mechanism distinct from transcription. The authors intriguingly point to a model in which the assembly of proteasomes is regulated. If true, this would be a significant finding, but for now, this model remains more speculative.

Strengths:

The pulsed treatment of proteasome inhibitors is a strength of this lab that few others use. It better mimics the clinical use of these inhibitors and allows for a more detailed analysis of the initial response to inhibition. The authors have used multiple different clones of Ddi2 knockouts and siRNA against Ddi2 to rule out the necessity of Ddi2 in the early production of proteasomes when cells are inhibited with proteasomes. establishing a thorough knockout approach while also avoiding compensatory mutations. These experiments are well controlled, showing both the levels of Ddi2 upon knockout or knockdown and demonstrating that the cleavage of Nrf1, one of two known targets of Ddi2, is impaired. However, it should be noted that faint bands for Ddi2 mysteriously remain even in the knockout.

This article sensitively monitors the recovery of proteasome function with the β5 activity assay and for the production of new proteasome transcripts by qPCR. This precision and a detailed analysis of the timing are strengths that pointed to a more rapid recovery than transcription alone.

Weaknesses:

This paper's major weakness is the difficulty in establishing the authors' model that assembly is regulating this process. They do a convincing job demonstrating that activity recovers before transcription. The evidence that translation is unaffected depends entirely on the polysome RNA profiling from two replicates. Clearer and orthogonal data would help establish this finding. The stability of subunits is interesting and important in its own right.

In short, the authors establish that Ddi2 is unnecessary for the initial, non-transcriptional recovery of proteasome activity after a pulse of proteasome inhibition.

It is not clear what clinical impact this work will have. Although it models the pulse of proteasome inhibition more perfectly, it only looks at a single pulse rather than multiple treatments. Thus, ruling out Ddi2's importance for clinical benefit may be premature. More significantly, this work suggests that assembling proteasomes might be a regulated process worth substantial follow-up that will be interesting to follow.

Reviewer #2 (Public Review):

Harnessing macrophages to attack cancer is an immunotherapy strategy that has been steadily gaining interest. Whether macrophages alone can be powerful enough to permanently eliminate a tumor is a high-priority question. In addition, the factors making different tumors more vulnerable to macrophage attack have not been completely defined. In this paper, the authors find that MSP1 inhibition, most notable for causing chromosomal instability (CIN), in cancer cells improves the effect of macrophage targeted immunotherapies. They demonstrate that MSP1 inhibited tumors secrete factors that polarize macrophages to a more tumoricidal fate through several methods. The most compelling experiment is transferring conditioned media from MSP1 inhibited and control cancer cells, then using RNAseq to demonstrate that the MSP1-inhibited conditioned media causes a shift towards a more tumoricidal macrophage phenotype. In mice with MSP1 inhibited (CIN) B16 melanoma tumors, a combination of CD47 knockdown and anti-Tyrp1 IgG is sufficient for long term survival in nearly all mice. This combination is a striking improvement from conditions without CIN.

Like any interesting paper, this study leaves several unanswered questions. First, how do CIN tumors repolarize macrophages? The authors demonstrate that conditioned media is sufficient for this repolarization, implicating secreted factors, but the specific mechanism is unclear. The main caveat of the study is that chromosomal instability is driven by MSP1 inhibition in all the experiments, leaving open the possibility that some effects are due to MSP1 inhibition specifically rather than CIN more generally. To specifically connect CIN and macrophage repolarization, future studies will need to examine tumors with CIN unrelated to MSP1 inhibition to determine if these are also able to repolarize macrophages.

Overall, this is a thought-provoking study that will be of broad interest to many different fields including cancer biology, immunology and cell biology.

Reviewer #2 (Public Review):

Summary:

The work by Varadharajan et. al. explored a previously known genetic variant and its pathophysiology in the development of alcohol-associated liver injury. It provides a plausible mechanism for how varying levels of MBOAT7 could impact the lipid metabolomics of the cell, leading to a deleterious phenotype in MBOAT7 knockout. The authors further characterized the impact of the lipidomic changes and raised lysosomal biogenesis and autophagic flux as mechanisms of how MBOAT7 deletion causes the progression of ALD.

Strengths:

Connecting the GWAS data on MBOAT7 variants with plausible pathophysiology greatly enhances the translational relevance of these findings. The global lipidomic profiling of ALD mice is also very informative and may lead to other discoveries related to lipid handling pathways.

Weaknesses:

The rationale of why MBOAT7 metabolites are lower in heavy drinkers than in normal individuals is not well explained. MBOAT7 loss of function drives ALD, but unclear if MBOAT7 deletion also drives preference for alcohol or if alcohol inhibits MBOAT7 function. Presuming most individuals studied here were WT and expressed an appropriate level of MBOAT7?

Also, discussion of mechanisms of MBOAT7-induced dysregulation of lysosomal biogenesis/autophagy, while very interesting, seems incomplete. It is not clear how MBOAT7 an enzyme involved in membrane phospholipid remodeling increases mTOR which leads to decreased TFEB target gene transcription. Furthermore, given the significant disturbances of global lipidomic profiling in MBOAT7 knockout, many pathways are potentially affected by this deletion. Further in vivo modeling that specifically addresses these pathways (TFEB targeting, mTOR inhibitor) would help strengthen the conclusions of this paper.

Reviewer #2 (Public Review):

Summary:

The Meiri group previously showed that Notch1-activated human T-ALL cell lines are sensitive to a cannabis extract in vitro and in vivo (Ref. 32). In that article, the authors showed that Extract #12 reduced NICD expression and viability, which was partially rescued by restoring NICD expression. Here, the authors have identified three compounds of Extract #12 (CBD, 331-18A, and CBDV) that are responsible for the majority of anti-leukemic activity and NICD reduction. Using a pharmacological approach, the authors determined that Extract #12 exerted its anti-leukemic and NICD-reducing affects through the CB2 and TRPV1 receptors. To determine mechanism, the authors performed RNA-seq and observed that Extract #12 induces ER calcium depletion and stress-associated signals -- ATF4, CHOP, and CHAC1. Since CHAC1 was previously shown to be a Notch inhibitor in neural cells, the authors assume that the cannabis compounds repress Notch S1 cleavage through CHAC1 induction. The induction of stress-associated signals, Notch repression, and anti-leukemic effects were reversed by the integrated stress response (ISR) inhibitor ISRIB. Interestingly, combining the 3 cannabinoids gave synergistic anti-leukemic effects in vitro and had growth inhibitory effects in vivo.

Strengths:

(1) The authors show novel mechanistic insights that cannabinoids induce ER calcium release and that the subsequent integrated stress response represses activated NOTCH1 expression and kills T-ALL cells.

(2) This report adds to the evidence that phytocannabinoids can show a so-called "entourage effect" in which minor cannabinoids enhance the effect of the major cannabinoid CBD.

(3) This report dissects out the main cannabinoids in the previously described Extract #12 that contribute to T-ALL killing.

(4) The manuscript is clear and generally well-written.

(5) The data are mostly high quality and with adequate statistical analyses.

(6) The data generally support the authors' conclusions. The main exception is the experiments related to Notch.

(7) The authors' discovery of the role of the integrated stress response might explain previous observations that SERCA inhibitors block Notch S1 cleavage and activation in T-ALL (Roti Cancer Cell 2013). The previous explanation by Roti et al was that calcium depletion causes Notch misfolding, which leads to impaired trafficking and cleavage. Perhaps this explanation is not entirely sufficient?

Weaknesses:

(1) Given the authors' previous Cancer Communications paper on the anti-leukemic effects and mechanism of Extract #12, the significance of the original manuscript was reduced. To increase significance, the authors provided a new Fig. S7 in the revision showing that Extract #12 inhibits PDX growth in vivo. This experiment is nicely supportive of the anti-leukemic effects of Extract #12, raising the significance of their previous Cancer Communication paper by using in vivo patient-derived cells. However, this reviewer had suggested testing the combination of 333-18A+CBVD+CBD since the combination is the focus of the current manuscript. For unclear reasons, the combination was not tested.

(2) It would be important to connect the authors' findings and a wealth of literature on the role of ER calcium/stress on Notch cleavage, folding, trafficking, and activation. The several references suggested by this reviewer were not included in the revised manuscript for unclear reasons. These references are important to show the current status of the field and help readers appreciate what this manuscript brings that is new to T-ALL. In particular, Roti et al (Cancer Cell 2013) showed that SERCA inhibitors like thapsigardin reduce ER calcium levels and block Notch signaling by inhibiting NOTCH1 trafficking and inhibiting Furin-mediated (S1) cleavage of Notch1 in T-ALL. Multiple EGF repeats and all three Lin12/Notch repeats in the extracellular domains of Notch receptors require calcium for proper folding (Aster Biochemistry 1999; Gordon Nat. Struct. Mol. Biol. 2007; Hambleton Structure 2004; Rand Protein Sci 1997). Thus, Roti et al concluded that ER calcium depletion blocks NOTCH1 S1 cleavage in T-ALL. This effect seems to be conserved in Drosophila as Periz and Fortiin (EMBO J, 1999) showed impaired Notch cleavage in Ca2+/ATPase-mutated Drosophila cells.

(3) There is an overreliance of the data on single cell line -- MOLT4. MOLT4 is a good initial choice as it is Notch-mutated, Notch-dependent, and representative of the most common T-ALL subtype -- TAL1. However, there is no confirmatory data in other TAL1-positive T-ALLs or interrogation of other T-ALL subtypes. While this reviewer appreciates that the authors showed that multiple T-ALL cell lines were killed in response to Extract #12 in a previous study, the current manuscript is a separate study that should stand on its own. T-ALLs can be killed by multiple mechanisms. It would be important to show a few pieces of key data illustrating that the mechanism of killing found in MOLT4 applies to other T-ALLs.

(4) Fig. 6H. The effects of the cannabinoid combination might be statistically significant but seems biologically weak.

(5) Fig. 3. Based on these data, the authors conclude that the cannabinoid combination induces CHAC1, which represses Notch S1 cleavage in T-ALL cells. The concern is that Notch signaling is highly context dependent. CHAC1 might inhibit Notch in neural cells (Refs. 34-35), but it might not do this in a different context like T-ALL. It would be important to show evidence that CHAC1 represses S1 cleavage in the T-ALL context. More importantly, Fig. 3H clearly shows the cannabinoid combination inducing ATF4 and CHOP protein expression, but the effects on CHAC1 protein do not seem to be satisfactory as a mechanism for Notch inhibition. Perhaps something else is blocking Notch expression?

In the rebuttal, the two references provided by the authors do not alleviate concern that CHAC1 might not be acting as a Notch cleavage inhibitor in the T-ALL context. The Meng et al paper studied B-ALL not T-ALL and did not evaluate CHAC1 as a possible Notch cleavage inhibitor. Likewise, the Chang et al paper did not evaluate CHAC1 as a possible Notch cleavage inhibitor. Therefore, whether CHAC1 is a Notch cleavage inhibitor in the T-ALL context remains an open question. While the authors are correct that Supplementary Fig. S4G-I show that Extract #12 clearly induces CHAC1 protein expression, Main Fig. 3H shows that the extract combination 333-18A+CBVD+CBD, which is the focus of this manuscript, has unclear effects. If the extract combination has no effect on CHAC1 but has the same effects on Notch1 expression as the full extract, then there is reduced support for the authors' conclusion that the full extract and the 333-18A+CBVD+CBD combination inhibit Notch through CHAC1 induction.

(6) The authors provide a new figure on page 5 of the rebuttal that was not requested. It is supposed to show that CHAC1 loss protects T-ALL cells from Extract #12-induced cell population decline. Unfortunately, this figure is not conclusive. The empty vector PLKO is not an appropriate negative control. The field uses non-targeting shRNA controls like pLKO-luciferase to control for induction of the RNA interference pathway. Further, the viability data in panel B is normalized such that the effect of shCHAC1 on viability is masked. Showing non-normalized data is important, because if shCHAC1 impairs viability compared to control shRNA, then CHAC1might have effects on non-Notch pathways, which would reinforce the above concern in Point #5 that CHAC1 might not act as a Notch inhibitor in the T-ALL context. Separately, if this experiment had tested whether CHAC1 knockdown increases Notch cleavage and Notch target gene expression like DTX1, HES1 and MYC, then such data would have helped address Point #5.

(7) Fig. 4B-C/S5D-E. These Western blots of NICD expression are consistent with the cannabinoid combination blocking Furin-mediated NOTCH1 cleavage, which is reversed by ISR inhibition. However, there are many mechanisms that regulate NICD expression. To support their conclusion that the effects are specifically Furin-medated, the authors should probe full length (uncleaved) NOTCH1 in their Western blots. While the authors showed that the full extract (#12) increased uncleaved NOTCH1 expression in their Cancer Communications paper, a major conclusion of the manuscript is that the cannabinoid combination 333-18A+CBVD+CBD reproduces the effect of the full extract (#12). To support this conclusion, the authors should probe key blots for full-length Notch to show that the cannabinoid combination increases uncleaved NOTCH1 just like Extract #12 did in the authors' Cancer Communications paper.

(8) Fig. S4A-B. While these pharmacologic data are suggestive that Extract #12 reduces NICD expression through the CB2 receptor and TRPV1 channel, the doses used are very high (50uM). To exclude off-target effects, these data should be paired with genetic data to support the authors' conclusions. In the rebuttal, the authors provide dose response cell viability curves of the CB2 and TRPV1 inhibitors. These curves do not exclude the possibility that 50uM has off-target effects. This reviewer notes that Reviewer #1 had similar concerns and that both reviewers requested genetic validation of the pharmacological data. These data were not provided in the revision.

(9) Since the authors have performed gene expression profiling, an orthogonal test to confirm that Extract #12 acts through the Notch pathway is to perform enrichment analysis using Notch target gene signatures in T-ALL (e.g. Wang PNAS 2013). In contrast to the authors' rebuttal, this reviewer does not see any enrichment analysis (e.g. GSEA plots) performed on the microarray data to show that Extract #12 inhibits the Notch pathway.

(10) The revised manuscript still retains references that microarray data are "RNA-seq" data, which is inaccurate (see page 10, line 160; Figure 3 legend; page 12, line 169; page 27, line 428; page 36, line 741)

Reviewer #1 (Public Review):

Weinberger et al. use different fate-mapping models, the FIRE model and PLX-diet to follow and target different macrophage populations and combine them with single-cell data to understand their contribution to heart regeneration after I/R injury. This question has already been addressed by other groups in the field using different models. However, the major strength of this manuscript is the usage of the FIRE mouse model that, for the first time, allows specific targeting of only fetal-derived macrophages.

The data show that the absence of resident macrophages is not influencing infarct size but instead is altering the immune cell crosstalk in response to injury, which is in line with the current idea in the field that macrophages of different origins have distinct functions in tissues, especially after an injury.

To fully support the claims of the study, specific targeting of monocyte-derived macrophages or the inhibition of their influx at different stages after injury would be of high interest.

In summary, the study is well done and important for the field of cardiac injury. But it also provides a novel model (FIRE mice + RANK-Cre fate-mapping) for other tissues to study the function of fetal-derived macrophages while monocyte-derived macrophages remain intact.

Reviewer #2 (Public Review):

In this study Weinberger et al. investigated cardiac macrophage subsets after ischemia/reperfusion (I/R) injury in mice. The authors studied a ∆FIRE mouse model (deletion of a regulatory element in the Csf1r locus), in which only tissue resident macrophages might be ablated. The authors showed a reduction of resident macrophages in ∆FIRE mice and characterized its macrophages populations via scRNAseq at baseline conditions and after I/R injury. 2 days after I/R protocol ∆FIRE mice showed an enhanced pro inflammatory phenotype in the RNAseq data and differential effects on echocardiographic function 6 and 30 days after I/R injury. Via flow cytometry and histology the authors confirmed existing evidence of increased bone marrow-derived macrophage infiltration to the heart, specifically to the ischemic myocardium. Macrophage population in ∆FIRE mice after I/R injury were only changed in the remote zone. Further RNAseq data on resident or recruited macrophages showed transcriptional differences between both cell types in terms of homeostasis-related genes and inflammation. Depleting all macrophage using a Csf1r inhibitor resulted in a reduced cardiac function and increased fibrosis.

Strengths:

(1) The authors utilized robust methodology encompassing state of the art immunological methods, different genetic mouse models and transcriptomics.<br /> (2) The topic of this work is important given the emerging role of tissue resident macrophages in cardiac homeostasis and disease.

Comments on revised version:

The authors have responded to all questions. I have no further comments and congratulate the authors on their work.

Reviewer #1 (Public Review):

Klupt, Fam, Zhang, Hang, and colleagues present a novel study examining the function of sagA in E. faecium, including impacts on growth, peptidoglycan cleavage, cell separation, antibiotic sensitivity, NOD2 activation, and modulation of cancer immunotherapy. This manuscript represents a substantial advance over their prior work, where they found that sagA-expressing strains (including naturally-expressing strains and versions of non-expressing strains forced to overexpress sagA) were superior in activating NOD2 and improving cancer immunotherapy. Prior to the current study, an examination of sagA mutant E. faecium was not possible and sagA was thought to be an essential gene.

The study is overall very carefully performed with appropriate controls and experimental checks, including confirmation of similar densities of ΔsagA throughout. Results are overall interpreted cautiously and appropriately.

I have only two comments that I think addressing would strengthen what is already an excellent manuscript.

In the experiments depicted in Figure 3, the authors should clarify the quantification of peptidoglycans from cellular material vs supernatants. It should also be clarified whether the sagA need to be expressed endogenously within E. faecium, and whether ambient endopeptidases (perhaps expressed by other nearby bacteria or recombinant enzymes added) can enzymatically work on ΔsagA cell wall products to produce NOD2 ligands?

In the murine experiments depicted in Figure 4, because the bacterial intervention is being performed continuously in the drinking water, the investigators have not distinguished between colonization vs continuous oral dosing of the mice peptidoglycans. While I do not think additional experimentation is required to distinguish the individual contributions of these 2 components in their therapeutic intervention, I do think the interpretation of their results should include this perspective.

Reviewer #2 (Public Review):

Summary:

The gut microbiome contributes to variation in the efficacy of immune checkpoint blockade in cancer therapy; however, the mechanisms responsible remain unclear. Klupt et al. build upon prior data implicating the secreted peptidoglycan hydrolase SagA produced by Enterococcus faecium in immunotherapy, leveraging novel strains with sagA deleted and complemented. They find that sagA is non-essential, but sagA deletion leads to a marked growth defect due to impaired cell division. Furthermore, sagA is necessary for the immunogenic and anti-tumor effects of E. faecium. Together, this study utilizes compelling methods to provide fundamental new insights into E. faecium biology and host interactions, and a proof-of-concept for identifying the bacterial effectors of immunotherapy response.

Strengths:

Klupt et al. provide a well-written manuscript with clear and compelling main and supplemental figures. The methods used are state-of-the-art, including various imaging modalities, bacterial genetics, mass spectrometry, sequencing, flow cytometry, and mouse models of immunotherapy response. Overall, the data supports the conclusions, which are a valuable addition to the literature.

Weaknesses:

Only minor revision recommendations were noted.

Reviewer #1 (Public Review):

Summary:<br /> The authors have created a system for designing and running experimental pipelines to control and coordinate different programs and devices during an experiment, called Heron. Heron is based around a graphical tool for creating a Knowledge Graph made up of nodes connected by edges, with each node representing a separate Python script, and each edge being a communication pathway connecting a specific output from one node to an input on another. Each node also has parameters that can be set by the user during setup and runtime, and all of this behavior is concisely specified in the code that defines each node. This tool tries to marry the ease of use, clarity, and self-documentation of a purely graphical system like Bonsai with the flexibility and power of a purely code-based system like Robot Operating System (ROS).

Strengths:<br /> The underlying idea behind Heron, of combining a graphical design and execution tool with nodes that are made as straightforward Python scripts seems like a great way to get the relative strengths of each approach. The graphical design side is clear, self-explanatory, and self-documenting, as described in the paper. The underlying code for each node tends to also be relatively simple and straightforward, with a lot of the complex communication architecture successfully abstracted away from the user. This makes it easy to develop new nodes, without needing to understand the underlying communications between them. The authors also provide useful and well-documented templates for each type of node to further facilitate this process. Overall this seems like it could be a great tool for designing and running a wide variety of experiments, without requiring too much advanced technical knowledge from the users.

The system was relatively easy to download and get running, following the directions and already has a significant amount of documentation available to explain how to use it and expand its capabilities. Heron has also been built from the ground up to easily incorporate nodes stored in separate Git repositories and to thus become a large community-driven platform, with different nodes written and shared by different groups. This gives Heron a wide scope for future utility and usefulness, as more groups use it, write new nodes, and share them with the community. With any system of this sort, the overall strength of the system is thus somewhat dependent on how widely it is used and contributed to, but the authors did a good job of making this easy and accessible for people who are interested. I could certainly see Heron growing into a versatile and popular system for designing and running many types of experiments.

Weaknesses:<br /> The number one thing that was missing from the paper was any kind of quantification of the performance of Heron in different circumstances. Several useful and illustrative examples were discussed in depth to show the strengths and flexibility of Heron, but there was no discussion or quantification of performance, timing, or latency for any of these examples. These seem like very important metrics to measure and discuss when creating a new experimental system.

After downloading and running Heron with some basic test Nodes, I noticed that many of the nodes were each using a full CPU core on their own. Given that this basic test experiment was just waiting for a keypress, triggering a random number generator, and displaying the result, I was quite surprised to see over 50% of my 8-core CPU fully utilized. I don't think that Heron needs to be perfectly efficient to accomplish its intended purpose, but I do think that some level of efficiency is required. Some optimization of the codebase should be done so that basic tests like this can run with minimal CPU utilization. This would then inspire confidence that Heron could deal with a real experiment that was significantly more complex without running out of CPU power and thus slowing down.

I was also surprised to see that, despite being meant specifically to run on and connect diverse types of computer operating systems and being written purely in Python, the Heron Editor and GUI must be run on Windows. This seems like an unfortunate and unnecessary restriction, and it would be great to see the codebase adjusted to make it fully cross-platform-compatible.

Lastly, when I was running test experiments, sometimes one of the nodes, or part of the Heron editor itself would throw an exception or otherwise crash. Sometimes this left the Heron editor in a zombie state where some aspects of the GUI were responsive and others were not. It would be good to see a more graceful full shutdown of the program when part of it crashes or throws an exception, especially as this is likely to be common as people learn to use it. More problematically, in some of these cases, after closing or force quitting Heron, the TCP ports were not properly relinquished, and thus restarting Heron would run into an "address in use" error. Finding and killing the processes that were still using the ports is not something that is obvious, especially to a beginner, and it would be great to see Heron deal with this better. Ideally, code would be introduced to carefully avoid leaving ports occupied during a hard shutdown, and furthermore, when the address in use error comes up, it would be great to give the user some idea of what to do about it.

Overall I think that, with these improvements, this could be the beginning of a powerful and versatile new system that would enable flexible experiment design with a relatively low technical barrier to entry. I could see this system being useful to many different labs and fields.

Reviewer #2 (Public Review):

Summary:<br /> The authors provide an open-source graphic user interface (GUI) called Heron, implemented in Python, that is designed to help experimentalists to<br /> (1) design experimental pipelines and implement them in a way that is closely aligned with their mental schemata of the experiments,<br /> (2) execute and control the experimental pipelines with numerous interconnected hardware and software on a network.

The former is achieved by representing an experimental pipeline using a Knowledge Graph and visually representing this graph in the GUI. The latter is accomplished by using an actor model to govern the interaction among interconnected nodes through messaging, implemented using ZeroMQ. The nodes themselves execute user-supplied code in, but not limited to, Python.

Using three showcases of behavioral experiments on rats, the authors highlighted three benefits of their software design:<br /> (1) the knowledge graph serves as a self-documentation of the logic of the experiment, enhancing the readability and reproducibility of the experiment,<br /> (2) the experiment can be executed in a distributed fashion across multiple machines that each has a different operating system or computing environment, such that the experiment can take advantage of hardware that sometimes can only work on a specific computer/OS, a commonly seen issue nowadays,<br /> (3) the users supply their own Python code for node execution that is supposed to be more friendly to those who do not have a strong programming background.

Strengths:<br /> (1) The software is light-weight and open-source, provides a clean and easy-to-use GUI,<br /> (2) The software answers the need of experimentalists, particularly in the field of behavioral science, to deal with the diversity of hardware that becomes restricted to run on dedicated systems.<br /> (3) The software has a solid design that seems to be functionally reliable and useful under many conditions, demonstrated by a number of sophisticated experimental setups.<br /> (4) The software is well documented. The authors pay special attention to documenting the usage of the software and setting up experiments using this software.

Weaknesses:<br /> (1) While the software implementation is solid and has proven effective in designing the experiment showcased in the paper, the novelty of the design is not made clear in the manuscript. Conceptually, both the use of graphs and visual experimental flow design have been key features in many widely used softwares as suggested in the background section of the manuscript. In particular, contrary to the authors' claim that only pre-defined elements can be used in Simulink or LabView, Simulink introduced MATLAB Function Block back in 2011, and Python code can be used in LabView since 2018. Such customization of nodes is akin to what the authors presented.

(2) The authors claim that the knowledge graph can be considered as a self-documentation of an experiment. I found it to be true to some extent. Conceptually it's a welcoming feature and the fact that the same visualization of the knowledge graph can be used to run and control experiments is highly desirable (but see point 1 about novelty). However, I found it largely inadequate for a person to understand an experiment from the knowledge graph as visualized in the GUI alone. While the information flow is clear, and it seems easier to navigate a codebase for an experiment using this method, the design of the GUI does not make it a one-stop place to understand the experiment. Take the Knowledge Graph in Supplementary Figure 2B as an example, it is associated with the first showcase in the result section highlighting this self-documentation capability. I can see what the basic flow is through the disjoint graph where 1) one needs to press a key to start a trial, and 2) camera frames are saved into an avi file presumably using FFMPEG. Unfortunately, it is not clear what the parameters are and what each block is trying to accomplish without the explanation from the authors in the main text. Neither is it clear about what the experiment protocol is without the help of Supplementary Figure 2A.

In my opinion, text/figures are still key to documenting an experiment, including its goals and protocols, but the authors could take advantage of the fact that they are designing a GUI where this information, with properly designed API, could be easily displayed, perhaps through user interaction. For example, in Local Network -> Edit IPs/ports in the GUI configuration, there is a good tooltip displaying additional information for the "password" entry. The GUI for the knowledge graph nodes can very well utilize these tooltips to show additional information about the meaning of the parameters, what a node does, etc, if the API also enforces users to provide this information in the form of, e.g., Python docstrings in their node template. Similarly, this can be applied to edges to make it clear what messages/data are communicated between the nodes. This could greatly enhance the representation of the experiment from the Knowledge graph.

(3) The design of Heron was primarily with behavioral experiments in mind, in which highly accurate timing is not a strong requirement. Experiments in some other areas that this software is also hoping to expand to, for example, electrophysiology, may need very strong synchronization between apparatus, for example, the record timing and stimulus delivery should be synced. The communication mechanism implemented in Heron is asynchronous, as I understand it, and the code for each node is executed once upon receiving an event at one or more of its inputs. The paper, however, does not include a discussion, or example, about how Heron could be used to address issues that could arise in this type of communication. There is also a lack of information about, for example, how nodes handle inputs when their ability to execute their work function cannot keep up with the frequency of input events. Does the publication/subscription handle the queue intrinsically? Will it create problems in real-time experiments that make multiple nodes run out of sync? The reader could benefit from a discussion about this if they already exist, and if not, the software could benefit from implementing additional mechanisms such that it can meet the requirements from more types of experiments.

(4) The authors mentioned in "Heron GUI's multiple uses" that the GUI can be used as an experimental control panel where the user can update the parameters of the different Nodes on the fly. This is a very useful feature, but it was not demonstrated in the three showcases. A demonstration could greatly help to support this claim.

(5) The API for node scripts can benefit from having a better structure as well as having additional utilities to help users navigate the requirements, and provide more guidance to users in creating new nodes. A more standard practice in the field is to create three abstract Python classes, Source, Sink, and Transform that dictate the requirements for initialisation, work_function, and on_end_of_life, and provide additional utility methods to help users connect between their code and the communication mechanism. They can be properly docstringed, along with templates. In this way, the com and worker scripts can be merged into a single unified API. A simple example that can cause confusion in the worker script is the "worker_object", which is passed into the initialise function. It is unclear what this object this variable should be, and what attributes are available without looking into the source code. As the software is also targeting those who are less experienced in programming, setting up more guidance in the API can be really helpful. In addition, the self-documentation aspect of the GUI can also benefit from a better structured API as discussed in point 2 above.

(6) The authors should provide more pre-defined elements. Even though the ability for users to run arbitrary code is the main feature, the initial adoption of a codebase by a community, in which many members are not so experienced with programming, is the ability for them to use off-the-shelf components as much as possible. I believe the software could benefit from a suite of commonly used Nodes.

(7) It is not clear to me if there is any capability or utilities for testing individual nodes without invoking a full system execution. This would be critical when designing new experiments and testing out each component.

Reviewer #3 (Public Review):

Summary:<br /> The authors present a Python tool, Heron, that provides a framework for defining and running experiments in a lab setting (e.g. in behavioural neuroscience). It consists of a graphical editor for defining the pipeline (interconnected nodes with parameters that can pass data between them), an API for defining the nodes of these pipelines, and a framework based on ZeroMQ, responsible for the overall control and data exchange between nodes. Since nodes run independently and only communicate via network messages, an experiment can make use of nodes running on several machines and in separate environments, including on different operating systems.

Strengths:<br /> As the authors correctly identify, lab experiments often require a hodgepodge of separate hardware and software tools working together. A single, unified interface for defining these connections and running/supervising the experiment, together with flexibility in defining the individual subtasks (nodes) is therefore a very welcome approach. The GUI editor seems fairly intuitive, and Python as an accessible programming environment is a very sensible choice. By basing the communication on the widely used ZeroMQ framework, they have a solid base for the required non-trivial coordination and communication. Potential users reading the paper will have a good idea of how to use the software and whether it would be helpful for their own work. The presented experiments convincingly demonstrate the usefulness of the tool for realistic scientific applications.

Weaknesses:<br /> In my opinion, the authors somewhat oversell the reproducibility and "self-documentation" aspect of their solution. While it is certainly true that the graph representation gives a useful high-level overview of an experiment, it can also suffer from the same shortcomings as a "pure code" description of a model - if a user gives their nodes and parameters generic/unhelpful names, reading the graph will not help much. Making the link between the nodes and the actual code is also not straightforward, since the code for the nodes is spread out over several directories (or potentially even machines), and not directly accessible from within the GUI. The authors state that "[Heron's approach] confers obvious benefits to the exchange and reproducibility of experiments", but the paper does not discuss how one would actually exchange an experiment and its parameters, given that the graph (and its json representation) contains user-specific absolute filenames, machine IP addresses, etc, and the parameter values that were used are stored in general data frames, potentially separate from the results. Neither does it address how a user could keep track of which versions of files were used (including Heron itself).

Another limitation that in my opinion is not sufficiently addressed is the communication between the nodes, and the effect of passing all communications via the host machine and SSH. What does this mean for the resulting throughput and latency - in particular in comparison to software such as Bonsai or Autopilot? The paper also states that "Heron is designed to have no message buffering, thus automatically dropping any messages that come into a Node's inputs while the Node's worker function is still running."- it seems to be up to the user to debug and handle this manually?

As a final comment, I have to admit that I was a bit confused by the use of the term "Knowledge Graph" in the title and elsewhere. In my opinion, the Heron software describes "pipelines" or "data workflows", not knowledge graphs - I'd understand a knowledge graph to be about entities and their relationships. As the authors state, it is usually meant to make it possible to "test propositions against the knowledge and also create novel propositions" - how would this apply here?

Reviewer #1 (Public Review):

In this study by Yaghmaeian Salmani et al., the authors performed single-nuclei RNA sequencing of a large number of cells (>70,000) in the ventral midbrain. The authors focused on cells in the ventral tegmental area (VTA) and substantia nigra (SN), which contain heterogeneous cell populations comprising dopaminergic, GABAergic, and glutamatergic neurons. Dopamine neurons are known to consist of heterogeneous subtypes, and these cells have been implicated in various neuropsychiatric diseases. Thus, identifying specific marker genes across different dopamine subpopulations may allow researchers in future studies to develop dopamine subtype-specific targeting strategies that could have substantial translational implications for developing more specific therapies for neuropsychiatric diseases.

A strength of the authors' approach compared to previous work is that a large number of cells were sequenced, which was achieved using snRNA-seq, which the authors found to be superior compared to scRNA-seq for reducing sampling bias. A weakness of the study is that relatively little new information is provided as the results are largely consistent with previous studies (e.g., Poulin et al., 2014). Nevertheless, it should be noted that the authors found some more nuanced subdivisions in several genetically identified DA subtypes.

Lastly, the authors performed molecular analysis of ventral midbrain cells in response to 6-OHDA exposure, which leads to the degeneration of SN dopamine neurons, whereas VTA dopamine neurons are largely unaffected. Based on this analysis, the authors identified several candidate genes that may be linked to neuronal vulnerability or resilience.

Overall, the authors present a comprehensive mouse brain atlas detailing gene expression profiles of ventral midbrain cell populations, which will be important to guide future studies that focus on understanding dopamine heterogeneity in health and disease.

Comments on the revised version

The authors have addressed all of my concerns.

Reviewer #2 (Public Review):

In the manuscript by Salmani et al., the authors explore the transcriptomic characterization of dopamine neurons in order to explore which neurons are particularly vulnerable to 6-OHDA-induced toxicity. To do this they perform single nucleus RNA sequencing of a large number of cells in the mouse midbrain in control animals and those exposed to 6-OHDA. This manuscript provides a detailed atlas of the transcriptome of various types of ventral midbrain cells - though the focus here is on dopaminergic cells, the data can be mined by other groups interested in other cell types as well. The results in terms of cell type classification are largely consistent with previous studies, though a more nuanced picture of cellular subtypes is portrayed here, a unique advantage of the large dataset obtained. The major advance here is exploring the transcriptional profile in the ventral midbrain of animals treated with 6-OHDA, highlighting potential candidate genes that may influence vulnerability. This approach could be generalizable to investigate how various experiences and insults alter unique cell subtypes in the midbrain, providing valuable information about how these stimuli impact DA cell biology and which cells may be the most strongly affected.

Comments on the revised version

The authors addressed most of my concerns about the depth of analysis and implemented further analyses of the data. However I still think that the manuscript would be strengthened with an acknowledgement and deeper integration with the concepts from recent papers in the field, as mentioned by Reviewer 1. There is a rich amount of biology that can be gleaned from understanding the anatomical topology of the VTA and how that relates to gene expression patterns, both at a basal state and following 6-OHDA injection. For example, I made the point about medially-located DA cells in the VTA being the DA that co-express vGluT2. The work would provide more value to the field if more effort was made in the introduction and discussion to briefly mention the recent key papers in the field and how their work relates to our knowledge of the VTA and adjacent SNc in terms of cell-type identity, spatial location, and co-expression of various genes e.g., DAT and vGluT2.

Reviewer # 1 (Public Review):

Summary:<br /> The paper nicely confirms the phenotype of Lama2 knockout mice and extends the phenotypic description with a set of new molecular studies (transcriptomics) that might serve as a resource for other scientists interested in the LAMA2-MD.

Strengths:<br /> Set of new molecular studies (transcriptomics) that might serve as a resource for other scientists interested in the LAMA2-MD.

Weaknesses:<br /> Some of the figures are of rather poor quality. For example, the H&E and Sirius Red stainings in Figures 3 and 4 are quite poor so it is difficult to see what is going on in the muscles. The authors should take note of another publication on dy3K/dy3K mice of similar age (PMID: 31586140) where such images are of much higher quality. Similarly, the Western blot for laminin-alpha2 (Figure 4B) of the wild-type mouse needs improvement. If the single laminin-alpha2 protein is not detected, there is an issue with the denaturation buffer used to load the protein.

My biggest concern is, however, the many overstatements in the manuscript and the over-interpretation of the data. This already starts with the first sentence in the abstract where the authors write: "Understanding the underlying pathogenesis of LAMA2-related muscular dystrophy (LAMA2-MD) have been hampered by lack of genuine mouse model." This is not correct as the dy3K/dy3K, generated in 1997 (PMID: 9326364), are also Lama2 knockout mice; there are also other strains (dyW/dyW mice) that are severely affected and there are the dy2J/dy2J mice that represent a milder form of LAMA2-MD.

Similarly, the last two sentences of the abstract "This is the first reported genuine model simulating human LAMA2-MD. We can use it to study the molecular pathogenesis and develop effective therapies." are a clear overstatement. The mechanisms of the disease are well studied and the above-listed mouse models have been amply used to develop possible treatment options.

The overinterpretation concerns the results from transcriptomics. The fact that Lama2 is expressed in particular cell types of the brain does not at all imply that Lama2 knockout mice have a defect in the blood-brain barrier as the authors state. If there are no functional data, this cannot be stated. Indications for a blood-brain barrier defect come from work in dy3K/dy3K mice (PMID: 25392494) and this needs to be written like this.

Finally, the bulk RNA-seq data also needs to be presented in a disease context. The authors, again, mix up changes in expression with functional impairment. All gene expression changes are interpreted as direct evidence of an involvement of the cytoskeleton. In fact, changes in the cytoskeleton are more likely a consequence of the severe muscle phenotype and the delay in muscle development. This is particularly possible as muscle samples from 14-day-old mice are compared; a stage at which muscle still develops and grows tremendously. Thus, all the data need to be interpreted with caution.

In summary, the authors need to improve data presentation and, most importantly, they need to tone down the interpretation and they must be fully aware that their work is not as novel as they present it.

Reviewer #2 (Public Review):

Summary:<br /> This manuscript describes the production of a mouse model for LAMA2-CMD. This mouse was produced using CRISPR-Cas9 and deleted exon 3 of the Lama2 gene. The mice exhibit reduced life expectancy, muscle pathology, and disruption of the gliovascular basal lamina assembly leading to defects in the blood-brain barrier. Single-cell RNAseq was used to explore the effect that loss of Laminin-211/221 had on gene expression.

Strengths:<br /> (1) The authors produced a mouse model of LAMA2-CMD using CRISPR-Cas9.

(2) The authors identify cellular changes that disrupt the blood-brain barrier.

Weaknesses:<br /> (1) The major weakness is the manuscript reads like this was the first-ever knockout mouse model generated for LAMA2-CMD. There are in fact many Lama2 knockout mice (dy, dy2J, dy4k, dyW, and more) which have all been extensively studied with publications. It is important for the authors to comment on these other published studies that have generated these well-studied mouse lines. Therefore, there is a lack of background information on these other Lama2 null mice.

(2) The phenotypes of dyH/dyH are similar to, if not identical to dy/dy, dy2J/dy2J, dy4k/dy4k, dyW/dyW including muscle wasting, muscle weakness, compromised blood-brain barrier, and reduced life expectancy. This should be addressed, and a comparison made with Lama2 deficient mice in published literature.

(3) Recent published studies (Chen et al., Development (2023), PMID 36960827) show loss of Itga7 causes disruption of the brain-vascular basal lamina leading to defects in the blood-brain barrier. This should be referenced in the manuscript since this integrin is a major Laminin-211/221 receptor in the brain and the mouse model appears to phenocopy the dyH/dyH mouse model.

Reviewer #1 (Public Review):

In this manuscript, the authors investigated the dynamics of a neural network model characterized by sparsely connected clusters of neuronal ensembles. They found that such a network could intrinsically generate sequence preplay and place maps, with properties like those observed in the real-world data. Strengths of the study include the computational model and data analysis supporting the hippocampal network mechanisms underlying sequence preplay of future experiences and place maps.

Previous models of replay or theta sequences focused on circuit plasticity and usually required a pre-existing place map input from the external environment via upstream structures. However, those models failed to explain how networks support rapid sequential coding of novel environments or simply transferred the question to the upstream structure. On the contrary, the current proposed model required minimal spatial inputs and was aimed at elucidating how a preconfigured structure gave rise to preplay, thereby facilitating the sequential encoding of future novel environments.

In this model, the fundamental units for spatial representation were clusters within the network. Sequential representation was achieved through the balance of cluster isolation and their partial overlap. Isolation resulted in a self-reinforced assembly representation, ensuring stable spatial coding. On the other hand, overlap-induced activation transitions across clusters, enabling sequential coding.

This study is important when considering that previous models mainly focused on plasticity and experience-related learning, while this model provided us with insights into how network architecture could support rapid sequential coding with large capacity, upon which learning could occur efficiently with modest modification via plasticity.

I found this research very inspiring and, below, I provide some comments aimed at improving the manuscript. Some of these comments may extend beyond the scope of the current study, but I believe they raise important questions that should be addressed in this line of research.

(1) The expression 'randomly clustered networks' needs to be explained in more detail given that in its current form risks to indicate that the network might be randomly organized (i.e., not organized). In particular, a clustered network with future functionality based on its current clustering is not random but rather pre-configured into those clusters. What the authors likely meant to say, while using the said expression in the title and text, is that clustering is not induced by an experience in the environment, which will only be later mapped using those clusters. While this organization might indeed appear as randomly clustered when referenced to a future novel experience, it might be non-random when referenced to the prior (unaccounted) activity of the network. Related to this, network organization based on similar yet distinct experiences (e.g., on parallel linear tracks as in Liu, Sibille, Dragoi, Neuron 2021) could explain/configure, in part, the hippocampal CA1 network organization that would appear otherwise 'randomly clustered' when referenced to a future novel experience.

(2) The authors should elaborate more on how the said 'randomly clustered networks' generate beyond chance-level preplay. Specifically, why was there preplay stronger than the time-bin shuffle? There are at least two potential explanations:

(1) - When the activation of clusters lasts for several decoding time bins, temporal shuffle breaks the continuity of one cluster's activation, thus leading to less sequential decoding results. In that case, the preplay might mainly outperform the shuffle when there are fewer clusters activating in a PBE. For example, activation of two clusters must be sequential (either A to B or B to A), while time bin shuffle could lead to non-sequential activations such as a-b-a-b-a-b where a and b are components of A and B;

(2) - There is a preferred connection between clusters based on the size of overlap across clusters. For example, if pair A-B and B-C have stronger overlap than A-C, then cluster sequences A-B-C and C-B-A are more likely to occur than others (such as A-C-B) across brain states. In that case, authors should present the distribution of overlap across clusters, and whether the sequences during run and sleep match the magnitude of overlap. During run simulation in the model, as clusters randomly receive a weak location cue bias, the activation sequence might not exactly match the overlap of clusters due to the external drive. In that case, the strength of location cue bias (4% in the current setup) could change the balance between the internal drive and external drive of the representation. How does that parameter influence the preplay incidence or quality?

(3). The manuscript is focused on presenting that a randomly clustered network can generate preplay and place maps with properties similar to experimental observations. An equally interesting question is how preplay supports spatial coding. If preplay is an intrinsic dynamic feature of this network, then it would be good to study whether this network outperforms other networks (randomly connected or ring lattice) in terms of spatial coding (encoding speed, encoding capacity, tuning stability, tuning quality, etc.)

(4) The manuscript mentions the small-world connectivity several times, but the concept still appears too abstract and how the small-world index (SWI) contributes to place fields or preplay is not sufficiently discussed.

For a more general audience in the field of neuroscience, it would be helpful to include example graphs with high and low SWI. For example, you can show a ring lattice graph and indicate that there are long paths between points at opposite sides of the ring; show randomly connected graphs indicating there are no local clustered structures, and show clustered graphs with several hubs establishing long-range connections to reduce pair-wise distance.

How this SWI contributes to preplay is also not clear. Figure 6 showed preplay is correlated with SWI, but maybe the correlation is caused by both of them being correlated with cluster participation. The balance between cluster overlap and cluster isolation is well discussed. In the Discussion, the authors mention "...Such a balance in cluster overlap produces networks with small-world characteristics (Watts and Strogatz, 1998) as quantified by a small-world index..." (Lines 560-561). I believe the statement is not entirely appropriate, a network similar to ring lattice can still have the balance of cluster isolation and cluster overlap, while it will have small SWI due to a long path across some node pairs. Both cluster structure and long-range connection could contribute to SWI. The authors only discuss the necessity of cluster structure, but why is the long-range connection important should also be discussed. I guess long-range connection could make the network more flexible (clusters are closer to each other) and thus increase the potential repertoire.

(5) What drives PBE during sleep? Seems like the main difference between sleep and run states is the magnitude of excitatory and inhibitory inputs controlled by scaling factors. If there are bursts (PBE) in sleep, do you also observe those during run? Does the network automatically generate PBE in a regime of strong excitation and weak inhibition (neural bifurcation)?

(6) Is the concept of 'cluster' similar to 'assemblies', as in Peyrache et al, 2010; Farooq et al, 2019? Does a classic assembly analysis during run reveal cluster structures?

(7) Can the capacity of the clustered network to express preplay for multiple distinct future experiences be estimated in relation to current network activity, as in Dragoi and Tonegawa, PNAS 2013?

Reviewer #1 (Public Review):

Summary:

Animals in natural environments need to identify predator-associated cues and respond with the appropriate behavioral response to survive. In rodents, some chemical cues produced by predators (e.g., cat saliva) are detected by chemosensory neurons in the vomeronasal organ (VNO). The VNO transmits predator-associated information to the accessory olfactory bulb, which in turn projects to the medial amygdala and the bed nucleus of the stria terminalis, two regions implicated in the initiation of antipredator defensive behaviors. A downstream area to these two regions is the ventromedial hypothalamus (VMH), which has been shown to control both active (i.e., flight) and passive (i.e, freezing) antipredator defensive responses via distinct efferent projections to the anterior hypothalamic nucleus or the periaqueductal gray, respectively. However, whether differences in predator-associated sensory information initially processed in the VNO and further conveyed to the VMH can trigger different types of behavioral responses remained unexplored. To address this question, here the authors investigated the behavioral responses of mice exposed to either fresh or old cat saliva, and further compared the underlying neural circuits that are activated by cat saliva with different freshness.

The scientific question of the study is valid, the experiments were well-performed, and the statistical analyses are appropriate. However, there are some concerns that may directly affect the main interpretation of the results.

Major Concerns:

(1) An important point that the authors should clarify in this study is whether mice are detecting qualitative or quantitative differences between the fresh and old cat saliva. Do the environmental conditions in which the old saliva was maintained cause a degradation of Fel d 4, the main protein known for inducing a defensive response in rodents? (see Papes et al, 2010 again). If that is the case, one would expect that a lower concentration of Fel d 4 in the old saliva after protein degradation would result in reduced antipredator responses. Alternatively, if the authors believe that different proteins that are absent in the old saliva are contributing to the increased defensive responses observed with the fresh saliva, further protein quantification experiments should be performed. An important experiment to differentiate qualitative versus quantitative differences between the two types of saliva would be diluting the fresh saliva to verify if the amount of protein, rather than the type of protein, is the main factor regulating the behavioral differences.

(2) The authors claim that fresh saliva is recognized as an immediate danger by rodents, whereas old saliva is recognized as a trace of danger. However, the study lacks empirical tests to support this interpretation. With the current experimental tests, the behavioral differences between animals exposed to fresh vs. old saliva could be uniquely due to the reduced amount of the exact same protein (e.g., Fel d 4) in the two samples of saliva.

(3) In Figure 4H, the authors state that there were no significant differences in the number of cFos-positive cells between the two saliva-exposed groups. However, this result disagrees with the next result section showing that fresh and old saliva differentially activate the VMH. It is unclear why cFos quantification and behavioral correlations were not performed in other upstream areas that connect the VNO to the VMH (e.g., BNST, MeA, and PMCo). That would provide a better understanding of how brain activity correlates with the different types of behaviors reported with the fresh vs. old saliva.

(4) The interpretation that fresh and old saliva activates different subpopulations of neurons in the VMH based on the observation that cFos positively correlates with freezing responses only with the fresh saliva lacks empirical evidence. To address this question, the authors should use two neuronal activity markers to track the response of the same population of VHM cells within the same animals during exposure to fresh vs. old saliva. Alternatively, they could use single cell electrophysiology or imaging tools to demonstrate that cat saliva of distinct freshness activates different subpopulations of cells in the VMH. Any interpretation without a direct within-subject comparison or the use of cell-type markers would become merely speculative. Furthermore, the authors assume that differential activations of mitral cells between fresh and old saliva result in the differential activation of VMH subpopulations (page 13, line 3). However, there are intermediate structures between the mitral cells and the VMH, which are completely ignored in this study (e.g., BNST, medial amygdala).

(5) The authors incorrectly cited the Papes et al., 2010 article on several occasions across the manuscript. In the introduction, the authors cited the Papes et al 2010 study to make reference to the response of rodents to chemical cues, but the Papes et al. study did not use any of the chemical cues listed by the authors (e.g., fox feces, snake skin, cat fur, and cat collars). Instead, the Papes et al. 2010 article used the same chemical cue as the present study: cat saliva. The Papes et al. 2010 article was miscited again in the results section where the authors cited the study to make reference to other sources of cat odor that differ from the cat saliva such as cat fur and cat collars. Because the Papes et al. 2010 article has previously shown the involvement of Trpc2 receptors in the VNO for the detection of cat saliva and the subsequent expression of defensive behaviors by using Trpc2-KO mice, the authors should properly cite this study in the introduction and across the manuscript when making reference to their findings.

(6) In the introduction, the authors hypothesized that the VNO detects predator cues and sends sensory signals to the VMH to trigger defensive behavioral decisions and stated that direct evidence to support this hypothesis is still missing. However, the evidence that cat saliva activates the VMH and that activity in the VMH is necessary for the expression of antipredator defensive response in rodents has been previously demonstrated in a study by Engelke et al., 2021 (PMID: 33947849), which was entirely omitted by the authors.

(7) In the discussion, the authors stated that their findings suggest that the induction of robust freezing behavior is mediated by a distinct subpopulation of VMH neurons. The authors should cite the study by Kennedy et al., 2020 (PMID: 32939094) that shows the involvement of VMH in the regulation of persistent internal states of fear, which may provide an alternative explanation for why distinct concentrations of saliva could result in different behavioral outcomes.

(8) The anatomical connectivity between the olfactory system and the ventromedial hypothalamus (VMH) in the abstract is unclear. The authors should clarify that the VMH does not receive direct inputs from the vomeronasal organ (VNO) nor the accessory olfactory bulb (AOB) as it seems in the current text.

UNADDRESSED AND ADDITIONAL CONCERNS (RE-SUBMISSION)

In this revised version of the manuscript, the authors have made important modifications in the text, inserted new references, and incorporated additional quantifications of cFos immunolabeling in three brain regions, as recommended by the reviewers. While these modifications have significantly improved the quality of the manuscript, other critical concerns raised during the initial submission of the manuscript (Major concerns 1, 2, and 4; some of them also raised by the other reviewers) were not properly addressed by the authors. On several occasions, the authors recognize the importance of clarifying the points for the correct interpretation of the results but opt for leaving the open questions to be addressed during future studies. Therefore, the authors might consider adding a new section at the end of the manuscript to include all the caveats and future directions.

In addition to these unaddressed concerns, some new issues have emerged in the new version of the manuscript. For example, the following paragraph introduced in the discussion section is not supported by the experimental findings.

"We assume that such differential activations of the mitral cells between fresh and old saliva result in the differential activation of targeting neural substrates, possibly MeApv, which results in differential activation of VMH neurons (Figure 7)."

Although the authors did not observe statistical differences in cFos expression in the pvMeA among groups, they claim that the differences in cFos expression in the VMH between fresh vs. old saliva are mediated by differential activation of upstream neurons in the MeApv. The lack of statistical differences may be caused by the reduced number of subjects in each group, as recognized in the text by the authors. Moreover, the authors propose that in addition to fel d 4, multiple molecules present in the cat saliva can be inducing distinct defensive responses in the animals, but they do not provide any reference to support their claim.

Reviewer #2 (Public Review):

In this study, Nguyen et al. showed that cat saliva can robustly induce freezing behavior in mice. This effect is mediated through the accessory olfactory system as it requires physical contact and is abolished in Trp2 KO mice. The authors further showed that V2R-A4 cluster is responsive to cat saliva. Lastly, they demonstrated c-Fos induction in AOB and VMHdm/c by the cat saliva. The c-Fos level in the VMHdm/c is correlated with the freezing response.

Strength:

The study opens an interesting direction. It reveals the potential neural circuit for detecting cat saliva and driving defense behavior in mice. The behavior results and the critical role of the accessory olfactory system in detecting cat saliva are clear and convincing.

Weakness:

The findings are relatively preliminary. The identities of the receptor and the ligand in the cat saliva that induces the behavior remain unclear. The identity of VMH cells that are activated by the cat saliva remains unclear. There is a lack of targeted functional manipulation to demonstrate the role of V2R-A4 or VMH cells in the behavioral response to the cat saliva.

Reviewer #3 (Public Review):

Summary:

Nguyen et al show data indicating that the vomeronasal organ (VNO) and ventromedial hypothalamus (VMH) are part of a circuit that elicits defensive responses induced by predator odors. They also show that using fresh or old predator saliva may be a method to change the perceived imminence of predation. The authors also identify a family of VNO receptors that are activated by cat saliva. Next, the authors show how different components of this defensive circuit are activated by saliva, as measured by fos expression. Though interesting, the findings are not all integrated into a single narrative, and some of the results are only replications of earlier findings using modern methods. Overall, these findings provide incremental advance.

Strengths:

(1) Predator saliva is a stimulus of high ethological relevance

(2) The authors performed a careful quantification of fos induction across the anterior-posterior axis in figure 6

Weaknesses:

(1) It is unclear if fresh and old saliva indeed alter the perceived imminence of predation, as claimed by the authors. Prior work indicates that lower imminence induces anxiety-related actions, such as re-organization of meal patterns and avoidance of open spaces, while slightly higher imminence produces freezing. Here, the authors show that fresh and old predator saliva only provoke different amounts of freezing, rather than changing the topography of defensive behaviors, as explained above. Another prediction of predatory imminence theory would be that lower imminence induced by old saliva should produce stronger cortical activation, while fresh saliva would activate amygdala, if these stimuli indeed correspond to significantly different levels of predation imminence.

(2) It is known that predator odors activate and require AOB, VNO and VMH, thus replications of these findings are not novel, decreasing the impact of this work.

(3) There is a lack of standard circuit dissection methods, such as characterizing the behavioral effects of increasing and decreasing neural activity of relevant cell bodies and axonal projections, significantly decreasing the mechanistic insights generated by this work

(4) The correlation shown in Figure 5c may be spurious. It appears that the correlation is primarily driven by a single point (the green square point near the bottom left corner). All correlations should be calculated using Spearman correlation, which is non-parametric and less likely to show a large correlation due to a small number of outliers. Regardless of the correlation method used, there are too few points in Figure 5c to establish a reliable correlation. Please add more points to 5c.

(5) Please cite recent relevant papers showing VMH activity induced by predators, such as https://pubmed.ncbi.nlm.nih.gov/33115925/ and https://pubmed.ncbi.nlm.nih.gov/36788059/

(6) Add complete statistical information in the figure legends of all figures, which should include n, name of test used and exact p values.

(7) Some of the findings are disconnected from the story. For example, the authors show V2R-A4-expressing cells are activated by predator odors. Are these cells more likely to be connected to the rest of the predatory defense circuit than other VNO cells?

(8) Please paste all figure legends directly below their corresponding figure to make the manuscript easier to read

(9) Were there other behavioral differences induced by fresh compared to old saliva? Do they provoke differences in stretch-attend risk evaluation postures, number of approaches, average distance to odor stimulus, velocity of movements towards and away the odor stimulus, etc?

Reviewer #1 (Public Review):

Oemisch and Seo use sophisticated reinforcement learning (RL) modeling to show that acute ketamine reduces the strength impact of losses vs neutral/gains on the subsequent trial performance of a token-based biased matching-pennies task. In this version, the authors make more measured interpretations about the potential relevance of their results to ketamine's antidepressant effects for the most part.

My prior review emphasized what I considered to be an over-interpretation of the relevance of their data (that I find interesting and of value) to mechanisms of action of ketamine's antidepressant effects. The authors have corrected those excesses exception for the last sentence of the introduction, which continues to suggest they are studying both mechanisms of antidepressant actions as well as the pathophysiology of depression.

Reviewer #2 (Public Review):

Oemisch and Seo set out to examine the effects of low-dose ketamine on reinforcement learning, with the idea that alterations in reinforcement learning and/or motivation might inform our understanding of what alterations co-occur with potential antidepressant effects. Macaques performed a reinforced/punished matching pennies task while under effects of saline or ketamine administration and the data were fit to a series of reinforcement learning models to determine which model described behavior under saline most closely and then what parameters of this best-fitting model were altered by ketamine. They found a mixed effect, with two out of three macaques primarily exhibiting an effect of ketamine on the processing of losses and one out of three macaques exhibiting an effect of ketamine on processing losses and perseveration. They found that these effects of ketamine appeared to be dissociable from the nystagmus effects of the ketamine.

The findings are novel, and the data suggesting that ketamine primarily affects on the processing of losses (under the procedures used) are solid. However, it is unclear whether the connection between the processing of losses and the antidepressant effects of ketamine is justified, and the current findings may be more useful for those studying reinforcement learning than those studying depression and antidepressant effects. In addition, the co-occurrence of different behavioral procedures with different patterns of ketamine effects, with one macaque tested with different parameters than the other two exhibiting effects of ketamine that were best fit with a different model than the other two macaques, suggests that there may be difficulty in generalizing these findings to reinforcement learning more generally.

(1) First, the authors should be more explicit and careful in the connection they are trying to make about the link between loss processing and depression. The authors call their effect a "robust antidepressant-like behavioral effect." However, there are no references to support this or discussion of how the altered loss processing would relate directly to the antidepressant effects. A few statements about a link to antidepressant effects have been removed or moderated, but many remain, including those in the abstract. The authors provide little to no support for this link, so the current version represents solid evidence for an effect on loss processing and incomplete or weak evidence for an antidepressant effect.

(2) It appears that the monkey P was given smaller rewards and punishers than the other two monkeys, and this monkey had an effect of ketamine on perseveration that was not observed in the other two monkeys. This may be due to this monkey being trained and tested before the other animals, but it does raise the issue of the generality of the authors' findings. It seems possible that the procedures used for the other two monkeys (with no deviation at all) might support the best-fit model that the authors favor. However, if changes in the size of the rewards and punishments suddenly make ketamine affect perseveration, then it suggests that ketamine's effect is highly parameter-specific. For example, might there be some parameters where ketamine would only alter perseveration and not loss processing?

Reviewer #1 (Public Review):

The authors present a study of visuo-motor coupling primarily using wide-field calcium imaging to measure activity across the dorsal visual cortex. They used different mouse lines or systemically injected viral vectors to allow imaging of calcium activity from specific cell-types with a particular focus on a mouse-line that expresses GCaMP in layer 5 IT (intratelencephalic) neurons. They examined the question of how the neural response to predictable visual input, as a consequence of self-motion, differed from responses to unpredictable input. They identify layer 5 IT cells as having a different response pattern to other cell-types/layers in that they show differences in their response to closed-loop (i.e. predictable) vs open-loop (i.e. unpredictable) stimulation whereas other cell-types showed similar activity patterns between these two conditions. They also analyzed the responses to visuomotor prediction errors obtained by briefly pausing the display while the mouse is running, causing a negative prediction error, or by presenting an unpredicted visual input causing a positive prediction error. Surprisingly, they find that presentation of a visual grating actually decreases the responses of L5 IT cells in V1. They interpret their results within a predictive coding framework that the last author has previously proposed. The response pattern of the L5 IT cells leads them to propose that these cells may act as 'internal representation' neurons that carry a representation of the brain's model of its environment. Though this is rather speculative. They subsequently examine the responses of these cells to anti-psychotic drugs (e.g. clozapine) with the reasoning that a leading theory of schizophrenia is a disturbance of the brain's internal model and/or a failure to correctly predict the sensory consequences of self-movement. They find that anti-psychotic drugs strongly enhance responses of L5 IT cells to locomotion while having little effect on other cell-types. Finally, they suggest that anti-psychotics reduce long-range correlations between (predominantly) L5 cells and reduce the propagation of prediction errors to higher visual areas and suggest this may be a mechanism by which these drugs reduce hallucinations/psychosis.

This is a large study containing a screening of many mouse-lines/expression profiles using wide-field calcium imaging. Wide-field imaging has its caveats, including a broad point-spread function of the signal and susceptibility to hemodynamic artifacts, which can make the interpretation of results difficult. The authors acknowledge these problems and directly address the hemodynamic occlusion problem. It was reassuring to see supplementary 2-photon imaging of soma to complement this data-set, even though this is rather briefly described in the paper. Some comparisons in the paper are underpowered as a result of including only a small number of mice (e.g. the PV, Ntsr1 and Cux2 mice) and results involving these mice should be cautiously interpreted, but in general the results are robust. Overall the paper's strengths are its identification of a very different response profile in the L5 IT cells compared to other layers/cell-types which suggests an important role for these cells in handling integration of self-motion generated sensory predictions with sensory input. The interpretation of the responses to anti-psychotic drugs is more speculative but the result appears robust and provides an interesting basis for further studies of this effect with more specific recording techniques and possibly behavioral measures.

Reviewer #2 (Public Review):

This study by Adelus et al. profiled the transcriptome and chromatin accessibility in cultured human aortic endothelial cells (ECs) at single-cell resolution. They also stimulated these cells with EC-activating agents, such as IL1b, TGFB2, or si-EGR, to knock down this master transcription factor in ECs. The results show a subpopulation, EC3, with the highest plasticity and sensitivity to perturbations. The authors also reviewed and meta-analyzed three independent publicly available scRNA-seq datasets, identifying two distinct EC subpopulations. Additionally, they aligned CAD-related SNPs with open chromatin regions in EC subpopulations. This study provides fundamental evidence to enrich our understanding of vascular ECs and highlights potential subpopulations that may contribute to health and diseases. The work exhibits the potential impact in the field.

Comments on revised version:

I appreciate their revision, which addressed all my concerns. I understand the current technique's limitation in distinguishing bona fide cell lineages from human tissue explants, but it merits further investigation. This is because EC4 may also be involved in critical pathological processes. Again, this work established a solid foundation for exploring endothelial cell plasticity.

Reviewer #2 (Public Review):

Summary:<br /> The authors describe the discovery of a filovirus neutralizing antibody, AF03, by phage display, and its subsequent improvements to include NPC2 that resulted in greater breadth of neutralization. Overall, the manuscript is much improved from first review.

While the authors only use docking studies and this does not convincingly map the AF03 epitope, they do provide compelling evidence that residues Q128, N129, and possibly C226 are part of the epitope or at least close enough to affect binding and neutralisation. This is not conclusive support for their assumption that AF03 targets the NPC1 binding site. However, the authors do show that AF03 competes for MR78 binding to its epitope (in the NPC1 binding site), and this is enough to roughly place the epitope in this region (barring the possibility of an adjacent binding site with steric occlusion of the MR78 epitope).<br /> The authors provide evidence for broad neutralisation, and also provide good support for the internalization of AF03-NL as the mechanism for improved breadth over the original AF03 antibody.

Strengths:<br /> This study shows convincing binding to Marburgvirus GP and neutralization of Marburg viruses by AF03, as well as convincing neutralization of Ebolaviruses by AF03-NL. While there is not good separation of PE-stained populations by FACS in figure 5A, the cell staining data in Figure 5C are compelling to a non-expert in endosomal staining like myself. The control experiments in Figure 7 are compelling showing neutralization by AF03-NL but not AF03 or NPC2 alone or in combination. Altogether these data support the internalisation and stabilisation mechanism that is proposed for the gain in neutralization breadth observed for Ebolaviruses by AF03-NL over AF03 alone.

Weaknesses:<br /> To support their affinity measurements, the authors argue that they show GP is a monomer in Figure 1A by SDS-PAGE. SDS-PAGE cannot be used to assess oligomerisation of GP. Native PAGE or size exclusion profiles would have been better suited to this purpose. If affinity was calculated on a 1GP:2IgG binding sites as the authors imply, then the affinity data are incorrect due to avidity effects. As suggested by a previous reviewer, using monomeric Fab would solve this problem.

The information for figure 2 states: "we investigated if this mutated MARV species was STILL sensitive o AF-03 treatment". But, "we sought to determine whether AF-03 could impede pseudotyped MARV viral entry" only happens in Figure 3. This information for figure 3 has now already been determined in Figure 2 where wildtype MARV is neutralised (black curves) introducing redundancy. The authors should first show that AF-03 can neutralise MARV pseudotyped virus, and then assess whether mutants are STILL sensitive to AF-03.

Figure 1: The visualisation of AF03 modelling and docking is better on a white background, but still difficult to interpret as currently presented. The labels of predicted contact residues are still impossible to read, and the yellow text does not show. As suggested previously, a zoom-in showing predicted co-location with Q128 and N129 would show these data better. It would also be useful to orient the reader with respect to trimeric membrane bound GP.

Figure 2: The presentation of these data is much improved and support the text.

Figure 3: The presentation of these data is much improved and support the text.

Figure 4: The presentation of these data is much improved and support the text.

Figure 5: The presentation of these data is much improved and support the text.

Reviewer #1 (Public Review):

Aiming at the problem that Staphylococcus aureus can cause apoptosis of macrophages, the authors found and verified that drug (R)-DI-87 can inhibit mammalian deoxycytidine kinase (dCK), weaken the killing effect of staphylococcus aureus on macrophages, and reduce the apoptosis of macrophages. And increase the infiltration of macrophages to the abscess, thus weakening the damage of Staphylococcus aureus to the host. This work provides new insights and ideas for understanding the effects of Staphylococcus aureus infection on host immunity and discovering corresponding therapeutic interventions. This work is important and groundbreaking.

Comments on revised version:

The changes made by the authors addressed my previous concerns about the manuscript and greatly improved the quality of the article.

Reviewer #2 (Public Review):

Summary:

The manuscript focuses on comparison of two PLP-dependent enzyme classes that perform amino acyl decarboxylations. The goal of the work is to understand the substrate specificity and factors that influence catalytic rate in an enzyme linked to theanine production in tea plants.

Strengths:

The work includes x-ray crystal structures of modest resolution of the enzymes of interest. These structures provide the basis for design of mutagenesis experiments to test hypotheses about substrate specificity and the factors that control catalytic rate. These ideas are tested via mutagenesis and activity assays, in some cases both in vitro and in plants.

Weaknesses:

Although improved in a revision, the manuscript could be more clear in explaining the contents of the x-ray structures and how the complexes studied relate to the reactant and product complexes. The manuscript could also be more concise, with a discussion section that is largely redundant with the results and lacking in providing scholarly context from the literature to help the reader understand how the current findings fit in with work to characterize other PLP-dependent enzymes or protein engineering efforts. Some of the figures lack sufficient clarity and description. Some of the claims about the health benefits of tea are not well supported by literature citations.

Reviewer #3 (Public Review):

In the manuscript titled "Structure and Evolution of Alanine/Serine Decarboxylases and the Engineering of Theanine Production," Wang et al. solved and compared the crystal structures of Alanine Decarboxylase (AlaDC) from Camellia sinensis and Serine Decarboxylase (SerDC) from Arabidopsis thaliana. Based on this structural information, the authors conducted both in vitro and in vivo functional studies to compare enzyme activities using site-directed mutagenesis and subsequent evolutionary analyses. This research has the potential to enhance our understanding of amino acid decarboxylase evolution and the biosynthetic pathway of the plant specialized metabolite theanine, as well as to further its potential applications in the tea industry.

Reviewer #1 (Public Review):

Summary

The authors investigated the antigenic diversity of recent (2009-2017) A/H3N2 influenza neuraminidases (NAs), the second major antigenic protein after haemagglutinin. They used 27 viruses and 43 ferret sera and performed NA inhibition. This work was supported by a subset of mouse sera. Clustering analysis determined 4 antigenic clusters, mostly in concordance with the genetic groupings. Association analysis was used to estimate important amino acid positions, which were shown to be more likely close to the catalytic site. Antigenic distances were calculated and a random forest model used to determine potential important sites.

This revision has addressed many of my concerns of inconsistencies in the methods, results and presentation. There are still some remaining weaknesses in the computational work.

Strengths

(1) The data cover recent NA evolution and a substantial number (43) of ferret (and mouse) sera were generated and titrated against 27 viruses. This is laborious experimental work and is the largest publicly available neuraminidase inhibition dataset that I am aware of. As such, it will prove a useful resource for the influenza community.

(2) A variety of computational methods were used to analyse the data, which give a rounded picture of the antigenic and genetic relationships and link between sequence, structure and phenotype.

(3) Issues raised in the previous review have been thoroughly addressed.

Weaknesses

(1) Some inconsistencies and missing data in experimental methods<br /> Two ferret sera were boosted with H1N2, while recombinant NA protein for the others. This, and the underlying reason, are clearly explained in the manuscript. The authors note that boosting with live virus did not increase titres. Additionally, one homologous serum (A/Kansas/14/2017) was not generated, although this would not necessarily have impacted the results.

(2) Inconsistency in experimental results<br /> Clustering of the NA inhibition results identifies three viruses which do not cluster with their phylogenetic group. Again this is clearly pointed out in the paper and is consistent with the two replicate ferret sera. Additionally, A/Kansas/14/2017 is in a different cluster based on the antigenic cartography vs the clustering of the titres

(3) Antigenic cartography plot would benefit from documentation of the parameters and supporting analyses<br /> a. The number of optimisations used<br /> b. The final stress and the difference between the stress of the lowest few (e.g. 5) optimisations, or alternatively a graph of the stress of all the optimisations. Information on the stress per titre and per point, and whether any of these were outliers<br /> c. A measure of uncertainty in position (e.g. from bootstrapping)

(4) Random forest<br /> The full dataset was used for the random forest model, including tuning the hyperparameters. It is more robust to have a training and test set to be able to evaluate overfitting (there are 25 features to classify 43 sera).

Reviewer #2 (Public Review):

Summary:<br /> The authors characterized the antigenicity of N2 protein of 43 selected A(H3N2) influenza A viruses isolated from 2009-2017 using ferret and mice immune sera. Four antigenic groups were identified, which the authors claimed to be correlated with their respective phylogenic/ genetic groups. Among 102 amino acids differed by the 44 selected N2 proteins, the authors identified residues that differentiate the antigenicity of the four groups and constructed a machine-learning model that provides antigenic distance estimation. Three recent A(H3N2) vaccine strains were tested in the model but there was no experimental data to confirm the model prediction results.

Strengths:<br /> This study used N2 protein of 44 selected A(H3N2) influenza A viruses isolated from 2009-2017 and generated corresponding panels of ferret and mouse sera to react with the selected strains. The amount of experimental data for N2 antigenicity characterization is large enough for model building.

Weaknesses:<br /> The main weakness is that the strategy of selecting 43 A(H3N2) viruses from 2009-2017 was not explained. It is not clear if they represent the overall genetic diversity of human A(H3N2) viruses circulating during this time. In response to the reviewer's comment, the authors have provided a N2 phylogenetic tree using180 randomly selected N2 sequences from human A(H3N2) viruses from 2009-2017. While the 43 strains seems to scatter across the N2 tree, the four antigenic groups described by the author did not correlated with their respective phylogenic/ genetic groups as shown in Fig. 2. The authors should show the N2 phylogenic tree together with Fig. 2 and discuss the discrepancy observed.

The second weakness is the use of double-immune ferret sera (post-infection plus immunization with recombinant NA protein) or mouse sera (immunized twice with recombinant NA protein) to characterize the antigenicity of the selected A(H3N2) viruses. Conventionally, NA antigenicity is characterized using ferret sera after a single infection. Repeated influenza exposure in ferrets has been shown to enhance antibody binding affinity and may affect the cross-reactivity to heterologous strains (PMID: 29672713). The increased cross-reactivity is supported by the NAI titers shown in Table S3, as many of the double immune ferret sera showed the highest reactivity not against its own homologous virus but to heterologous strains. In response to the reviewer's comment, the authors agreed the use of double-immune ferret sera may be a limitation of the study. It would be helpful if the authors can discuss the potential effect on the use of double-immune ferret sera in antigenicity characterization in the manuscript.

Another weakness is that the authors used the newly constructed a model to predict antigenic distance of three recent A(H3N2) viruses but there is no experimental data to validate their prediction (eg. if these viruses are indeed antigenically deviating from group 2 strains as concluded by the authors). In response to the comment, the authors have taken two strains out of the dataset and use them for validation. The results is shown as Fig. R7. However, it may be useful to include this in the main manuscript to support the validity of the model.

Reviewer #3 (Public Review):

Summary:<br /> This paper by Portela Catani et al examines the antigenic relationships (measured using monotypic ferret and mouse sera) across a panel of N2 genes from the past 14 years, along with the underlying sequence differences and phylogenetic relationships. This is a highly significant topic given the recent increased appreciation of the importance of NA as a vaccine target, and the relative lack of information about NA antigenic evolution compared with what is known about HA. Thus, these data will be of interest to those studying the antigenic evolution of influenza viruses. The methods used are generally quite sound, though there are a few addressable concerns that limit the confidence with which conclusions can be drawn from the data/analyses.

Strengths:<br /> -The significance of the work, and the (general) soundness of the methods.<br /> -Explicit comparison of results obtained with mouse and ferret sera

Weaknesses:<br /> - Approach for assessing influence of individual polymorphisms on antigenicity does not account for potential effects of epistasis (this point is acknowledged by the authors).<br /> - Machine learning analyses neither experimentally validated nor shown to be better than simple, phylogenetic-based inference.

Reviewer #1 (Public Review):

Summary:

The investigators employed multi-omics approach to show the functional impact of partial chemical reprogramming in fibroblasts from young and aged mice.

Strengths:

Multi-omics data was collected, including epigenome, transcriptome, proteome, phosphoproteome, and metabolome. Different analyses were conducted accordingly, including differential expression analysis, gene set enrichment analysis, transcriptomic and epigenetic clock-based analyses. The impact of partial chemical reprogramming on aging was supported by these multi-source results.

Reviewer #2 (Public Review):

The short-term administration of reprogramming factors to partially reprogram cells has gained traction in recent years as a potential strategy to reverse aging in cells and organisms. Early studies used Yamanaka factors in transgenic mice to reverse aging phenotypes, but chemical cocktails could present a more feasible approach for in vivo delivery. In this study, Mitchell et al sought to determine the effects that short-term administration of chemical reprogramming cocktails have on biological age and function. To address this question, they treated young and old mouse fibroblasts with chemical reprogramming cocktails and performed transcriptome, proteome, metabolome, and DNA methylation profiling pre- and post-treatment. For each of these datasets, they identified changes associated with treatment, showing downregulation of some previously identified molecular signatures of aging in both young and old cells. From these data, the authors conclude that partial chemical reprogramming can rejuvenate both young and old fibroblasts.

The main strength of this study is the comprehensive profiling of cells pre- and post-treatment with the reprogramming cocktails, which will be a valuable resource for better understanding the molecular changes induced by chemical reprogramming. The authors highlighted consistent changes across the different datasets that are thought to be associated with aging phenotypes, showing reduction of age-associated signatures previously identified in various tissues.

Reviewer #1 (Public Review):

Summary:

The authors identified that genetically and pharmacological inhibition of CERS1, an enzyme implicated in ceramides biosynthesis worsen muscle fibrosis and inflammation during aging.

Strengths:

The study points out an interesting issue on excluding CERS1 inhibition as a therapeutic strategy for sarcopenia. Overall, the article it's well written and clear.

Reviewer #2 (Public Review):

Summary:

The manuscript by Wohlwend et al. investigates the implications of inhibiting ceramide synthase Cers1 on skeletal muscle function during aging. The authors propose a role for Cers1 in muscle myogenesis and aging sarcopenia. Both pharmacological and AAV-driven genetic inhibition of Cers1 in 18-month-old mice lead to reduced C18 ceramides in skeletal muscle, exacerbating age-dependent features such as muscle atrophy, fibrosis, and center-nucleated fibers. Similarly, inhibition of the Cers1 orthologue in C. elegans reduces motility and causes alterations in muscle morphology.

Strengths:

The study is well-designed, carefully executed, and provides highly informative and novel findings that are relevant to the field.

Reviewer #1 (Public Review):

Summary:

In this manuscript, the authors used machine learning algorithm to analyze published exosome datasets to find biomarkers to differentiate exosomes of different origin. By applying the method to "exosomes" sample, the author discovered common exosome markers and cancer-type specific markers.

Strengths:

The performance of the algorithm are generally of good quality.

Reviewer #2 (Public Review):

Summary:

This is a fine work on the development of computational approaches to detect cancer through exosomes. Exosomes are an emerging biomarker resource and have attracted considerable interests in the biomedical field. Kalluri and co-workers collected a large sample pool and used random forest to identify a group of protein markers that are universal to exosomes and to cancer exosomes. The results are very exciting and not only added new knowledge in cancer research but also a new and advanced method to detect cancer. Data was presented very nicely and the manuscript was well written.

Strengths:

Identified new biomarkers for cancer diagnosis via exosomes.<br /> Developed a new method to detect cancer noninvasively.<br /> Results were presented nicely and manuscript were well written.

Reviewer #1 (Public Review):

As a pathogen, S. aureus has evolved strategies to evade the host's immune system. It effectively remains 'under the radar' in the host until it reaches high population densities, at which point it triggers virulence mechanisms, enabling it to spread within the host. The agr quorum sensing system is central to this process, as it coordinates the pathogen's virulence in response to its cell density.

In this study, Podkowik and colleagues suggest that cells activating agr signaling also benefit from protection against H2O2 stress, whereas inactivation of agr increases cell death. The underlying cause of this lack of protection is tied to an ATP deficit in the agr mutant, leading to increased glucose consumption and NADH production, ultimately resulting in a redox imbalance. In response to this imbalance, the agr mutant increases respiration, resulting in the endogenous production of ROS which synergizes with H2O2 to mediate killing of the agr mutant. Suppressing respiration in the agr mutant restored protection against H2O2 stress.

Additionally, the authors establish that agr-dependent protection against oxidative stress is also linked to RNAIII activation, and the subsequent block of Rot translation. However, the specific protective genes regulated by Rot remain unidentified. Thus, according to the evidence provided, agr triggers intrinsic mechanisms that not only decrease harmful ROS production within the cell but also alleviate its detrimental effects.

Interestingly, these protective mechanisms are long-lived, and guard the cells against external oxidative stressors such as H2O2, even after the agr system has been 'turned off' in the population.

While the study offers valuable insight into how agr signaling protects cells against H2O2 stress, a reevaluation of the interpretation of redox imbalance is warranted.

Reviewer #2 (Public Review):

In their study, Podkowik et al. elucidate the protective role of the accessory gene regulator (agr) system in Staphylococcus aureus against hydrogen peroxide (H2O2) stress. Their findings demonstrate that agr safeguards the bacterium by controlling the accumulation of reactive oxygen species (ROS), independent of agr activation kinetics. This protection is facilitated through a regulatory interaction between RNAIII and Rot, impacting virulence factor production and metabolism, thereby influencing ROS levels. Notably, the study highlights the remarkable adaptive capabilities of S. aureus conferred by agr. The protective effects of agr extend beyond the peak of agr transcription at high cell density, persisting even during the early log-phase. This indicates the significance of agr-mediated protection throughout the infection process. The absence of agr has profound consequences, as observed by the upregulation of respiration and fermentation genes, leading to increased ROS generation and subsequent cellular demise. Interestingly, the study also reveals divergent effects of agr deficiency on susceptibility to hydrogen peroxide compared to ciprofloxacin. While agr deficiency heightens vulnerability to H2O2, it also upregulates the expression of bsaA, countering the endogenous ROS induced by ciprofloxacin. These findings underscore the complex and context-dependent nature of agr-mediated protection. Furthermore, in vivo investigations using murine models provide valuable insights into the importance of agr in promoting S. aureus fitness, particularly in the context of neutrophil-mediated clearance, with notable emphasis on the pulmonary milieu. Overall, this study significantly advances our understanding of agr-mediated protection in S. aureus and sheds light on the sophisticated adaptive mechanisms employed by the bacterium to fortify itself against oxidative stress encountered during infection.

The conclusions drawn in this paper are generally well-supported by the data. To enhance the clarity of the study, it is recommended that the authors consider refraining from combining the data for lactate production during microaerobic growth with the remaining data obtained for aerobic growth. Different aeration conditions can significantly impact the metabolic status of the cells.

In this regard, the statement, "Collectively, these data suggest that Δagr increases respiration and aerobic fermentation to compensate for low metabolic efficiency," might be potentially misleading and could benefit from a revision to accurately reflect the nuances of the experimental conditions.

Additionally, the authors' statement, 'The tendency of Δagr cells to forgo the additional ATP yield from acetate production in favor of NAD+-generating lactate (23, 24) underscores the importance of redox balance in Δagr cells,' appears contradictory to the data presented in Fig 5, where the Δagr mutant demonstrates an approximately threefold increase in acetate production during exponential growth compared to the wild-type strain. A clarification or adjustment in the manuscript may be necessary to ensure consistency and accurate interpretation.

Furthermore, the authors' statement, 'Collectively, these observations suggest that a surge in NADH consumption and reductive stress in the Δagr strain induces a burst in respiration, but levels of NADH are saturating, thereby driving fermentation in the presence of oxygen,' may need revision. Data presented in Figure 5 suggest the opposite - a surge in NADH accumulation leading to a decrease in the NAD/NADH ratio, rather than a surge in the 'consumption' of NADH. Clarifying this point in the manuscript would ensure accurate representation of the findings.

The authors attention to these matters would greatly contribute to the precision and clarity of the findings.

Reviewer #2 (Public Review):

In a study by Shen et al.. al., the authors investigated YAP/TAZ target genes that play a role in the formation of processing bodies (P-bodies). P-bodies are membraneless cytoplasmic granules that contain translationally repressed mRNAs and components of mRNA turnover. GO enrichment analysis of the RNA-Seq data of colorectal cancer cells (HCT116) after YAP/TAZ knockdown showed that the downregulated genes were enriched in P-body resident proteins. Overexpression, knockdown, and ChIP-qPCR analyses showed that SAMD4A, PNRC1, AJUBA, and WTIP are YAP-TEAD target genes that also play a role in P-body biogenesis. Using P-body markers such as DDX6 and DCP1A, the authors showed that knockdown of YAP in the HCT116 cell line causes a reduction in the number of P-bodies. Similarly, overexpression of constitutively active YAP (YAP 5SA) increased the P-body number. The YAP-TEAD target genes SAMD4A and AJUBA positively regulate P-body formation, because lowering their expression levels using siRNA reduces the number of P-bodies. The other YAP target gene, PNRC1, is a negative regulator of P-body biogenesis and consistently YAP suppresses its expression through the recruitment of the NuRD complex. YAP target genes that modulate P-body formation play prominent roles in oncogenesis. PNRC1 suppression is key to YAP-mediated proliferation, colony formation, and tumorigenesis in HCT116 xenografts. Similarly, SAMD4 and AJUBA knockdown abrogated cell viability. In summary, this study demonstrated that SAMD4, AJUBA, WTIP, and PNRC1 are bona fide YAP-TEAD target genes that play a role in P-body formation, which is also linked to the oncogenesis of colon cancer cells.

Major Strengths:

The majority of the experiments were appropriately planned so that the generated data could support the conclusions drawn by the authors. The phenotype observed with YAP/TAZ knockdown correlated inversely with YAP5SA overexpression, which is complementary. Where possible, the authors also used point mutations that selectively disrupt protein-protein interactions, such as YAP S94A and PNRC1 W300A. The CRC cell line HCT116 was used throughout the study; additionally, data from other cancer cell lines were used to support the generality of the findings.

Weaknesses:

The authors did not elucidate the mechanistic link between P-body formation and oncogenesis; therefore, it is unclear why an increase in the number of P-bodies is pro-tumorigenic. The authors extrapolated and suggested that PNRC1 expression could be exploited therapeutically, without providing much detail. How do they plan to stimulate the expression of PNRC1? It is not necessary for every scientific finding to lead to a therapeutic benefit; therefore, they can tone down such statements if therapeutic exploitation is not realistic. The authors elucidated a mechanism for PNRC1 repression and one wonders why no attempts were made to understand the mechanism of activation of SAMD4, AJUBA, and WTIP expression.

Reviewer #1 (Public Review):

In this study, the authors investigate the role of triglycerides in spermatogenesis. This work is based on their previous study (PMID: 31961851) on triglyceride sex differences in which they showed that somatic testicular cells play a role in whole body triglyceride homeostasis. In the current study, they show that lipid droplets (LDs) are significantly higher in the stem and progenitor cell (pre-meiotic) zone of the adult testis than in the meiotic spermatocyte stages. The distribution of LDs anti-correlates with the expression of the triglyceride lipase Brummer (Bmm), which has higher expression in spermatocytes than early germline stages. Analysis of a bmm mutant (bmm[1]) - a P-element insertion that is likely a hypomorphic - and its revertant (bmm[rev]) as a control shows that bmm acts autonomously in the germline to regulate LDs. In particular, the number of LDs is significantly higher in spermatocytes from bmm[1] mutants than from bmm[rev] controls. Testes from males with global loss of bmm (bmm[1]) are shorter than controls and have fewer differentiated spermatids. The zone of bam expression, typically close to the niche/hub in WT, is now many cell diameters away from the hub in bmm[1] mutants. There is an increase in the number of GSCs in bmm[1] homozygotes, but this phenotype is probably due to the enlarged hub. However, clonal analyses of GSCs lacking bmm indicate that a greater percentage of the GSC pool is composed of bmm[1]-mutant clones than of bmm[rev]-clones. This suggests that loss of bmm could impart a competitive advantage to GSCs, but this is not explored in greater detail. Despite the increase in number of GSCs that are bmm[1]-mutant clones, there is a significant reduction in the number of bmm[1]-mutant spermatocyte and post-meiotic clones. This suggests that fewer bmm[1]-mutant germ cells differentiate than controls. To gain insights into triglyceride homeostasis in the absence of bmm, they perform mass spec-based lipidomic profiling. Analyses of these data support their model that triglycerides are the class of lipid most affected by loss of bmm, supporting their model that excess triglycerides are the cause of spermatogenetic defects in bmm[1]. Consistent with their model, a double mutant of bmm[1] and a diacylglycerol O-acyltransferase 1 called midway (mdy) reverts the bmm-mutant germline phenotypes.

There are numerous strengths of this paper. First, the authors report rigorous measurements and statistical analyses throughout the study. Second, the authors utilize robust genetic analyses with loss-of-function mutants and lineage-specific knockdown. Third, they demonstrate the appropriate use of controls and markers. Fourth, they show rigorous lipidomic profiling. Lastly, their conclusions are appropriate for the results. In other words, they don't over-state the results. Overall, the rigorously quantified results support the major aim that appropriate regulation of triglycerides are needed in a germline cell-autonomous manner for spermatogenesis.

This paper should have a positive impact on the field. First and foremost, there is limited knowledge about the role of lipid metabolism in spermatogenesis. The lipidomic data will be useful to researchers in the field who study various lipid species. Going forward, it will be very interesting to determine what triglycerides regulate in germline biology. In other words, what functions/pathways/processes in germ cells are negatively impacted by elevated triglycerides. And as the authors point out in the discussion, it will be important to determine what regulates bmm expression such that bmm is higher in later stages of germline differentiation.

Reviewer #2 (Public Review):

Summary:

Here, the authors show that neutral lipids play a role in spermatogenesis. Neutral lipids are components of lipid droplets, which are known to maintain lipid homeostasis, and to be involved in non-gonadal differentiation, survival, and energy. Lipid droplets are present in the testis in mice and Drosophila, but not much is known about the role of lipid droplets during spermatogenesis. The authors show that lipid droplets are present in early differentiating germ cells, and absent in spermatocytes. They further show a cell autonomous role for the lipase brummer in regulating lipid droplets and, in turn, spermatogenesis in the Drosophila testis. The data presented show that a relationship between lipid metabolism and spermatogenesis is congruous in mammals and flies, supporting Drosophila spermatogenesis as an effective model to uncover the role lipid droplets play in the testis.

Strengths and weaknesses:

The authors do a commendably thorough characterization of where lipid droplets are detected in normal testes: located in young somatic cells, and early differentiating germ cells. They use multiple control backgrounds in their analysis, including w[1118], Canton S, and Oregon R, which adds rigor to their interpretations. The authors employ markers that identify which lipid droplets are in somatic cells, and which are in germ cells. The authors use these markers to present measured distances of somatic and germ cell-derived lipid droplets from the hub. Because they can also measure the distance of somatic and germ cells with age-specific markers from the hub, these results allow the authors to correlate position of lipid droplets with the age of cells in which they are present. This analysis is clearly shown and well quantified.

The quantification of lipid droplet distance from the hub is applied well in comparing brummer mutant testes to wild type controls. The authors measure the number of lipid droplets of specific diameters, and the spatial distribution of lipid droplets as a function of distance from the hub. These measurements quantitatively support their findings that lipid droplets are present in an expanded population of cells further from the hub in brummer mutants. The authors further quantify lipid droplets in germline clones of specified ages; the quantitative analysis here is displayed clearly and supports a cell autonomous role for brummer in regulating lipid droplets in spermatocytes.

Data examining testis size and number of spermatids in brummer mutants clearly indicates the importance of regulating lipid droplets to spermatogenesis. The authors show beautiful images supported by rigorous quantification supporting their findings that brummer mutants have both smaller testes with fewer spermatids at both 29 and 25C. There is also significant data supporting defects in testis size, but not spermatid number, in 14-day-old brummer mutant animals compared to controls. Their analysis clearly shows an expanded region beyond the testis apex that includes younger germ cells, supporting a role for lipid droplets influencing germ cell differentiation during spermatogenesis.

The authors present a series of data exploring a cell autonomous role for brummer in the germline, including clonal analysis and tissue specific manipulations. The clonal data indicating increased lipid droplets in spermatocyte clones, and a higher proportion of brummer mutant GSCs at the hub are convincing and supported by quantitation. The authors also show a tissue specific rescue of the brummer testis size phenotype by knocking down mdy specifically in germ cells, which is also supported by statistically significant quantitation. The authors present data examining the number of spermatocyte and post-meiotic clones 14 days after clonal induction. Their finding is significant with a p-value of 0.0496, which they acknowledge is less robust than their other data reported in this study, and could be a result of a low sample size. They indicate that future studies might validate these results with additional samples.

The authors do a beautiful job of validating where they detect brummer-GFP by presenting their own pseudotime analysis of publicly available single cell RNA sequencing data. Their data is presented very clearly, and supports expression of brummer in older somatic and germline cells of the age when lipid droplets are normally not detected. The authors also present a thorough lipidomic analysis of animals lacking brummer to identify triglycerides as an important lipid droplet component regulating spermatogenesis.

Impact:

The authors present data supporting the broad significance of their findings across phyla. This data represents a key strength of this manuscript. The authors show that loss of a conserved triglyceride lipase impacts testis development and spermatogenesis, and that these impacts can be rescued by supplementing diet with medium-chain triglycerides. The authors point out that these findings represent a biological similarity between Drosophila and mice, supporting the relevance of the Drosophila testis as a model for understanding the role of lipid droplets in spermatogenesis. The connection buttresses the relevance of these findings and this model to a broad scientific community.

Reviewer #2 (Public Review):

Summary:

In the manuscript, Yu et al reported a two-sample Mendelian randomization study to evaluate the causation between polyunsaturated fatty acids (PUFA) and cerebral aneurysm, based on summary statistics from published genome-wide association studies. The authors identified that omega-3 fatty acids and Docosahexaenoic acid decreased the risk for intracranial aneurysm (IA) and aneurysmal subarachnoid hemorrhage (aSAH). COLOC analysis suggested that the acids and IA, aSAH likely share causal variants in gene fatty acid desaturase 2.

Strengths:

The methodology is sound, with appropriate sensitivity analysis.

Weaknesses:

The results did not provide significant novel findings. The interpretation of the results is not sound.

Reviewer #1 (Public Review):

Summary:

The authors performed two-sample MR combined with sensitivity analyses and colocalization to test the effect of PUFA on cerebral aneurysms. They found that genetically predicted omega-3 and DHA decreased the risk for intracranial aneurysm (IA) and subarachnoid haemorrhage (SAH) but not for unruptured IA (uIA).

Strengths:

PUFA on the risk of cerebral aneurysms is of clinical importance; the authors performed multiple sensitivity analyses to ensure MR fulfills its assumptions.

Weakness:

In my opinion, the major weakness is the selection of IVs, the same IVs should be used for each exposure, especially when the outcomes (IA, SAH, and uIA) are closely related. The removal of IVs was inconsistent, for example, why was LPA rs10455872 removed for SAH but not for uIA? (significantly more IVs were used for uIA). The authors should provide more details for the justification of the removal of IVs other than only indicating "confounder" in supplementary tables. The authors should also perform additional analyses including all IVs and IVs from other PUFA GWAS.

In addition, it seems that the SNPs in the FADS locus were driving the MR association, while FADS is a very pleiotropic locus associated with many lipid traits, removing FADS could attenuate the MR effect. The authors should perform a sensitivity analysis to remove this locus.

Instead of removing multiple "confounder" IVs which I think may bias the MR results due to very closely related lipid traits, the authors should perform multivariable MR to identify independent effects of PUFAs to IA, conditioning on other PUFAs and/or other lipids.

Colocalization was not well described, the authors should include the colocalization results for each locus in a supplementary table. They also mentioned "a large PP for H4 (PP.H4 above 0.75) strongly supports shared causal variants affecting both gene expression and phenotype". The authors should make sure that the colocalization was performed using the expression data of each gene or using the GWAS summary of each PUFA locus.

Reviewer #2 (Public Review):

Significance of the findings:

In this study, blood donors were assessed using serology and viral neutralization assays to determine the prevalence of SARS-CoV-2 antibodies. S1 and NCP antibodies were used to distinguish between vaccination and natural infection and virus-specific neut titers were used to determine which variants the antibodies respond to. The study reports almost universal antibody prevalence and increases in antibodies against specific variants at different points corresponding to circulating variants identified phylogenetically in neighbouring countries. The authors propose this approach for settings like Bolivia where genetic sequencing is not readily available. Unfortunately, there are significant limitations to this approach that limit its utility - serological data are available after the fact in a fast-moving pandemic and so are a poor alternative to phylogenetic data. Rather, serological information can supplement phylogenetic data and is most useful in estimating population-level immunity.

(1) Considerations in interpreting the results:

a. Serology provides different information to phylogenetic sequencing of the viruses and so both are important. Viral sequencing provides real-time information on circulating variants and indicates the proportion of each variant in circulation at any point as there are almost always multiple variants spreading but it is the fastest spreading variant that comes to dominate. Importantly serology measures asymptomatic infections as well, providing population estimates of infection that are not available through viral gene sequencing.

b. A major concern in the interpretation of serology is that antibody titers vary markedly over time with rapid declines in the first year post-infection or post-vaccination. However, these declines vary depending on whether hybrid immunity is present. Disentangling this retrospectively is a challenge. A low antibody titer could reflect an infection that occurred a few months ago but may be below the threshold for positivity at the time of testing. There is also substantial individual variability in antibody responses.

c. Serology becomes increasingly difficult to untangle when an individual has had doses of vaccine and multiple natural infections with different variants. Due to the importance of hybrid immunity in population risk to new variants, it would be useful for estimates of hybrid immunity to be generated based on anti-S1 and anti-NCP antibodies. From a population immunity perspective, this could be important in guiding future protection and boosting strategies.

d. Since there is cross-neutralization by the antibodies stimulated by each variant, it is important to establish the sensitivity and specificity of each of the neutralization assays in a panel comprising multiple variants. An assessment of the accuracy of the neut assay for each variant is needed to be confident that it is able to distinguish between variants.

e. Blood donors are notoriously poor representations of the general population in many countries, driven partly by whether donation is financially rewarded. For example, in the USA, drug addicts are disproportionately over-represented in blood donor populations as they use it as a source of money. The authors provide no information on whether the blood donor population in Bolivia is representative of the entire population. Comparison of the prevalence of specific disease markers in the general population and in blood donors could provide a signal of their comparability.

(2) Please provide the sensitivity and specificity of each of the assays so that the reader can assess the degree of accuracy in the assay that claims that the prevalent antibodies are due to, for example, omicron.

(3) Please provide an assessment of the representativity of the blood donor population eg. Is the prevalence of hepatitis B serological markers in the blood donor population comparable with the prevalence of hepatitis B serological markers in the general population from community-based studies?

Reviewer #1 (Public Review):

Summary:

This study provides valuable and comprehensive information about the SARS-CoV-2 seroprevalence during 2021 and 2022 in different regions of Bolivia. Moreover, data on immune responses against the SARS-CoV-2 variants based on neutralization tests denotes the presence of several virus variants circulating in the Bolivian population. Evidence for seroprevalence data provided by the authors is solid, across the study period, while data regarding variant circulation is limited to the early stages of the pandemic.

Strengths:

The major strength of this study is that it provided nationwide seroprevalence estimates from infection and/or vaccination based on antibodies against both spike and the nucleocapsid protein in a large representative sample of sera collected at two time-points from all departments of Bolivia, gaining insight into COVID-19 epidemiology. On the other hand, data from virus neutralization assays inferred the circulation during the study period of four SARS-CoV-2 variants in the population. Overall, the study results provide an overview of the level of viral transmission and vaccination and insights into the spread across the country of SARS-CoV-2 variants.

Weaknesses:

The assessment of a Lambda variant that circulated in several neighboring countries (Peru, Chile, and Argentina), which had a significant impact on the COVID-19 pandemic in the region, may have strengthened the study to contrast Gamma spread. In addition, even though neutralizing antibodies can certainly reveal previous infections of SARSCOV2 variants in the population, it is of limited value to infer from this information some potential timing estimates of specific variant circulation, considering the heterogeneous effects that past infections, vaccinations, or a combination of both could have on the level of variant-specific neutralizing antibodies and/or their cross-neutralization capacity.

An appraisal of whether the authors achieved their aims, and whether the results support their conclusions:

The conclusions of this paper are well supported by data, particularly regarding seroprevalence that reliably reflects the epidemiology of COVID-19 in Bolivia, and seroprevalence trends in other low- and middle-income countries.

A discussion of the likely impact of the work on the field, and the utility of the methods and data to the community:

Since this is the first study that has been conducted to assess indicators of immunity against SARS-CoV-2 in the population of Bolivia at a nationwide scale, seroprevalence data provided by geographic regions at two time-points can be useful as a reference for potential retrospective global meta-analysis and further explore and compare the risk factors for infection, variant distribution, and the impact on infection and vaccination, gaining deeper insights into understanding the evolution of the COVID-19 pandemic in Bolivia and in the region.

Reviewer #1 (Public Review):

Summary:<br /> This research used cell-based signaling assay and Gaussian-accelerated molecular dynamics (GaMD) to study peptide-mediated signaling activation of Polycystin-1 (PC1), which is responsible for the majority of autosomal dominant polycystic kidney disease (ADPKD) cases. Synthetic peptides of various lengths derived from the N-terminal portion of the PC1 C-terminal fragment (CTF) were applied to HEK293T cells transfected with stalkless mouse CTF expression construct. It was shown that peptides including the first 7, 9, and 17 residues of the N-terminal portion could activate signaling to the NFAT reporter. To further understand the underlying mechanism, docking and peptide-GaMD simulations of peptides composed of the first 9, 17, and 21 residues from the N-terminal portion of the human PC1 CTF were performed. These simulations revealed the correlation between peptide-CTF binding and PC1 CTF activation characterized by the close contact (salt bridge interaction) between residues R3848 and E4078. Finally, a Potts statistical model was inferred from diverged PC1 homologs to identify strong/conserved interacting pairs within PC1 CTF, some of which are highly relevant to the findings from the peptide GaMD simulations. The peptide binding pockets identified in the GaMD simulations may serve as novel targets for the design of therapeutic approaches for treating ADPKD.

Strengths:<br /> (1) The experimental and computational parts of this study complement and mostly support each other, thus increasing the overall confidence in the claims made by the authors.

(2) The use of exogenous peptides and a stalkless CTF in the GaMD is a step forward compared to earlier simulations using the full CTF, CTF mutants, or the stalkless CTF alone. And it led to findings of novel binding pockets.

(3) Since the PC1 shares characteristics with the Adhesion class of GPCRs, the approaches used in this work may be extended to other similar systems.

Weaknesses:<br /> (1) The GaMD simulations all include the exogenous peptides, thus lacking a control where no such peptide is present (and only stalkless CTF). An earlier study (PNAS 2022 Vol. 119 No. 19 e2113786119) covered this already but it should be mentioned here that there was no observation of close/activation for the stalkless CTF.

(2) Although 5 independent trajectories were generated for each peptide, the authors did not provide sufficient details regarding the convergence of the simulation. This leaves some uncertainties in their results. Given that the binding poses changed relative to the starting docked poses for all three peptides, it is possible that some other binding pockets and/or poses were not explored.

(3) The free energy profiles (Figures 2 to 4) based on the selected coordinates provide important information regarding binding and CTF conformational change. However, it is a coarse-grained representation and complementary analysis such as RDFs, and/or contact maps between the peptide and CTF residues might be helpful to understand the details of their interactions. These details are currently only available in the text.

(4) The use of a stalkless CTF is necessary for studying the functions of the exogenous peptides. However, the biological relevance of the stalkless CTF to ADPKD was not clearly explained, if any.

Reviewer #2 (Public Review):

Summary:<br /> The autosomal dominant polycystic kidney disease (ADPKD) is a major form of polycystic kidney disease (PKD). To provide better treatment and avoid side effects associated with currently available options, the authors investigated an interesting GPCR, polycystin-1 (PC1), as a potential therapeutic target. In vitro and in silico studies were combined to identify peptide agonists for PC1 and to elucidate their roles in PC1 signaling. Overall, regarding the significance of the findings, this work described valuable peptide agonists for PC1 and the combined in vitro and in silico approach can be useful to study a complex system like PC1. However, the strength of the evidence is incomplete, as more experiments are needed as controls to validate the computational observations. The work appears premature.

Strengths:<br /> (1) This work first described the experimental discovery of short peptides designed to mimic the stalk region of PC1, followed by computational investigation using docking and MD simulations. PC1 is a complex membrane protein and an emerging target for ADPKD, but it can be challenging to study. The knowledge and the peptide discovery can be valuable and useful to understand the mechanism and potential modulation of PC1.

(2) The authors published the mechanistic study of PC1 and identified key interacting residues such as N3074-S3585 and R3848-E4078, using very similar techniques (PNAS 2022, 119(19), e2113786119). This work furthers this research by identifying peptides that are stalk mimics for PC1 activation.

(3) Eight peptides were designed and tested experimentally first; three were computationally studied with docking and GaMD simulations to understand their mechanism (s).

Weaknesses:<br /> (1) The therapeutic potential of PC1 peptide agonists is unclear in the introduction. For example, while the FDA-approved drug Jynarque was mentioned, the text was misleading as it sounded like Jynarque targeted PC1. In fact, it targets another GPCR, the vasopressin receptor 2 (V2). A clear comparison of targeting PC1 over V2 pathways and their therapeutic relevance can help the readers better understand the importance of this work. Importantly, a clear background on the relationship between PC1 agonism and treatments for ADPKD is necessary.

(2) PC1 is a complex membrane protein, and most figures focus on the peptide-binding site. For general readers (or readers that did not read the previous PNAS publication), it is hard to imagine the overall structure and understand where the key interactions (e.g., R3848-E4078) are in the protein and how peptide binding affects locally and globally. I suggest enhancing the illustrations.

(3) The authors used the mouse construct for the cellular assays and the peptide designs in preparation for future in vivo assays. This is helpful in understanding biology, but the relevance of drug discovery is weakened. Related to Point 1, the therapeutic potential of PC1 peptide agonist is largely missing.

(4) More control experiments are needed. For example, a 7-residue hydrophilic sequence (GGKKKKK) is attached to the peptide design to increase solubility. This 7-residue peptide should be tested for PC1 activation as a control. Second, there is no justification for why the peptide design must begin with residue T3041. Can other segments of the stalk also be agonists?

(5) There are some major concerns about the simulations: The GaMD simulations showed different binding sites of p-21, p-17, and p-9, and the results report the simulated conformations as "active conformational states". However, these are only computational findings without structural biology or mutagenesis data to validate. Further, neither docking nor the simulation data can explain the peptide SAR. Finally, it will be interesting if the authors can use docking or GaMD and explain why some peptide designs (like P11-P15) are less active (as control simulations).

Reviewer #3 (Public Review):

Summary:<br /> The authors demonstrate the activation of Polycystin-1 (PC1), a G-protein coupled receptor, using small peptides derived from its original agonist, the stalk TA protein. In the experimental part of the study, the authors performed cellular assays to check the peptide-induced reactivation of a mutant form of PC1 which does not contain the stalk agonist. The experimental data is supported by computational studies using state-of-the-art Gaussian accelerated Molecular Dynamics (GaMD) and bioinformatics analysis based on sequence covariance. The computer simulations revealed the mechanistic details of the binding of the said peptides with the mutant PC1 protein and discovered different bound, unbound, and intermediate conformations depending on the peptide size and sequence. The use of reliable and well-established molecular simulation algorithms and the physiological relevance of this protein autosomal dominant polycystic kidney disease (ADPKD) make this work particularly valuable.

Strengths:<br /> This work is exploratory and its goal is to establish that small peptides can be used to probe the PC1 signaling process. The authors have provided sufficient evidence to justify this claim. Their GaMD simulations have produced free-energy landscapes that differentiate the interaction of PC1 with three different synthetic peptides and demonstrate the associated conformational dynamics of the receptor protein. Their trajectory analysis and sequence covariance analysis could identify residue-specific interactions that facilitate this process.

Weaknesses:<br /> The following minor weaknesses should be taken into account by the reader when interpreting the results:

(1) No control has been used for the computational (GaMD) study as the authors only report the free energy surface for 3 highly agonistic peptides but for none of the other peptides that did not induce an agonistic effect. Therefore, in the current version, the reliability of the computational results is not foolproof.

(2) All discussions about the residue level interactions focused only on geometric aspects (distance, angle, etc) but not the thermodynamic aspect (e.g. residue-wise interaction energy). Considering they perform a biased simulation, the lack of interaction energy analysis only provides a qualitative picture of the mechanism.

(3) It is not mentioned clearly whether the reader should interpret the free energy landscapes quantitatively or qualitatively. Considering no error analysis or convergence plots are reported for the GaMD free energy surfaces, it may be assumed the results are qualitative. The readers should consider this caveat and not try to quantitatively reproduce these free energy landscapes with other comparable techniques.

Reviewer #1 (Public Review):

Summary:

The authors show that upon treatment with Doxorubicin (Doxo), there is an increase in senescence and inflammatory markers in the muscles. They also show these genes get upregulated in C2C12 myoblasts when treated with conditioned media or 15d-PGJ2. 15dPGJ2 induces cell death in the myoblasts, decreases proliferation (measured by cell numbers), and decreases differentiation and fusion. 15d-PGJ2 modified Cys184 of HRas, which is required for its activation as indicated by the FRET analysis with RAF RBD. They also showed that 15d-PGJ2 activates ERK signaling, but not Akt signaling, through the electrophilic center. 15d-PGJ2 inhibits Golgi localization of HRAS (only WT, not C181 or C184 mutant). They also showed that expressing the WT HRas followed by 15d-PGJ2 treatment led to a decrease in the levels of MHC mRNA and protein, and this defect is dependent on C184. This is a well-written manuscript with interesting insights into the mechanism of action of 15d-PGJ2. However, some clarification and experiments will help the paper advance the field significantly.

Strengths:

The data clearly shows that 15d-PGJ2 has a negative role in the myoblast cells and that it leads to modification of HRas protein. Moreover, the induction of biosynthetic enzymes in the PGD2 pathway also supports the induction of 15d-PGJ2 in Doxorubicin-treated cells. Both conditioned media experiments and the 15d-PGJ2 experiments show that 15d-PGJ2 could be the active component secreted by the senescent myoblasts.

Weaknesses:

The genes that are upregulated in the muscles upon injection with Doxo are also markers for inflammation. Since Doxo is also known to induce systemic inflammation, it is important to delineate these two effects (inflammatory cells vs senescent cells). The expression of beta Gal and other markers of senescence in the tissue sections will help to delineate these.

In Figure 2, where the defect in the differentiation of myoblasts upon treatment with 15d-PGJ2 is shown, most of the cells die within 48 hours at higher concentrations, making it difficult to perform the experiments. This also shows that 15d-PGJ2 was toxic to these cells. Lower concentrations show a decrease in the differentiation based on the lower number of nuclei in fibers and low expression of MyoD, MyoG, and MHC. However, it is unclear if this is due to increased cell death or defective differentiation. It would be a lot more informative if the cell count, cell division, and cell death could be plotted for these concentrations of the drug during the experiment. Also, in the myoblast experiments, are the effects of treatment with Dox reversible?

In Figure 3, most of the experiments are done at a high concentration, which induces almost complete cell death within 48 hours. Even at such a high concentration of 15dPGJ2, the increase in ERK phosphorylation is minimal.

The experiment Figure 4C shows that C181 and C84 mutants of the HRas show higher levels in Golgi compared with WT. However, this could very well be due to the defect in palmitoylation rather than the modification with 15d-PGJ2. Though the authors allude to the possibility that intracellular redistribution of HRas by 15d-PGJ2 requires C181 palmitoylation, the direct influence of C184 modification on C181 palmitoylation is not shown. To have a meaningful conclusion, the authors need to compare the palmitoylation and modification with 15d-PGJ2.

To test if the inhibition of myoblast differentiation depends on HRas, they overexpressed the HRas and mutants in the C2C12 lines. However, this experiment does not take the endogenous HRAs into consideration, especially when interpreting the C184 mutant. An appropriate experiment to test this would be to knock down or knock out HRas (or make knock-in mutations of C184) and show that the effect of 15d-PGJ2 disappears. Moreover, in this specific experiment, it is difficult to interpret without a control with no HRas construct and another without the 15d-PGJ2 treatment.

Moreover, the overall study does not delineate the toxic effects of 15d-PGJ2 from its effect on the differentiation.

Reviewer #2 (Public Review):

Summary:

In this study, Swarang and colleagues identified the lipid metabolite 15d-PGJ2 as a potential component of senescent myoblasts. They proposed that 15d-PGJ2 inhibits myoblast proliferation and differentiation by binding and regulating HRas, suggesting its potential as a target for restoring muscle homeostasis post-chemotherapy.

Strengths:

The regulation of HRas by 15d-PGJ2 is well controlled.

Weaknesses:

The novelty of the study is compromised as the activation of PGD and 15d-PGJ2, as well as the regulation of HRas and cell proliferation, have been previously reported. Additionally, there are major technical concerns related to the senescence models, limiting data interpretation regarding the relevance to senescent cells.

Major concerns:<br /> (1) The C2C12 cell line is not an ideal model for senescence study due to its immortalized nature and lack of normal p16 expression. A more suitable myoblasts model is recommended, with a more comprehensive characterization of senescence features.

(2) The source of increased PGD or its metabolites in the conditioned medium is unclear. Including other senescence models, such as replicative or oncogene-induced senescence, would strengthen the study. Again, C2C12 is not suitable for replicative senescence due to its immortalized status.

(3) In the in vivo part, it's unclear whether the increased expression of PTGS1, PTGS2, and PTGDS is due to senescence or other side effects of DOXO.

(4) Figure 2A lacks an important control from non-senescent cells during the measurement of C2C12 differentiation in the presence of a conditioned medium. There is no explanation of how differentiation was quantified or how the fusion index was calculated.

Reviewer #1 (Public Review):

This study makes an interesting finding: a polyunsaturated fatty acid, Lin-Glycine, increases the conductance of KCNQ1/KCNE1 channels by stabilizing a state of the selectivity filter that allows K+ conduction. The stabilization of a conducting state appears well supported by single-channel analysis, though some method details are missing. The linkage to PUFA action through the selectivity filter is supported by the disruption of PUFA effects by mutation of residues which change conformation in two KCNQ1 structures from the literature. Claims about differences in Lin-Glycine binding to these two structural conformations seem to lack clear support, thus the claim seems speculative that PUFAs increase Gmax by binding to a crevice in the pore domain. A potentially definitive functional experiment is conducted by single-channel recordings with selectivity filter domain mutation Y315F which ablates the Lin-Glycine effect on Gmax. However, this appears to be an n=1 experiment. Overall, the major claim of the abstract is supported: "... that the selectivity filter in KCNQ1 is normally unstable ... and that the PUFA-induced increase in Gmax is caused by a stabilization of the selectivity filter in an open-conductive state." However, the claim in the abstract that selectivity filter instability "explains the low open probability" seems too general.

Reviewer #2 (Public Review):

Summary:

Golluscio et al. address one of the mechanisms of IKs (KCNQ1/KCNE1) channel upregulation by polyunsaturated fatty acids (PUFA). PUFA is known to upregulate KCNQ1 and KCNQ1/KCNE1 channels by two mechanisms: one shifts the voltage dependence to the negative direction, and the other increases the maximum conductance (Gmax). While the first mechanism is known to affect the voltage sensor equilibrium by charge effect, the second mechanism is less known. By applying the single-channel recordings and mutagenesis on the putative binding sites (most of them related to the selectivity filter), they concluded that the selectivity filter is stabilized to a conductive state by PUFA binding.

Strengths:<br /> They mainly used single-channel recordings and directly assessed the behavior of the selectivity filter. The method is straightforward and convincing enough to support their claims.

Weaknesses:<br /> The structural model they used is the KCNQ1 channel without KCNE1 because KCNQ1/KCNE1 channel complex is not available yet. As the binding site of PUFAs might overlap with KCNE1, it is not very clear how PUFA binds to the KCNQ1 channel in the presence of KCNE1.

Using other previous PUFA-related KCNQ1 mutants will strengthen their conclusions. For example, the Gmax of the K326E mutant is reduced by PUFA binding. Examining whether K326E shows reduced numbers of non-empty sweeps in the single-channel recordings will be a good addition.

Reviewer #3 (Public Review):

Summary:

This manuscript reveals an important mechanism of KCNQ1/IKs channel gating such that the open state of the pore is unstable and undergoes intermittent closed and open conformations. PUFA enhances the maximum open probability of IKs by binding to a crevice adjacent to the pore and stabilizing the open conformation. This mechanism is supported by convincing single-channel recordings that show empty and open channel traces and the ratio of such traces is affected by PUFA. In addition, mutations of the pore residues alter PUFA effects, convincingly supporting that PUFA alters the interactions among these pore residues.

Strengths:<br /> The data are of high quality and the description is clear.

Weaknesses:<br /> Some comments about the presentation.

(1) The structural illustrations in this manuscript in general need to be more clarified.

(2) The manuscript heavily relies on the comparison between the S4-down and S4-up structures (Figures 3, 4, and 7) to illustrate the difference between the extracellular side of the pore and to lead to the hypothesis of open-state stability being affected by PUFA. This may mislead the readers to think that the closed conformation of the channel in the up-state is the same as that in the down-state.

Reviewer #1 (Public Review):

Summary:

This study provides the detailed molecular mechanism of how OGT, an O-GlcNac transferase, promotes cancer progression. Using loss-of-function OGT models, the authors demonstrated that OGT cleaves HCF-1, an important guardian of genomic stability. The resulting genomic instability in OGT-knockout tumors leads to cytosolic DNA accumulation, the activation of cGAS-mediated type I IFN responses, and increased CD8+ T cell infiltration into the tumors. Moreover, treatment with OGT inhibitor synergized with anti-PDL1 immune-checkpoint blockade.

Strengths:

Novel findings of how OGT promotes tumor progression.

Weaknesses:

(1) Some of the data is problematic and does not always support the authors' conclusions.<br /> (2) The writing needs significant improvement. In places, it is hard to understand or could mislead the readers.<br /> (3) Figure legends are minimalistic and do not provide sufficient information.<br /> (4) Discussion does not put the findings of this study into a broader context of the field but merely restates them.

Reviewer #2 (Public Review):

Summary:

In this study, the author demonstrates that deficiency or pharmacological inhibition of O-glcNac transferase (OGT) enhances tumor immunity in colorectal cancer models. The authors propose that OGT deficiency triggers a DNA damage response, activating the cGAS-STING innate immunity pathway and promoting a Type I interferon response. They suggest that OGT-mediated processing of HSF1 is crucial in maintaining genomic integrity. This research is significant as it identifies OGT inhibition as a potential immunomodulatory target in cancer treatment.

Strengths:

The strength of the paper lies primarily in the in vivo data, demonstrating the impact of OGT deficiency or inhibition on modulating tumor growth and anti-tumor immunity. The experiments are well-controlled. However, there are several unresolved questions:

Weaknesses:

The mechanisms of how OGT deficiency can trigger DNA damage and the role of this response in promoting immunity are only partially addressed in the manuscript.

Reviewer #1 (Public Review):

The manuscript by Wu et al. explores the role of the histone reader protein SntB in Aspergillus flavus, claiming it to be a key regulator of development and aflatoxin biosynthesis. While the study incorporates various techniques, including gene deletion, ChIP-seq, and RNA-seq, several concerns and omissions in the paper raise questions about the validity and completeness of the presented findings.

(1) Omissions of Prior Work:<br /> The authors fail to acknowledge and integrate prior research by Pfannenstiel et al. (2018) on the sntB gene in A. flavus, which covered phenotypic changes, RNA-seq data, and histone modifications. This omission raises concerns about the transparency and completeness of the current study.

The absence of reference to studies by Karahoda et al. (2022, 2023) revealing SntB's involvement in the KERS complex in A. flavus and A. nidulans is a major oversight. This raises questions about the specificity of SntB's regulatory functions, as it may be part of a larger complex. The authors should clarify why these studies were omitted and how they ensure that SntB alone, and not the entire KERS complex, is responsible for the observed effects.

(2) Transparency and Accessibility of Data:<br /> The lack of accessibility and visualization tools for ChIP-seq and RNA-seq data poses a challenge for independent verification and in-depth analysis. The authors should address this issue by providing more accessible data or explaining the limitations of data availability. A critical component missing from the paper is a detailed presentation of ChIP-seq data, specifically demonstrating SntB binding patterns on key promoters. This omission weakens the link between SntB and the mentioned regulatory genes. The authors should include these crucial data visualizations to strengthen their claims.

(3) SntB Binding Sites and Consensus Sequence:<br /> The study mentions several genes upregulated in the sntB mutant without demonstrating SntB binding sites on their promoters. A detailed analysis of SntB binding maps is necessary to establish a direct link between SntB and these regulatory genes.

(4) Mechanistic Insight into Peroxisome Biogenesis:<br /> If SntB indeed regulates peroxisome biogenesis, the absence of markers for peroxisomes and the localization of peroxisomes in the sntB mutant vs. WT strains is a significant gap. Providing evidence for peroxisome regulation is crucial for understanding the proposed mechanism and validating the study's claims.

In summary, while the manuscript presents intriguing findings regarding SntB's role in A. flavus, the omissions of prior work, lack of transparency in data accessibility, and insufficient mechanistic insights call for revisions and additional experimental evidence to strengthen the validity and impact of the study. Addressing these concerns will enhance the manuscript's contribution to the field.

Additionally, the way the English language is used could be improved.

Reviewer #2 (Public Review):

Summary:<br /> This work is of great significance in revealing the regulatory mechanisms of pathogenic fungi in toxin production, pathogenicity, and in its prevention and pollution control. Overall, this is generally an excellent manuscript.

Strengths:<br /> The data in this manuscript is robust and the experiments conducted are appropriate.

Weaknesses:<br /> (1) The authors found that SntB played key roles in the oxidative stress response of A. flavus by ChIP-seq and RNA sequencing. To confirm the role of SntB in oxidative stress, the authors have to better measure the ROS levels in the ΔsntB and WT strains, besides the ΔcatC strain.

(2) Why did the authors only study the function of catC among the 7 genes related to an oxidative response listed in Table S14?

Reviewer #1 (Public Review):

Summary:

In their manuscript, Yu et al. describe the chemotactic gradient formation for CCL5 bound to - i.e. released from - glycosaminoglycans. The authors provide evidence for phase separation as the driving mechanism behind chemotactic gradient formation. A conclusion towards a general principle behind the finding cannot be drawn since the work focuses on one chemokine only, which is particularly prone to glycan-induced oligomerisation.

Strengths:

The principle of phase separation as a driving force behind and thus as an analytical tool for investigating protein interactions with strongly charged biomolecules was originally introduced for protein-nucleic acid interactions. Yu et al. have applied this in their work for the first time for chemokine-heparan sulfate interactions. This opens a novel way to investigate chemokine-glycosaminoglycan interactions in general.

Weaknesses:

As mentioned above, one of the weaknesses of the current work is the exemplification of the phase separation principle by applying it only to CCL5-heparan sulfate interactions. CCL5 is known to form higher oligomers/aggregates in the presence of glycosaminoglycans, much more than other chemokines. It would therefore have been very interesting to see, if similar results in vitro, in situ, and in vivo could have been obtained by other chemokines of the same class (e.g. CCL2) or another class (like CXCL8).

In addition, the authors have used variously labelled CCL5 (like with the organic dye Cy3 or with EGFP) for various reasons (detection and immobilisation). In the view of this reviewer, it would have been necessary to show that all the labelled chemokines yield identical/similar molecular characteristics as the unlabelled wildtype chemokine (such as heparan sulfate binding and chemotaxis). It is well known that labelling proteins either by chemical tags or by fusion to GFPs can lead to manifestly different molecular and functional characteristics.

Reviewer #2 (Public Review):

Although the study by Xiaolin Yu et al is largely limited to in vitro data, the results of this study convincingly improve our current understanding of leukocyte migration.

(1) The conclusions of the paper are mostly supported by the data although some clarification is warranted concerning the exact CCL5 forms (without or with a fluorescent label or His-tag) and amounts/concentrations that were used in the individual experiments. This is important since it is known that modification of CCL5 at the N-terminus affects the interactions of CCL5 with the GPCRs CCR1, CCR3, and CCR5 and random labeling using monosuccinimidyl esters (as done by the authors with Cy-3) is targeting lysines. Since lysines are important for the GAG-binding properties of CCL5, knowledge of the number and location of the Cy-3 labels on CCL5 is important information for the interpretation of the experimental results with the fluorescently labeled CCL5. Was the His-tag attached to the N- or C-terminus of CCL5? Indicate this for each individual experiment and consider/discuss also potential effects of the modifications on CCL5 in the results and discussion sections.

(2) In general, the authors appear to use high concentrations of CCL5 in their experiments. The reason for this is not clear. Is it because of the effects of the labels on the activity of the protein? In most biological tests (e.g. chemotaxis assays), unmodified CCL5 is active already at low nM concentrations.

(3) For the statistical analyses of the results, the authors use t-tests. Was it confirmed that data follow a normal distribution prior to using the t-test? If not a non-parametric test should be used and it may affect the conclusions of some experiments.

Reviewer #3 (Public Review)

Summary:

The authors are trying to find out whether the levels of omega-6 and omega-3 fatty acids in the blood are linked to the likelihood of dying from anything, of dying from cancer and of dying from cardiovascular disease. They use a large dataset called UKBiobank where fatty acid levels were measured in blood at the start of the study and what happened to the participants over the following years (average of 12.7 years) was followed. They find that both omega-6 AND omega-3 fatty acids were linked with less likelihood of dying from anything, from cancer and from cardiovascular disease. The effects of omega-3s were stronger. They then made a ratio of omega-6 to omega-3 fatty acids and found that as that ratio increased risk of dying also increased. This supports the idea that omega-3s have stronger effects than omega-6s.

Strengths:

This is a large study (over 85,000 participants) with a good follow up period (average 12.7 years). Using blood levels of fatty acids is superior to using estimated dietary intakes. The authors take account of many variables that could interfere with the findings (confounding variables) - they do this using statistical methods.

Weaknesses:

UKBioBank is not entirely representative of the UK population.

Reviewer #1 (Public Review):

Summary:<br /> Honzejkova K., et al. resolved the structure of one of the MAP3K proteins. Apoptosis signal-regulating kinase 1 (ASK1) is one of the main crucial stress sensors, which directs cells toward differentiation, and apoptosis. As a result, ASK1 dysregulation has been associated with a multitude of diseases like neurodegenerative, cardiovascular, and cancer. Understanding the structural-functional interplay of ASK1 would help researchers target this member of the MAP3K proteins to develop therapeutic interventions for these disorders.

Strengths:

Major strengths:<br /> • Structure of the C-terminal truncated ASK1 protein.

Weaknesses:<br /> • Lack of ASK1:TRX1 complex structure. The authors used instead SV AUC and HDX-MS techniques to compensate for the inability to get a sufficiently stable ASK1:TRX complex.<br /> • There is not enough information about Cryo-EM data processing like 2D classification averages, local resolution of the EM map, or FSC figures.<br /> • You can't reliably report the presence of a hydrogen bond with a 3.7Å resolution.

Reviewer #2 (Public Review):

Summary:<br /> The authors attempted to solve the 3D structure of ASK1 by Cryo-EM.

Strengths:<br /> The authors solved the 3D structure of N-terminal domain s of ASK1 complexed with TRX. They found TRX1 functions as a negative allosteric effector of ASK1, modifying the structure of the TRX1-binding domain and changing its interaction with the tetratricopeptide repeats domain. The conclusions drawn from this paper are convincing and will greatly contribute to the development of new drugs targeting ASK1.

Weaknesses:<br /> To study the ASK1 structure, C-terminally truncated ASK1 was used in the study, but not the full-length form of ASK1.

Reviewer #1 (Public Review):

The manuscript by Lu et al aims to study the effects of tubulin post-translational modification in C. elegans touch receptor neurons. Authors use gene editing to engineer various predicted PTM mutations in a-tubulin MEC-12 and b-tubulin MEC-7. Authors generate and analyze an impressive battery of mutants in predicted phosphorylation site and acetylation site of b-tubulin MEC-7, K40 acetylation site in a-tubulin MEC-12, enzymatic site of the a-tubulin acetyltransferase MEC-17, and PTM sites in the MEC-12 and MEC-7 C-tails (glutamylation, detyrosination, delta-tubulin). This represents a lot of work, and will appeal to a readership interested in C. elegans touch receptor neurons. The major concern/criticism of this manuscript is whether the introduced mutation(s) directly affects a specific PTM or whether the mutation affects gene expression, protein expression/stability/localization, etc. As such, this work does convincingly demonstrate, as stated in the title, that "Editing of endogenous tubulins reveals varying effects of tubulin posttranslational modifications on axonal growth and regeneration."

For example, the authors manipulate the C-terminal tail of MEC-12 and MEC-7, to test the idea that polyglutamylation may be an important PTM. These mutants displayed subtle phenotypes. The authors show that branch point GT335 and polyglutamyation polyE recognizing antibodies stain cultured embryonic touch receptor neurons (TRNs), but did not examine staining in C. elegans TRNs in situ. To my knowledge, these antibodies have not been shown to stain the TRNs in any published papers, raising the question of how these "glutamylation" mutations are affecting mec-12 and -7. The rationale for using cultured embryonic TRNs and the relevance of the data and its interpretation are not clear.

The final paragraph of the discussion is factually incorrect. The C. elegans homologs of the CCP carboxypeptidases are called CCPP-1 and CCPP-6. There are several publications on their functions in C. elegans.

Reviewer #1 (Public Review):

In their revised manuscript Hijaze et al. adequately addressed the majority of my previous concerns in a satisfactory manner. In particular, they validated their morpholino knock-down experiments by explaining how they determined the optimal concentrations and provided an immunohistological evidence for the reduction in ROCK protein abundance. The authors also added new antibody stainings providing evidence that ROCK and F-actin do not interact directly but likely through other kinases that modulate f-actin, and that the localization of f-actin at the spicule tips remains unaffected by the knock-down. In addition, the authors revised their discussion to not overstate their observations, and by focusing on the potential mechanisms by which ROCK may affect biomineralization (i.e. mechano sensing and exocytosis of vesicles). Here I would like to add, that f-actin mediated exocytosis does not necessarily target mineral baring vesicles but may also promote the exocytosis of matrix proteins that are essential for the normal formation of the spicules and that are an integral component of other biominerals, as well. I strongly encourage the authors to continue on this exciting research, including the development of methods to analyze the molecular mechanisms that control vesicular trafficking in mineralizing systems.

Reviewer #2 (Public Review):

This project is on the role of ROCK in skeletogenesis during sea urchin development. That skeleton is produced by a small number of cells in the embryo with signaling inputs from the ectoderm providing patterning cues. The skeleton is built from secretion of CaCO3 by the skeletogenic cells. The authors conclude that ROCK is involved in the regulation of skeletogenesis with a role both in regulating actomyosin in the process, and in the gene regulatory network (GRN) underlying the entire sequence of events.

The strength of the paper is that they show in detail how perturbations of ROCK results in abnormal actomyosin activity in the skeletogenic cells, and they show alterations both in expression of transcription factors of the GRN, and expression of genes involved in assembly of the skeletal matrix. Two different approaches lead to this conclusion: morpholino perturbations and the actions of a selective inhibitor of the kinase activity. Thus, they achieved their goal which was to test the hypothesis that ROCK is involved in the process of skeletogenesis. Those tests support the hypothesis with data that was quantitatively significant.

The discussion was transparent regarding where the analysis ended and where the next phase of work should begin. While actomyosin involvement was altered when ROCK was perturbed, it isn't known how direct or indirect the role of ROCK might be. Also, while the regulatory input to spicule initiation and growth is affected when ROCK is inhibited, it isn't clear exactly where ROCK is involved.

Reviewer #1 (Public Review):

Summary:

The OSCA/TMEM63 channels have recently been identified as mechanosensitve channels. In a previous study, the authors found that OSCA subtypes (1, 2, and 3) respond differently to stretch and poke stimuli. For example, OSCA1.2 is activated by both poke and stretch, while OSCA3.1, responds strongly to stretch but poorly to poke stimuli. In this study the authors use cryo-EM, mutagenesis, and electrophysiology to dissect the mechanistic determinants that underlie the channels' ability to respond to poke and stretch stimuli.

The starting hypothesis of the study is that the mechanical activation of OSCA channels relies on the interactions between the protein and the lipid bilayer and that the differential responses to poke and stretch might stem from variations in the lipid-interacting regions of OSCA proteins. The authors specifically identify the amphipathic helix (AH), the fenestration, and the Beam Like Domain (BLD) as elements that might play a role in mechanosensing.

The authors use solid methodology to show that poke and stretch responses likely use different mechanisms in OSCA channels and that the poke response can be uncoupled from the stretch response in OSCA1.2 by mutations in the AH and the positively charged residues in the fenestration. However, the study falls short of explaining why OSCA3.1 does not respond efficiently to poke stimuli. This question is particularly important as the AH residues that are important for the poke response in OSCA1.2 are present in OSCA3.1.

Unfortuntately, due to staffing issues, the authors were unable to perform additional experiments that would address some of the critical issues that were brought up during peer review. Nevertheless, the structural and functional data presented is of high quality and the findings on OSCA1.2 will be of interest to anyone working in the fields of mechanosensation, sensory biology, and ion channels.

Reviewer #2 (Public Review):

Jojoa-Cruz et al. have submitted a revised manuscript and their responses to reviewers' comments on the major weaknesses of the paper and recommendations. The authors have made minimal changes to the manuscript itself, which highly resembles the initial submission. Most concerningly, the authors appeared to agree with reviewers' comments, but did not and are not going to carry out any of the recommended experiments, including electrophysiology [Reviewer 2- major point 3), recommended point 5; Reviewer 3- recommended point 4] and western blot [Reviewer 3- recommended point 3], by explaining that they have left the lab. The major weakness and issues raised in the previous review process therefore remain in the current version of the manuscript.

Moreover, in the public review major weakness, the reviewer pointed out issues on the inadequacy of the functional validation on the structural domains based on mutagenesis of OSCA1.2 vs. OSCA3.1 and using poke and stretch assays, as well as weakness in the corresponding mechanistic interpretation of the functional data. These issues need to be addressed or improved to a certain extent through revised study design and execution of experiments.

Reviewer #3 (Public Review):

Summary:

Jojoa-Cruz et al provide a new structure of At-OSCA3.1. The structure of OSCA 3.1 is similar to previous OSCA cryo-em structures of both OSCA3.1 and other homologues validating the new structure. Using the novel structure of OSCA3.1 as a guide they created several point mutations to investigate two different mechanosensitive modalities: poking and stretching. To investigate the ability of OSCA channels to gate in response to poking they created point mutations in OSCA1.2 to reduce sensitivity to poking based on the differences between the OSCA1.2 and 3.1 structures. Their results suggest that two separate regions are responsible for gating in response to poking and stretching.

Strengths:

Through a detailed structure based analysis, the authors identified structural differences between OSCA3.1 and OSCA1.2. The use of technically sound data supports the hypothesis that poking and stretching are sensed by two unique regions in the protein. These subtle structural changes between homologues identify regions in the amphipathic helix and near the pore that are essential for gating of OSCA1.2 in response to poking and stretching. Mutations in the AH of OSCA1.2 decrease the sensitivity to poking stimulus however these mutations have similar stretch activated currents to the WT. The point mutations described in the manuscript will set the foundation for investigations into how these two channels sense tension using different regions of structurally similar proteins.

Weaknesses:

Mutations in the amphipathic helix at W75 and L80 show reduced gating in response to poking stimuli. The gating observed occurs at poking depths similar to cellular rupture, the similarity in depths suggests that these mutations could be a complete loss of functions.

Reviewer #1 (Public Review):

Summary:

In the current manuscript, the authors find distinct roles for the calcium sensors Syt7 and Doc2alpha in the regulation of asynchronous release and calcium-dependent synaptic vesicle docking in hippocampal neurons. The authors data indicate that Doc2 functions in activating a component of asynchronous release beginning with the initial stimulus, while Syt7 does not appear to have a role at this early stage. A role for Syt7 in supporting both synchronous and asynchronous release appears during stimulation trains, where Syt7 is proposed to promote synaptic vesicle docking or capture during stimulation. Doc2 mutants show facilitation initially during a train and display higher levels of synchronous release initially, before reaching a similar plateau to controls later in the train. The authors contribute the increased synchronous release in Doc2 mutants to Syt1 having access to more SVs that can fuse synchronously. In contrast, Syt7 mutants show depression during a train, and continue to decline during stimulation. The authors contribute this to a role for Syt7 in promoting calcium-dependent SV docking and capture that feeds SVs to both synchronous and asynchronous fusion pathways. Importantly, phenotypes of a double Doc2/Syt7 mutant collapse onto the Doc2 phenotype, suggesting the two proteins are not additive in their role in supporting distinct aspects of SV release. Rapid freeze EM after stimulation provides support for a role for Syt7 in SV docking/capture at release sites, as they display less docked SVs after stimulation. In the case of Doc2, EM reveals fewer SVs fusion pits later during a stimulation, consistent with fewer asynchronous fusion events. The authors also provide modeling that supports aspects of their conclusions from the experimental data. I cannot evaluate the modeling data or the specific experimental subtlities of the GluSnFR quantification approach, as these are outside of my reviewer expertise.

Strengths:

The use of multiple approaches (optical imaging, physiology, rapid freeze EM, modeling, double mutant analysis) provides compelling support for distinct roles of the two proteins in regulating SV release.

Weaknesses:

Some of the phenotypes for both Doc2 and Syt7 mutants have been reported in the authors' prior publications. It is not clear how well the GluSnFR approach is for accurately separating synchronous versus asynchronous release kinetics. The authors also tend to overstate the significance of the two proteins for asynchronous release in general, as a significant fraction of this release component is still intact in the double mutant, indicating these two proteins are only part of the asynchronous release mechanism.

Reviewer #2 (Public Review):

Summary:

The goal of this study is to provide a deeper understanding of the roles of syt7 and Doc2 in synaptic vesicle fusion. Depending on the system studied, and the nature of the preparation, it appears that syt7 functions as a sensor for asynchronous release, synaptic facilitation, both processes, or neither. The perspective offered by Chapman, Watanabe, and colleagues varies from those previously published, and is therefore novel and interesting.

Strengths:

The strengths of the study include the complementary imaging and electrophysiology approaches for assessing the function of syt7, and the use of appropriate knockout lines. High resolution imaging approaches to measure synaptic activity is also a strength.

Weaknesses:

It is not clear to this reviewer that the computational modeling effort is important or even necessary. The study also attempts to derive kinetic information (on the ms time scale) from EM. While the interpretations are not unreasonable, they should be taken with some caution.

Overall, the study does a good job of attempting to resolve the various ambiguities existing in the field regarding the potential roles of syt7 and Doc2 in membrane fusion. There are, of course, a great number of proteins which have been identified to act at fusion sites to drive or otherwise modify release phenotypes. Efforts such as this are going to become increasingly important as we work to attribute discrete roles to each one.

Reviewer #1 (Public Review):

This fascinating paper by A.L. Schneider et al. describes voyAGEr, a shiny-based interface for easy exploration of the GTEx dataset by non- or novice programmers. Importantly, voyAGEr is open source and available from github, which could greatly accelerate additional development and further uses of this interesting tool.

The authors developed a pipeline for modeling age-related changes in gene expression in the GTEx data called ShARP-LM, fitting a linear model for age, sex and age&sex interaction terms. This pipeline underlies the later analyses that can be applied within voyAGEr. These analyses are labeled by tissue so that users can easily begin a query based on a tissue or a gene of possible interest.

voyAGEr implements many kinds of interesting R-based tools such as pathway overrepresentation analysis and gene co-expression module analysis, in a way that akes these approaches accessible to non-bioinformaticist aging researchers.

As the tidal wave of publicly available large, high-dimensional datasets such as transcriptomes continues to grow exponentially, the usefulness of tools such as voyAGEr will only increase. While test users may be able to imagine features or refinements they wish were already present, due to the open source approach they or anyone else including but not limited to the present authors can implement additional features in the future. I look forward to using this tool and to staying abreast of its future development.

Overall, this study describes a new tool of interest to the field. The manuscript is clearly written overall, with a few minor suggested corrections, as noted below. The figures and supplementary information are all clear and all add to the manuscript.

Reviewer #2 (Public Review):

The purpose of this study is to develop a tool that serves as a starting point for investigating and uncovering genes and pathways associated with aging. The tool utilizes information from the GTEx public database, which contains post-mortem human data. It focuses on identifying age-related gene expression changes across different age range, biological sexes, and medical histories, with a focus on specific tissues.

Additionally, the authors envision the platform as continuously evolving, with ongoing development and expansion to include new data and features, ensuring it remains a cutting-edge resource for researchers studying aging.

voyAGEr presents a tool for exploring gene expression changes across multiple tissues in the context of aging. One of the main strengths of the tool is its intuitive and user-friendly interface, which allows for easy navigation and exploration of gene expression patterns for biologists. Users can explore changes in gene expression of single genes across multiple tissues, enabling them to identify genes of interest that can be further investigated.

A particularly noteworthy strength of the tool is its ability to show tissue-specific gene expression patterns. This feature is essential for elucidating the paradigm of tissue-specific asynchronous aging and provides a unique and valuable resource for the aging community.

However, the choice of the R shiny platform for visualization may not be the most conducive to extensibility and open-source collaboration, owing to its lack of modularity. Alternatives like Flask or FastAPI, which are more production-oriented, could be more appropriate. Additionally, despite using preprocessed data and functioning primarily as a visualization platform, the tool occasionally experiences lag, indicating room for performance improvement. These aspects are worth considering for future versions of the tool.

Overall, voyAGEr offers an entry point for further investigation of genes involved in aging, and its ability to show tissue-specific gene expression patterns provides a unique and valuable resource for the scientific community.

Finally, the tool is complemented by a comprehensive tutorial that elucidates each functionality and includes examples. The authors have shared the code for preprocessing and the tool itself. They also acknowledge the limitations of the statistical inference tests and their interpretation in the manuscript, contributing to its transparency.

Reviewer #3 (Public Review):

In their manuscript, Schneider et al. aim to develop voyAGEr, a web-based tool that enables the exploration of gene expression changes over age in a tissue- and sex-specific manner. The authors achieved this goal by calculating the significance of gene expression alterations within a sliding window, using their unique algorithm, Shifting Age Range Pipeline for Linear Modelling (ShARP-LM), as well as tissue-level summaries that calculated the significance of the proportion of differentially expressed genes by the windows and calculated enrichments of pathways for showing biological relevance. Furthermore, the authors examined the enrichment of cell types, pathways, and diseases by defining the co-expressed gene modules in four selected tissues. Although their algorithm ShARP-LM has limited statistical power due to its calculation within a 16-year window, the voyAGEr was developed as a discovery tool, giving researchers easy access to the vast amount of transcriptome data from the GTEx project. Overall, the research design is unique and well-performed in simulating age-dependent changes in gene expression. The interesting results provide useful resources for the field of human genetics of aging.

Reviewer #2 (Public Review):

Summary: In the revised manuscript, the authors aim to investigate brain-wide activation patterns following administration of the anesthetics ketamine and isoflurane, and conduct comparative analysis of these patterns to understand shared and distinct mechanisms of these two anesthetics. To this end, they perform Fos immunohistochemistry in perfused brain sections to label active nuclei, use a custom pipeline to register images to the ABA framework and quantify Fos+ nuclei, and perform multiple complementary analyses to compare activation patterns across groups.

In the latest revision, I am happy to say that the authors have greatly improved their manuscript. The data are now well analyzed and the experiments fully described. They addressed all of my concerns. It is an interesting study.

Reviewer #3 (Public Review):

The present study presents a comprehensive exploration of the distinct impacts of Isoflurane and Ketamine on c-Fos expression throughout the brain. To understand the varying responses across individual brain regions to each anesthetic, the researchers employ principal component analysis (PCA) and c-Fos-based functional network analysis. The methodology employed in this research is both methodical and expansive. Notably, the utilization of a custom software package to align and analyze brain images for c-Fos positive cells stands out as an impressive addition to their approach. This innovative technique enables effective quantification of neural activity and enhances our understanding of how anesthetic drugs influence brain networks as a whole.

The primary novelty of this paper lies in the comparative analysis of two anesthetics, Ketamine and Isoflurane, and their respective impacts on brain-wide c-Fos expression. The study reveals the distinct pathways through which these anesthetics induce loss of consciousness. Ketamine primarily influences the cerebral cortex, while Isoflurane targets subcortical brain regions. This finding highlights the differing mechanisms of action employed by these two anesthetics-a top-down approach for Ketamine and a bottom-up mechanism for Isoflurane. Furthermore, this study uncovers commonly activated brain regions under both anesthetics, advancing our knowledge about the mechanisms underlying general anesthesia.

Reviewer #1 (Public Review):

Summary:

In the paper "Disentangling the relationship between cancer mortality and COVID-19", the authors study whether the number of deaths in cancer patients in the USA went up or down during the first year (2020) of the COVID-19 pandemic. They found that the number of deaths with cancer mentioned on the death certificate went up, but only moderately. In fact, the excess with-cancer mortality was smaller than expected if cancer had no influence on the COVID mortality rate and all cancer patients got COVID with the same frequency as in the general population. The authors conclude that the data show no evidence of cancer being a risk factor for COVID and that the cancer patients were likely actively shielding themselves from COVID infections.

Strengths:

The paper studies an important topic and uses sound statistical and modeling methodology. It analyzes both, deaths with cancer listed as the primary cause of death, as well as deaths with cancer listed as one of the contributing causes. The authors argue, correctly, that the latter is a more important and reliable indicator to study relationships between cancer and COVID. The authors supplement their US-wide analysis by analysing three states separately.

Weaknesses:

The main findings of the paper can be summarized as six numbers. Nationally, in 2022, multiple-cause cancer deaths went up by 2%, Alzheimer's deaths by 31%, and diabetes deaths by 39%. At the same time, assuming no relationship between these diseases and either Covid infection risk or Covid mortality risk, the deaths should have gone up by 7%, 46%, and 28%. The authors focus on cancer deaths and as 2% < 7%, conclude that cancer is not a risk factor for COVID and that cancer patients must have "shielded" themselves against Covid infections.

However, I did not find any discussion of the other two diseases. For diabetes, the observed excess was 39% instead of "predicted by the null model" 28%. I assume this should be interpreted as diabetes being a risk factor for Covid deaths. I think this should be spelled out, and also compared to existing estimates of increased Covid IFR associated with diabetes.

And what about Alzheimer's? Why was the observed excess 31% vs the predicted 46%? Is this also a shielding effect? Does the spring wave in NY provide some evidence here? Why/how would Alzheimer's patients be shielded? In any case, this needs to be discussed and currently, it is not.

Reviewer #2 (Public Review):

The article is very well written, and the approach is quite novel. I have two major methodological comments, that if addressed will add to the robustness of the results.

(1) Model for estimating expected mortality. There is a large literature using a different model to predict expected mortality during the pandemic. Different models come with different caveats, see the example of the WHO estimates in Germany and the performance of splines (Msemburi et al Nature 2023 and Ferenci BMC Medical Research Methodology 2023). In addition, it is a common practice to include covariates to help the predictions (e.g., temperature and national holidays, see Kontis et al Nature Medicine 2020). Last, fitting the model-independent for each region, neglects potential correlation patterns in the neighbouring regions, see Blangiardo et al 2020 PlosONE.

Based on the above:<br /> a. I believe that the authors need to run a cross-validation to justify model performance. I would suggest training the data leaving out the last year for which they have mortality and assessing how the model predicts forward. Important metrics for the prediction performance include mean square error and coverage probability, see Konstantinoudis et al Nature Communications 2023. The authors need to provide metrics for all regions and health outcomes.

b. In the context of validating the estimates, I think the authors need to carefully address the Alzheimer case, see Figure 2. It seems that the long-term trends pick an inverse U-shape relationship which could be an overfit. In general, polynomials tend to overfit (in this case the authors use a polynomial of second degree). It would be interesting to see how the results change if they also include a cubic term in a sensitivity analysis.

c. The authors can help with the predictions using temperature and national holidays, but if they show in the cross-validation that the model performs adequately, this would be fine.

d. It would be nice to see a model across the US, accounting for geography and spatial correlation. If the authors don't want to fit conditional autoregressive models in the Bayesian framework, they could just use a random intercept per region.

(2) I think the demographic model needs further elaboration. It would be nice to show more details, the mathematical formula of this model in the supplement, and explain the assumptions.

Reviewer #3 (Public Review):

Summary:<br /> In this manuscript, entitled "Telomere length sensitive regulation of Interleukin Receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment", Dr. Mukherjee and colleagues pointed out clarifying the extra-telomeric role of TRF2 in regulating IL1R1 expression with consequent impact on TAMs tumor-infiltration.

Strengths:<br /> Upon careful manuscript evaluation, I feel that the presented story is undoubtedly well conceived. At the technical level, experiments have been properly performed and the obtained results support the authors' conclusions.

Weaknesses:<br /> Unfortunately, the covered topic is not particularly novel. In detail, the TRF2 capability of binding extratelomeric foci in cells with short telomeres has been well demonstrated in a previous work published by the same research group. The capability of TRF2 to regulate gene expression is well-known, the capability of TRF2 to interact with p300 has been already demonstrated and, finally, the capability of TRF2 to regulate TAMs infiltration (that is the effective novelty of the manuscript) appears as an obvious consequence of IL1R1 modulation (this is probably due to the current manuscript organization).

Reviewer #1 (Public Review):

Summary:<br /> This manuscript from Mukherjee et al examines potential connections between telomere length and tumor immune responses. This examination is based on the premise that telomeres and tumor immunity have each been shown to play separate, but important, roles in cancer progression and prognosis as well as prior correlative findings between telomere length and immunity. In keeping with a potential connection between telomere length and tumor immunity, the authors find that long telomere length is associated with reduced expression of the cytokine receptor IL1R1. Long telomere length is also associated with reduced TRF2 occupancy at the putative IL1R1 promoter. These observations lead the authors towards a model in which reduced telomere occupancy of TRF2 - due to telomere shortening - promotes IL1R1 transcription via recruitment of the p300 histone acetyltransferase. This model is based on earlier studies from this group (i.e. Mukherjee et al., 2019) which first proposed that telomere length can influence gene expression by enabling TRF2 binding and gene transactivation at telomere-distal sites. Further mechanistic work suggests that G-quadruplexes are important for TRF2 binding to IL1R1 promoter and that TRF2 acetylation is necessary for p300 recruitment. Complementary studies in human triple-negative breast cancer cells add potential clinical relevance but do not possess a direct connection to the proposed model. Overall, the article presents several interesting observations, but disconnection across central elements of the model and the marginal degree of the data leave open significant uncertainty regarding the conclusions.

Strengths:<br /> Many of the key results are examined across multiple cell models.

The authors propose a highly innovative model to explain their results.

Weaknesses:<br /> Although the authors attempt to replicate most key results across multiple models, the results are often marginal or appear to lack statistical significance. For example, the reduction in IL1R1 protein levels observed in HT1080 cells that possess long telomeres relative to HT1080 short telomere cells appears to be modest (Supplementary Figure 1I). Associated changes in IL1R1 mRNA levels are similarly modest.

Related to the point above, a lack of strong functional studies leaves an open question as to whether observed changes in IL1R1 expression across telomere short/long cancer cells are biologically meaningful.

Statistical significance is described sporadically throughout the paper. Most major trends hold, but the statistical significance of the results is often unclear. For example, Figure 1A uses a statistical test to show statistically significant increases in TRF2 occupancy at the IL1R1 promoter in short telomere HT1080 relative to long telomere HT1080. However, similar experiments (i.e. Figure 2B, Figure 4A - D) lack statistical tests.

Reviewer #2 (Public Review):

This study highlights the role of telomeres in modulating IL-1 signaling and tumor immunity. The authors demonstrate a strong correlation between telomere length and IL-1 signaling by analyzing TNBC patient samples and tumor-derived organoids. Mechanistic insights revealed non-telomeric TRF2 binding at the IL-1R1. The observed effects on NF-kB signaling and subsequent alterations in cytokine expression contribute significantly to our understanding of the complex interplay between telomeres and the tumor microenvironment. Furthermore, the study reports that the length of telomeres and IL-1R1 expression is associated with TAM enrichment. However, the manuscript lacks in-depth mechanistic insights into how telomere length affects IL-1R1 expression. Overall, this work broadens our understanding of telomere biology.

Reviewer #2 (Public Review):

In this study, the authors address discrepancies in determining the local bacterial burden in osteomyelitis between that determined by culture and enumeration by DNA-directed assay. Discrepancies between culture and other means of bacterial enumeration are long established and highlighted by Staley and Konopka's classic, "The great plate count anomaly" (1985). Here, the authors first present data demonstrating the emergence of discrepancies between CFU counts and genome copy numbers detected by PCR in S. aureus strains infecting osteocyte-like cells. They go on to demonstrate PCR evidence that S. aureus can be detected in bone samples from sites meeting a widely accepted clinicopathological definition of osteomyelitis. They conclude their approach offers advantages in quantifying intracellular bacterial load in their in vitro "co-culture" system.

Weaknesses<br /> - My main concern here is the significance of these results outside the model osteocyte system used by this group. Although they carefully avoid over-interpreting their results, there is a strong undercurrent suggesting their approach could enhance aetiologic diagnosis in osteomyelitis and that enumeration of the infecting pathogen might have clinical value. In the first place, molecular diagnostics such as 16S rDNA-directed PCR are well established in identifying pathogens that don't grow. Secondly, it is hard to see how enumeration could have value beyond in vitro and animal model studies since serial samples will rarely be available from clinical cases.

- I have further concerns regarding the interpretation of the combined bacterial and host cell-directed PCRs against the CFU results. Significance is attached to the relatively sustained genome counts against CFU declines. On the one hand, it must be clearly recognised that the detection of bacterial genomes does not equate to viable bacterial cells with the potential for further replication or production of pathogenic factors. Of equal importance is the potential contribution of extracellular DNA from lysed bacteria and host cells to these results. The authors must clarify what steps, if any, they have taken to eliminate such contributions for both bacteria and host cells. Even the treatment with lysotaphin may have coated their osteocyte cultures with bacterial DNA, contributing downstream to the ddPCR results presented.

Strengths<br /> - On the positive side, the authors provide clear evidence for the value of the direct buffer extraction system they used as well as confirming the utility of ddPCR for quantification. In addition, the successful application of MinION technology to sequence the EF-Tu amplicons from clinical samples is of interest.

- Moreover, the phenomenology of the infection studies indicating greater DNA than CFU persistence and differences between the strains and the different MOI inoculations are interesting and well-described, although I have concerns regarding interpretation.

Reviewer #1 (Public Review):

Summary:<br /> This work shows, based on basic laboratory investigations of in-vitro-grown bacteria as well as human bone samples, that conventional bacterial culture can substantially underrepresent the quantity of bacteria in infected tissues. This has often been mentioned in the literature, however, relatively limited data has been provided to date. This manuscript compares culture to a digital droplet PCR approach, which consistently showed greater levels of bacteria across the experiments (and for two different strains).

Strengths:<br /> Consistency of findings across in vitro experiments and clinical biopsies. There are real-world clinical implications for the findings of this study.

Weaknesses:<br /> No major weaknesses. Only three human samples were analyzed, although the results are compelling.

Reviewer #1 (Public Review):

This manuscript presents an extremely exciting and very timely analysis of the role that the nucleosome acidic patch plays in SWR1-catalyzed histone exchange. Intriguingly, SWR1 loses activity almost completely if any of the acidic patches are absent. To my knowledge, this makes SWR1 the first remodeler with such a unique and pronounced requirement for the acidic patch. The authors demonstrate that SWR1 affinity is dramatically reduced if at least one of the acidic patches is absent, pointing to a key role of the acidic patch in SWR1 binding to the nucleosome. The authors also pinpoint a specific subunit - Swc5 - that can bind nucleosomes, engage the acidic patch, and obtain a cryo-EM structure of Swc5 bound to a nucleosome. They also identify a conserved arginine-rich motif in this subunit that is critical for nucleosome binding and histone exchange in vitro and for SWR1 function in vivo. The authors provide evidence that suggests a direct interaction between this motif and the acidic patch.

Strengths:<br /> The manuscript is well-written and the experimental data are of outstanding quality and importance for the field. This manuscript significantly expands our understanding of the fundamentally important and complex process of H2A.Z deposition by SWR1 and would be of great interest to a broad readership.

Reviewer #2 (Public Review):

Summary:<br /> In this study, Baier et al. investigated the mechanism by which SWR1C recognizes nucleosomal substrates for the deposition of H2A.Z. Their data convincingly demonstrate that the nucleosome's acidic patch plays a crucial role in the substrate recognition by SWR1C. The authors presented clear evidence showing that Swc5 is a pivotal subunit involved in the interaction between SWR1C and the acidic patch. They pared down the specific region within Swc5 responsible for this interaction. However, two central assertions of the paper are less convincing. First, the data supporting the claim that the insertion of one Z-B dimer into the canonical nucleosome can stimulate SWR1C to insert the second Z-B dimer is somewhat questionable (see below). Given that this claim contradicts previous observations made by other groups, this hypothesis needs further testing to eliminate potential artifacts. Secondly, the claim that SWR1C simultaneously recognizes the acidic patch on both sides of the nucleosome also needs further investigation, as the assay used to establish this claim lacks the sensitivity necessary to distinguish any difference between nucleosomal substrates containing one or two intact acidic patches.

Strengths:<br /> As mentioned in the summary, the authors presented clear evidence demonstrating the role of Swc5 in recognition of the nucleosome acidic patch. The identification of the specific region in Swc5 responsible for this interaction is important.

Weaknesses:

Major comments:

(1) Figure 1B: It is unclear how much of the decrease in FRET is caused by the bleaching of fluorophores. The authors should include a negative control in which Z-B dimers are omitted from the reaction. In the absence of ZB dimers, SWR1C will not exchange histones. Therefore, any decrease in FRET should represent the bleaching of fluorophores on the nucleosomal substrate, allowing normalization of the FRET signal related to A-B eviction.

(2) Figure S3: The authors use the decrease in FRET signal as a metric of histone eviction. However, Figure S3 suggests that the FRET signal decrease could be due to DNA unwrapping. Histone exchange should not occur when SWR1C is incubated with AMP-PNP, as histone exchange requires ATP hydrolysis (10.7554/eLife.77352). And since the insertion of Z-B dimer and the eviction of A-B dimer are coupled, the decrease of FRET in the presence of AMP-PNP is unlikely due to histone eviction or exchange. Instead, the FRET decrease is likely due to DNA unwrapping (10.7554/eLife.77352). The authors should explicitly state what the loss of FRET means.

(3) Related to point 2. One way to distinguish nucleosomal DNA unwrapping from histone dimer eviction is that unwrapping is reversible, whereas A-B eviction is not. Therefore, if the authors remove AMP-PNP from the reaction chamber and a FRET signal reappears, then the initial loss of FRET was due to reversible DNA unwrapping. However, if the removal of AMP-PNP did not regain FRET, it means that the loss of FRET was likely due to A-B eviction. The authors should perform an AMP-PNP and/or ATP removal experiment to make sure the interpretation of the data is correct.

(4) The nature of the error bars in Figure 1C is undefined; therefore, the statistical significance of the data is not interpretable.

(5) The authors claim that the SWR1C requires intact acidic patches on both sides of the nucleosomes to exchange histone. This claim was based on the experiment in Figure 1C where they showed mutation of one of two acidic patches in the nucleosomal substrate is sufficient to inhibit SWR1C-mediated histone exchange activity. However, one could argue that the sensitivity of this assay is too low to distinguish any difference between nucleosomes with one (i.e., AB/AB-apm) versus two mutated acidic patches (i.e., AB-apm/AB-apm). The lack of sensitivity of the eviction assay can be seen when Figure 1B is taken into consideration. In the gel-shift assay, the AB-apm/AB-apm nucleosome exhibited a 10% SWR1C-mediated histone exchange activity compared to WT. However, in the eviction assay, the single AB/AB-apm mutant has no detectable activity. Therefore, to test their hypothesis, the authors should use the more sensitive in-gel histone exchange assay to see if the single AB/AB-apm mutant is more or equally active compared to the double AB-apm/AB-apm mutant.

(6) The authors claim that the AZ nucleosome is a better substrate than the AA nucleosome. This is a surprising result as previous studies showed that the two insertion steps of the two Z-B dimers are not cooperative (10.7554/eLife.77352 and 10.1016/J.CELREP.2019.12.006). The authors' claim was based on the eviction assay shown in Fig 1C. However, I am not sure how much variation in the eviction assay is contributed by different preparations of nucleosomes. The authors should use the in-gel assay to independently test this hypothesis.

Minor comments:

(1) Abstract line 4: To say 'Numerous' studies have shown acidic patch impact chromatin remodeling enzymes activity may be too strong.

(2) Page 15, line 15: The authors claim that swc5∆ was inviable on formamide media. However, the data in Figure 8 shows cell growth in column 1 of swc5∆.

(3) The authors should use standard yeast nomenclature when describing yeast genes and proteins. For example, for Figure 8 and legend, Swc5∆ was used to describe the yeast strain BY4741; MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; YBR231c::kanMX4. Instead, the authors should describe the swc5∆ mutant strain as BY4741 MAT a his3∆1 leu2∆0 met15∆0 ura3∆0 swc5∆::kanMX4. Exogenous plasmid should also be indicated in italics and inside brackets, such as [SWC5-URA3] or [swc5(R219A)-URA3].

(4) According to Lin et al. 2017 NAR (doi: 10.1093/nar/gkx414), there is only one Swc5 subunit per SWR1C. Therefore, the pincher model proposed by the authors would suggest that there is a missing subunit that recognizes the second acidic patch. The authors should point out this fact in the discussion. However, as mentioned in Major comment 6, I am not sure if the pincer model is substantiated.

Reviewer #2 (Public Review):

Greve et al. investigated the effects of a disease associated gamma-actin mutation (E334Q) on actin filament polymerization, association of selected actin-binding proteins, and myosin activity. Recombinant wildtype and mutant proteins expressed in sf9 cells were found to be folded and stable, and the presence of the mutation altered a number of activities. Given the location of the mutation, it is not surprising that there are changes in polymerization and interactions with actin binding proteins.

Comments on revised version:

I have nothing to add and am satisfied with the rebuttal.

Reviewer #1 (Public Review):

This paper is of importance to scientists interested in molecular mechanisms by which actin point mutations affect its function to ultimately lead to disease states. This work thoroughly characterizes the effect of the E334Q mutation in cytoplasmic gamma-actin on two binding partners: cofilin and myosin (non-muscle myosin 2 and myosin 5). Overall, the data showing effects on cofilin function and myosin binding are convincing and the experiments performed expertly using state-of-the art approaches. Additional binding partners of actin that were not examined here may also have altered function when interacting with the mutant actin.

Comments on revised version:

The authors seem to have done a pretty thorough job with the rebuttal.

Reviewer #1 (Public Review):

Summary:

This study, titled "Enhancing Bone Regeneration and Osseointegration using rhPTH(1-34) and Dimeric R25CPTH(1-34) in an Osteoporotic Beagle Model," provides valuable insights into the therapeutic effects of two parathyroid hormone (PTH) analogs on bone regeneration and osseointegration. The research is methodologically sound, employing a robust animal model and a comprehensive array of analytical techniques, including micro-CT, histological/histomorphometric analyses, and serum biochemical analysis.

Strengths:

The use of a large animal model, which closely mimics postmenopausal osteoporosis in humans, enhances the study's relevance to clinical applications. The study is well-structured, with clear objectives, detailed methods, and a logical flow from introduction to conclusion. The findings are significant, demonstrating the potential of rhPTH(1-34) and dimeric R25CPTH(1-34) in enhancing bone regeneration, particularly in the context of osteoporosis.

Weaknesses:

There are no major weaknesses.

Reviewer #2 (Public Review):

Summary:

This article explores the regenerative effects of recombinant PTH analogues on osteogenesis.

Strengths:

Although PTH has known to induce the activity of osteoclasts, accelerating bone resorption, paradoxically its intermittent use has become a common treatment for osteoporosis. Previous studies successfully demonstrated this phenomenon in vivo, but most of them used rodent animal models, inevitably having a limitation. In this article, the authors tried to address this, using a beagle model, and assessed the osseointegrative effect of recombinant PTH analogues. As a result, the authors clearly observed the regenerative effects of PTH analogues, and compared the efficacy, using histologic, biochemical, and radiologic measurement for surgical-endocrinal combined large animal models. The data seem to be solid, and has potential clinical implications.

Weaknesses:

As PTH's mechanism has already been widely accepted, and the main focus of this article was to compare the preclinical efficacy of PTH analogues, the lack of detail biologic mechanism could be allowed. However, there are some suggestions to enhance the readability of the article:

First, the authors should clarify why they compared the effects of rhPTH(1-34) and of dimeric R25C2 PTH(1-34)? In most of the parameters, rhPTH(1-34) seems to be superior to dimeric R25C2 PTH(1-34). Why did the authors insist that the anabolic effects of dimer were prominent? Even though implication of dimeric R25C2 PTH(1-34) was drawn from genetic mutation studies, the authors should describe more clearly in the discussion the potential clinical benefits of the dimeric R25C2 PTH(1-34) compared to rhPTH(1-34), especially if dimeric R25C2 PTH(1-34) has just partial agonistic effect in pharmacodynamics.

Second, please describe the intermittent and continuous application of PTH analogues. Many of the readers may misunderstand that the authors' daily injection of PTHs were actually to mimic the clinical intermittent application or continuous one. Incorporation of the author's intention for experimental design would be more helpful for readers.

Third, please unify the nomenclature. Ensure consistency in the nomenclature throughout the article. Unify the naming conventions for PTH analogues, such as rhPTH(1-34) vs teriparatide and (Cys25)PTH(1-84) vs R25CPTH(1-34) vs R25CPTH(1-34) vs (1-84). Choose one nomenclature for each analogue and use it consistently throughout the article.

Overall, this paper is well-written, but these suggestions aim to improve clarity and consistency for a broader readership.

Reviewer #3 (Public Review):

Summary:

The work submitted by Dr. Jeong-Oh Shin and co-workers aims to investigate the therapeutic efficacy of rhPTH(1-34) and R25CPTH(1-34) on bone regeneration and osseointegration of titanium implants using a postmenopausal osteoporosis animal model.<br /> In my opinion the findings presented are not strongly supported by the provided data since the methods utilized do not allow to significantly support the primary claims.

Strengths:

Strengths include certain good technologies utilized to perform histological sections (i.e. the EXAKT system).

Weaknesses:

Certain weaknesses significantly lower the enthusiasm for this work. Most important: the limited number of samples/group. In fact, as presented, the work has an n=4 for each treatment group. This limited number of samples/group significantly impairs the statistical power of the study. In addition, the implants were surgically inserted following a "conventional implant surgery", implying that no precise/guided insertion was utilized. This weakness is, in my opinion, particularly significant since the amount of bone osteointegration may greatly depend on the bucco-lingual positioning of each implant at the time of the surgical insertion (which should, therefore, be precisely standardized across all animals and for all surgical procedures).<br /> On a minor note: not sure why the authors present a methodology to evaluate the dynamic bone formation (line 272) but do not present results (i.e. by means of histomorphometrical analyses) utilizing this methodology.

Reviewer #3 (Public Review):

Chen et al. investigated how intermittent fasting causes metabolic benefits in obese mice and find that intestinal ILC3 and IL-22-IL-22R signaling contribute to the beiging of white adipose tissue (WAT) and consequent metabolic benefits including improved glucose and lipid metabolism in diet-induced obese mice. They demonstrate that intermittent fasting causes increased IL22+ILC3 in small intestines of mice. Adoptive transfer of purified intestinal ILC3 or administration of exogenous IL-22 can lead to increases in UCP1 gene expression and energy expenditure as well as improved glucose metabolism. Importantly, the above metabolic benefits caused by intermittent fasting are abolished in IL-22R-/- mice. Using an in vitro experiment, the authors show that ILC3-derived IL-22 may directly act on adipocytes to promote SVF beige differentiation. Finally, by performing sc-RNA-seq analysis of intestinal immune cells from mice with different treatments, the authors indicate a possible way of intestinal ILC3 being activated by intermittent fasting. Overall, this study provides a new mechanistic explanation for the metabolic benefits of intermittent fasting and reveals the role of intestinal ILC3 in the enhancement of the whole-body energy expenditure and glucose metabolism likely via IL-22-induced beige adipogenesis.

Although this study presents some interesting findings, particularly IL-22 derived from intestinal ILC3 could induce beiging of WAT by directly acting on adipocytes, the experimental data are not sufficient to support the key claims in the manuscript.

Reviewer #1 (Public Review):

In the present study, the authors carefully evaluated the metabolic effects of intermittent fasting on normal chow and HFD fed mice and reported that intermittent fasting induces beiging of subcutaneous white adipose tissue. By employing complementary mouse models, the authors provided compelling evidence to support a mechanism through ILC3/IL-22/IL22R pathway. They further performed comprehensive single-cell sequencing analyses of intestinal immune cells from lean, obese, obese undergone intermittent fasting mice and revealed altered interactome in intestinal myeloid cells and ILC3s by intermittent fasting via activating AhR. Overall, this is a very interesting and timely study uncovering a novel connection between intestine and adipose tissue in the context of executing metabolic benefits of intermittent fasting.

(1) The authors showed increased plasma IL-22 and its expression in intestine. Are intestinal ILC3s the main source of plasma IL-22?

(2) The authors transplanted intestinal ILC3s from NCD mice to DIO mice and showed significant metabolic improvements. However, in Fig. 1, intermittent fasting increased IL-22-positive ILC3s proportion rather than changing the total number. Please clarify whether this transplantation is due to increasing ILC3s number or introducing more IL-22 positive ILC3s (which are decreased in DIO). Are these transplanted ILC3s by default homing to intestine rather than to other tissues?

(3) The authors adopted cold challenge at 4 degree for 6 hours to assess beiging in subcutaneous WAT and showed difference in core temperature. However, thermogenesis in this acute cold challenge is mainly by brown adipose tissue. Beiging is a chronic and adaptive response. Based on the data in WAT, there is a beiging phenotype, but the core body temperature in acute cold challenge is not an accurate readout. It would be a missed opportunity by not evaluating thermogenic activity in BAT.<br /> More browning genes should be included to strengthen the beiging phenotype of WAT. Moreover, inflammation in WAT can be examined to provide a whole picture of adipose tissue remodeling through this pathway.

(4) For the SVF beige adipocyte differentiation, 100 ng/mL IL-22 was used. This is highly above the physiological concentration at ~5 pg/mL. Please justify this high concentration used.

The authors showed increased Ucp1 and Cidea expression by IL-22 treatment in SVFs. Please be aware that these increases are likely due to boosted adipogenesis as told by the morphology. Please examine more adipogenic markers to confirm. Is this higher adipogenesis caused by the high concentration of IL-22?<br /> In line 201, the authors drew the conclusion that IL-22 increased SVF beige differentiation. To fully support this conclusion, the authors should assure adipogenesis at the same baseline and then compare beiging, or examine the effect of IL-22 on normal adipogenesis to compare with beige differentiation.

Reviewer #2 (Public Review):

Summary:<br /> This study aims to investigate the mediatory role of intestinal ILC3-derived IL-22 in intermittent fasting-elicited metabolic benefits.

Strengths:<br /> The observation of induction of IL-22 production by intestinal ILC3 is significant, and the scRNAseq provides new information into intestine-resident immune cell profiling in response to repeated fasting and refeeding.

Weaknesses:<br /> The experimental design for some studies needs to be improved to enhance the rigor of overall study. There is a lack of direct evidence showing that the metabolically beneficial effects of IF are mediated by intestinal ILC3 and their derived IL-22. The mechanism by which IL-22 induces thermogenic program is unknown. The browning effect induced by IF may involve constitutive activation of lipolysis, which was not considered.

Majority of weaknesses have been addressed in the revision. Based on the analysis of thermogenic genes in addition to Ucp1 (Fig. 4D and S6F), the alteration on thermogenesis induced by IL-22 is dependent on UCP1 but not other markers such as PGC1a, PPARg, and Cidea. The data need to be discussed in the Section of Discussion.

Reviewer #1 (Public Review):

• A summary of what the authors were trying to achieve.

The authors cultured pre- and Post-vaccine PBMCs with overlapping peptides encoding S protein in the presence of IL-2, IL-7, and IL-15 for 10 days, and extensively analyzed the T cells expanded during the culture; by including scRNAseq, scTCRseq, and examination of reporter cell lines expressing the dominant TCRs. They were able to identify 78 S epitopes with HLA restrictions (by itself represents a major achievement) together with their subset, based on their transcriptional profiling. By comparing T cell clonotypes between pre- and post-vaccination samples, they showed that a majority of pre-existing S-reactive CD4+ T cell clones did not expand by vaccinations. Thus, the authors concluded that highly-responding S-reactive T cells were established by vaccination from rare clonotypes.

• An account of the major strengths and weaknesses of the methods and results.

Strengths:

• Selection of 4 "Ab sustainers" and 4 "Ab decliners" from 43 subjects who received two shots of mRNA vaccinations.<br /> • Identification of S epitopes of T cells together with their transcriptional profiling. This allowed the authors to compare the dominant subsets between sustainers and decliners.

Weaknesses were properly addressed in the revised manuscript, and I do not have any additional concerns.

Reviewer #3 (Public Review):

Summary: The paper aims to investigate the relationship between anti-S protein antibody titers with the phenotypes&clonotypes of S-protein-specific T cells, in people who receive SARS-CoV2 mRNA vaccines. To do this, the paper recruited a cohort of Covid-19 naive individuals that receives the SARS-CoV2 mRNA vaccines and collect sera and PBMCs samples on different timepoints. Then they mainly generate three sets of data: 1). Anti-S protein antibody titers on all timepoints. 2) Single-cell RNAseq/TCRseq dataset for divided T cells after stimulation by S-protein for 10 days. 3) Corresponding epitopes for each expanded TCR clones. After analyzing these result, the paper reports two major findings&claims: A) Individuals having sustained anti-S protein antibody response also have more so-called Tfh cells in their single-cell dataset. B). S-reactive T cells do exist before the vaccination, but they seems to be unable to response to Covid-19 vaccination properly.

The paper's strength is it uses a very systemic and thorough strategy trying to dissect the relationship between antibody titers, T cell phenotypes, TCR clonotypes and corresponding epitopes, and indeed it reports several interesting findings about the relationship of Tfh clonotypes/sustained antibody and about the S-reactive clones that exist before the vaccination. The conclusion is solid in general but some claims are overstated. My suggestion is the authors should further limit their claims in abstract, for example,

"Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which (MAY) cross-reacted with environmental or symbiotic bacteria" -- The paper don't have experimental evidence to show these TCR clones respond to these epitopes.

"These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination (LIKELY) contributes to the longevity of anti-S antibody titers." --Given the small sample size and the statistical analysis was not significant, this claim was overstated.

"S-reactive T cell clonotypes detected immediately after 2nd vaccination polarized to follicular helper T (Tfh)-like cells (UNDER IN VITRO CULTURE)". -- the conclusion was based on vitro cultured cells, which had limitation.

Reviewer #2 (Public Review):

Summary:

In this paper, the authors induced large doxorubicin-resistant (L-DOXR) cells by generating DOX gradients using their Cancer Drug Resistance Accelerator (CDRA) chip. The L-DOXR cells showed enhanced proliferation rates, migration capacity, and carcinogenesis. Then the authors identified that the chemoresistance of L-DOXR cells is caused by failed epigenetic control of NUPR1/HDAC11 axis.

Strengths:

- Chemoresistant cancer cells were generated using a novel technique and their oncogenic properties were clearly demonstrated using both in vivo and in vitro analysis.<br /> - The mechanisms of chemoresistance of the L-DOXR cells could be elucidated using in vivo chemoresistant xenograft models, an unbiased genome-wide transcriptome analysis, and a patient data/tissue analysis.<br /> - This technique has great capability to be used for understanding the chemoresistant mechanisms of tumor cells.

Reviewer #1 (Public Review):

Lim W et al. investigated the mechanisms underlying doxorubicin resistance in triple negative breast cancer cells (TNBC). They use a new multifluidic cell culture chamber to grow MB-231 TNBC cells in the presence of doxorubicin and identify a cell population of large, resistant MB-231 cells they term L-DOXR cells. These cells maintain resistance when grown as a xenograft model, and patient tissues also display evidence for having cells with large nuclei and extra genomic content. RNA-seq analysis comparing L-DOXR cells to WT MB-231 cells revealed upregulation of NUPR1. Inhibition or knockdown of NUPR1 resulted in increased sensitivity to doxorubicin. NUPR1 expression was determined to be regulated via HDAC11 via promoter acetylation. The data presented could be used as a platform to understand resistance mechanisms to a variety of cancer therapeutics.

Reviewer #3 (Public Review):

Summary:

In this manuscript, Lim and colleagues use an innovative CDRA chip platform to derive and mechanistically elucidate the molecular wiring of doxorubicin-resistant (DOXR) MDA-MB-231 cells. Given their enlarged morphology and polyploidy, they termed these cells as Large-DOXR (L-DORX). Through comparative functional omics, they deduce the NUPR1/HDAC11 axis to be essential in imparting doxorubicin resistance and, consequently, genetic or pharmacologic inhibition of the NUPR1 to restore sensitivity to the drug.

Strengths:

The study focuses on a major clinical problem of the eventual onset of resistance to chemotherapeutics in patients with triple-negative breast cancer (TNBC). They use an innovative chip-based platform to establish as well as molecularly characterize TNBC cells showing resistance to doxorubicin and uncover NUPR1 as a novel targetable driver of the resistant phenotype.

Weaknesses:

Critical weaknesses are the use of a single cell line model (i.e., MDA-MB-231) for all the phenotypic and functional experiments and absolutely no mechanistic insights into how NUPR1 functionally imparts resistance to doxorubicin. It is imperative that the authors demonstrate the broader relevance of NUPR1 in driving dox resistance using independent disease models.

Reviewer #2 (Public Review):

Summary:<br /> This is a very well-written manuscript by Saenz de Meira and colleagues on a careful study reporting on the key role of glutamate transporter vGlut2 expression in the neurons of the ventral perimammillary nucleus (PMv) of the hypothalamus expressing the leptin receptor LepRb in energy homeostasis, puberty, and estrous cyclicity. The authors first show using cre-dependent chemogenetic viral tools that the selective activation of the PMv LepRb induces luteinizing hormone (LH) release. Then the authors demonstrate that the selective invalidation of vGlut2 in LepRb-expressing cells in the all body induces obesity and mild alteration of sexual maturation in both sexes and blunted estrous cyclicity in females. Finally, the authors knock out vGlut2 in PMv neurons in which they reintroduce LepRb expression in an otherwise LepRb-null background using an AAV Cre approach. This latter very elegant experiment shows that while the sole re-expression of LepRb in PMv neurons in LepRb-null mice was shown before to restore puberty onset, deleting vGlut2 in LepRb-expressing PMv neurons blunts this effect.

Strengths:<br /> The authors employ state-of-the-art methods and their conclusions are robustly supported by the results.

Weaknesses:<br /> None identified. Only minor comments have been formulated.

Reviewer #1 (Public Review):

Summary:<br /> In previous work, the Elias group has shown that leptin-sensing PMv neurons make connections with the neuroendocrine reproductive axis and are involved in reproductive function/s. Sáenz de Miera et al. build on this body of work to investigate the sufficiency of leptin sensing PMv neurons to evoke the release of luteinizing hormone. The team further investigates how glutamate signaling from leptin-sensing neurons can influence pubertal timing in females, along with mature estrous cycles. Genetic ablation of Slc17a6 (Vglut2) from LepRb-expressing cells resulted in a delay of the first estrus cycle post-pubertal transition, along with a significantly lengthened estrous cycle in mature females. However, this deficit did not lengthen the latency to the birth of the first litter in experimental dams. Restoration of leptin signaling in LepRb PMv neurons was previously shown to induce puberty and instate reproductive function in LepRb knock-out female mice (Mahany et al., 2018). Here, Sáenz de Miera et al. use a combined genetic and viral strategy to demonstrate that glutamate signaling in LepRb PMv neurons is required for sexual maturation in LepRb knock-out female mice.

Strengths:<br /> Most of the experiments performed in this manuscript are well-justified and rigorously tested. The genetic method to simultaneously remove glutamate signaling and restore the leptin receptor in LepRb PMv neurons was well executed and showed that glutamate signaling in LepRb PMv neurons is necessary for leptin-dependent fertility.

Weaknesses:<br /> Analysis of experimentally induced luteinizing hormone release could be confounded by spontaneous pulses of luteinizing hormone that are independent of LepRb PMv neurons.

Reviewer #3 (Public Review):

Summary:<br /> The authors examined the effects of glutamate release from PMv LepR neurons in the regulation of puberty and reproduction in female mice.

Strengths:<br /> Multiple genetic mouse models were utilized to either manipulate PMv LepR neuron activities, or to delete glutamate vesicle transporters from LepR neurons. The authors have been quite rigorous in validating these models and exploring potential contaminations. Most of the data presented are solid and convincing and support the conclusion.

Weaknesses:<br /> Some results are hard to interpret.

Reviewer #1 (Public Review):

Summary:<br /> In this study, Maestri et al. use an integrative framework to study the evolutionary history of coronaviruses. They find that coronaviruses arose recently rather than having undergone ancient codivergences with their mammalian hosts. Furthermore, recent host switching has occurred extensively, but typically between closely related species. Humans have acted as an intermediate host, especially between bats and other mammal species.

Strengths:<br /> The study draws on a range of data sources to reconstruct the history of virus-host codivergence and host switching. The analyses include various tests of robustness and evaluations through simulation.

Weaknesses:<br /> The analyses are limited to a single genetic marker (RdRp) from coronaviruses, but using other sections of the genome might lead to different conclusions. The genetic marker also lacks resolution for recent divergences, which precludes the detailed examination of recent host switches. Careful and detailed reconstruction of the timescale would be helpful for clarifying the evolutionary history of coronaviruses alongside their hosts.

Reviewer #2 (Public Review):

Summary:<br /> In their study titled "Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses," authors Benoît Perez-Lamarque, Renan Maestri, Anna Zhukova, and Hélène Morlon investigate the complex evolutionary history of coronaviruses, particularly those affecting mammals, including humans. The study focuses on unraveling the evolutionary trajectory of these viruses, which have shown a high propensity for causing pandemics, as evidenced by the SARS-CoV2 outbreak.

The research addresses a significant gap in our understanding of the evolutionary dynamics of coronaviruses, particularly their history, patterns of host-to-host transmission, and geographical spread. These aspects are important for predicting and managing future pandemic scenarios.

Historically, studies have employed cophylogenetic tests to explore virus-host relationships within the Coronaviridae family, often suggesting a long history of virus-host codiversification spanning millions of years. However, the team led by Perez-Lamarque proposes a novel phylogenetic framework that contrasts this traditional view. Their approach, which involves adapting gene tree-species tree reconciliation, is designed to robustly test the validity of two competing scenarios: an ancient origination and codiversification versus a more recent emergence and diversification through host switching.

Upon applying this innovative framework to the study of coronaviruses and their mammalian hosts, the authors' findings challenge the prevailing notion of a deep evolutionary history. Instead, their results strongly support a scenario where coronaviruses have a more recent origin, likely in bat populations, followed by diversification predominantly through host-switching events. This diversification, interestingly, seems to occur preferentially within mammalian orders.

A critical aspect of their findings is the identification of hotspots of coronavirus diversity, particularly in East Asia and Europe. These regions align with the proposed scenario of a relatively recent origin and subsequent localized host-switching events. The study also highlights the rarity of spillovers from bats to other species, yet underscores the relatively higher likelihood of such spillovers occurring towards humans, suggesting a significant role for humans as an intermediate host in the evolutionary journey of these viruses.

The research also points out the high rates of host-switching within mammalian orders, including between humans, domesticated animals, and non-flying wild mammals.

In conclusion, the study by Perez-Lamarque and colleagues presents an important quantitative advance in our understanding of the evolutionary history of mammalian coronaviruses. It suggests that the long-held belief in extensive virus-host codiversification may have been substantially overestimated, paving the way for a reevaluation of how we understand, predict, and potentially control the spread of these viruses.

Strengths:<br /> The study is conceptually robust, and its conclusions are convincing.

Weaknesses:<br /> Despite the availability of a dated host tree the authors were only able to use the "undated" model in ALE, with the dated method (which only allows time-consistent transfers) failing on their dataset (possibly due to dataset size?). Further exploration of the question would be potentially valuable.

Reviewer #3 (Public Review):

Summary:<br /> This work uses tools and concepts from co-phylogenetic analyses to reconstruct the evolutionary and diversification history of coronaviruses in mammals. It concludes that cross-species transmissions from bats to humans are a relatively common event (compared to bats to other species). Across all mammals, the diversification history of coronaviruses suggests that there is potential for further evolutionary diversification.

Strengths:<br /> The article uses an interesting approach based on jointly looking at the extant network of coronaviruses-mammals interactions, and the phylogenetic history of both these organisms. The authors do an impressive job of explaining the challenges of reconstructing evolutionary dynamics for RNA viruses, and this helps readers appraise the relevance of their approach.

Weaknesses:<br /> I remain unconvinced by the argument that sampling does not introduce substantial biases in the analyses. As the authors highlight, incomplete knowledge of the extant interactions would lead to a biased reconstruction of the diversification history. In a recent paper (Poisot et al. 2023, Patterns), we look at sampling biases in the virome of mammals and suggest that is a fairly prominent issue, that is furthermore structured by taxonomy, space, and phylogenetic position. Case in point, even for betacoronaviruses, there have been many newly confirmed hosts in recent years. For organisms that have received less intense scrutiny, I think a thorough discussion of potential gaps in data would be required (see for example Cohen et al. 2022, Nat. Comms).

I was also surprised to see little discussion of the differences between alpha and beta coronaviruses - there is evidence that they may differ in their cross-species transmission (see Caraballo et al. 2022 Micr. Spectr.), which could call into question the relevance of treating all coronaviruses as a single, homogeneous group.

Some of the discussions in this paper also echo previous work by e.g. Geoghegan et al. (see 2017, PLOS Pathogens), which I was surprised to not see discussed, as it is a much earlier investigation of the relative frequencies of co-divergence and host switches for different viral families, with a deep discussion of how this may structure future evolutionary dynamics.

Reviewer #3 (Public Review):

Summary:<br /> The manuscript by Yujiro Umezaki and colleagues aims to describe how taste stimuli influence temperature preference in Drosophila. Under starvation flies display a strong preference for cooler temperatures than under fed conditions that can be reversed by refeeding, demonstrating the strong impact of metabolism on temperature preference. In their present study, Umezaki and colleagues observed that such changes in temperature preference are not solely triggered by the metabolic state of the animal but that gustatory circuits and peptidergic signalling play a pivotal role in gustation-evoked alteration in temperature preference.

The study of Umezaki is definitively interesting and the findings in this manuscript will be of interest to a broad readership.

Strengths:<br /> The authors demonstrate interesting new data on how taste input can influence temperature preference during starvation. They propose how gustatory pathways may work together with thermosensitive neurons, peptidergic neurons and finally try to bridge the gap between these neurons and clock genes. The study is very interesting and the data for each experiment alone are very convincing.

Weaknesses:<br /> In my opinion, the authors have opened many new questions but did not fully answer the initial question - how do taste-sensing neurons influence temperature preferences? What are the mechanisms underlying this observation? Instead of jumping from gustatory neurons to thermosensitive neurons to peptidergic neurons to clock genes, the authors should have stayed within the one question they were asking at the beginning. How does sugar sensing influence the physiology of thermos-sensation in order to change temperature preference? Before addressing all the following questions of the manuscript the authors should first directly decipher the neuronal interplay between these two types of neurons.

Reviewer #1 (Public Review):

Summary:<br /> This paper presents valuable findings that gustation and feeding state influence the preferred environmental temperature preference in flies. Interestingly, the authors showed that by refeeding starved animals with the non-nutritive sugar sucralose, they are able to tune their preference towards a higher temperature in addition to nutrient-dependent warm preference. The authors show that temperature-sensing and sweet-sensing gustatory neurons (SGNs) are involved in the former but not the latter. In addition, their data indicate that peptidergic signals involved in internal state and clock genes are required for taste-dependent warm preference behavior.

The authors made an analogy of their results to the cephalic phase response (CPR) in mammals where the thought, sight, and taste of food prepare the animal for the consumption of food and nutrients. They further linked this behavior to core regulatory genes and peptides controlling hunger and sleep in flies having homologues in mammals. These valuable behavioral results can be further investigated in flies with the advantage of being able to dissect the neural circuitry underlying CPR and nutrient homeostasis.

Strengths:<br /> (1) The authors convincingly showed that tasting is sufficient to drive warm temperature preference behavior in starved flies and that it is independent of nutrient-driven warm preference.

(2) By using the genetic manipulation of key internal sensors and genes controlling internal feeding and sleep states such as DH44 neurons and the per genes for example, the authors linked gustation and temperature preference behavior control to the internal state of the animal.

Weaknesses:<br /> (1) The title is somewhat misleading, as the term homeostatic temperature control linked to gustation only applies to starved flies.

(2) The authors used a temperature preference assay and refeeding for 5 minutes, 10 minutes, and 1 hour. Experimentally, it makes a difference if the flies are tested immediately after 10 minutes or at the same time point as flies allowed to feed for 1 hour. Is 10 minutes enough to change the internal state in a nutrition-dependent manner? Some of the authors' data hint at it (e.g. refeeding with fly food for 10 minutes), but it might be relevant to feed for 5/10 minutes and wait for 55/50min to do the assays at comparable time points.

(3) A figure depicting the temperature preference assay in Figure 1 would help illustrate the experimental approach. It is also not clear why Figure 1E is shown instead of full statistics on the individual panels shown above (the data is the same).

(4) The authors state that feeding rate and amount were not changed with sucralose and glucose. However, the FLIC assay they employed does not measure consumption, so this statement is not correct, and it is unclear if the intake of sucralose and glucose is indeed comparable. This limits some of the conclusions.

(5) The authors make a distinction between taste-induced and nutrient-induced warm preference. Yet the statistics in most figures only show the significance between the starved and refed flies, not the fed controls. As the recovery is in many cases incomplete and used as a distinction of nutritive vs non-nutritive signals (see Figure 1E) it will be important to also show these additional statistics to allow conclusions about how complete the recovery is.

(6) The starvation period used is ranging from 1 to 3 days, as in some cases no effect was seen upon 1 day of starvation (e.g. with clock genes or temperature sensing neurons). While the authors do provide a comparison between 18-21 and 26-29 hours old flies in Figure S1, a comparison for 42-49 and 66-69 hours of starvation is missing. This also limits the conclusion as the "state" of the animal is likely quite different after 1 day vs. 3 days of starvation and, as stated by the authors, many flies die under these conditions.

(7) In Figure 2, glucose-induced refeeding was not tested in Gr mutants or silenced animals, which would hint at post-ingestive recovery mechanisms related to nutritional intake. This is only shown later (in Figure S3) but I think it would be more fitting to address this point here. The data presented in Figure S3 regarding the taste-evoked vs nutrient-dependent warm preference is quite important while in some parts preliminary. It would nonetheless be justified to put this data in the main figures. However, some of the conclusions here are not fully supported, in part due to different and low n numbers, which due to the inherent variability of the behavior do not allow statistically sound conclusions. The authors claim that sweet GRNs are only involved in taste-induced warm preference, however, glucose is also nutritive but, in several cases, does not rescue warm preference at all upon removal of GRN function (see Figures S3A-C). This indicates that the Gal4 lines and also the involved GRs are potentially expressed in tissues/neurons required for internal nutrient sensing.

(8) In Figure 4, fly food and glucose refeeding do not fully recover temperature preference after refeeding. With the statistical comparison to the fed control missing, this result is not consistent with the statement made in line 252. I feel this is an important point to distinguish between state-dependent and taste/nutrition-dependent changes.

(9) The conclusion that clock genes are required for taste-evoked warm preference is limited by the observation that they ingest less sucralose. In addition, the FLIC assay does not allow conclusions about the feeding amount, only the number of food interactions. Therefore, I think these results do not allow clear-cut conclusions about the impact of clock genes in this assay.

(10) CPR is known to be influenced by taste, thought, smell, and sight of food. As the discussion focused extensively on the CPR link to flies it would be interesting to find out whether the smell and sight of food also influence temperature preference behavior in animals with different feeding states.

(11) In the discussion in line 410ff the authors claim that "internal state is more likely to be associated with taste-evoked warm preference than nutrient-induced warm preference." This statement is not clear to me, as neuropeptides are involved in mediating internal state signals, both in the brain itself as well as from gut to brain. Thus, neuropeptidergic signals are also involved in nutrient-dependent state changes, the authors might just not have identified the peptides involved here. The global and developmental removal of these signals also limits the conclusions that can be drawn from the experiments, as many of these signals affect different states, circuits, and developmental progression.

Reviewer #2 (Public Review):

Animals constantly adjust their behavior and physiology based on internal states. Hungry animals, desperate for food, exhibit physiological changes immediately upon sensing, smelling, or chewing food, known as the cephalic phase response (CPR), involving processes like increased saliva and gastrointestinal secretions. While starvation lowers body temperature, the mechanisms underlying how the sensation of food without nutrients induces behavioral responses remain unclear. Hunger stress induces changes in both behavior and physiological responses, which in flies (or at least in Drosophila melanogaster) leads to a preference for lower temperatures, analogous to the hunger-driven lower body temperature observed in mammals. In this manuscript, the authors have used Drosophila melanogaster to investigate the issue of whether taste cues can robustly trigger behavioral recovery of temperature preference in starving animals. The authors find that food detection triggers a warm preference in flies. Starved flies recover their temperature preference after food intake, with a distinction between partial and full recovery based on the duration of refeeding. Sucralose, an artificial sweetener, induces a warm preference, suggesting the importance of food-sensing cues. The paper compares the effects of sucralose and glucose refeeding, indicating that both taste cues and nutrients contribute to temperature preference recovery. The authors show that sweet gustatory receptors (Grs) and sweet GRNs (Gustatory Receptor Neurons) play a crucial role in taste-evoked warm preference. Optogenetic experiments with CsChrimson support the idea that the excitation of sweet GRNs leads to a warm preference. The authors then examine the internal state's influence on taste-evoked warm preference, focusing on neuropeptide F (NPF) and small neuropeptide F (sNPF), analogous to mammalian neuropeptide Y. Mutations in NPF and sNPF result in a failure to exhibit taste-evoked warm preference, emphasizing their role in this process. However, these neuropeptides appear not to be critical for nutrient-induced warm preference, as indicated by increased temperature preference during glucose and fly food refeeding in mutant flies. The authors also explore the role of hunger-related factors in regulating taste-evoked warm preference. Hunger signals, including diuretic hormone (DH44) and adipokinetic hormone (AKH) neurons, are found to be essential for taste-evoked warm preference but not for nutrient-induced warm preference. Additionally, insulin-like peptides 6 (Ilp6) and Unpaired3 (Upd3), related to nutritional stress, are identified as crucial for taste-evoked warm preference. The investigation then extends into circadian rhythms, revealing that taste-evoked warm preference does not align with the feeding rhythm. While flies exhibit a rhythmic feeding pattern, taste-evoked warm preference occurs consistently, suggesting a lack of parallel coordination. Clock genes, crucial for circadian rhythms, are found to be necessary for taste-evoked warm preference but not for nutrient-induced warm preference.

Strengths:<br /> A well-written and interesting study, investigating an intriguing issue. The claims, none of which to the best of my knowledge controversial, are backed by a substantial number of experiments.

Weakness:<br /> The experimental setup used and the procedures for assessing the temperature preferences of flies are rather sparingly described. Additional details and data presentation would enhance the clarity and replicability of the study. I kindly request the authors to consider the following points: i) A schematic drawing or diagram illustrating the experimental setup for the temperature preference assay would greatly aid readers in understanding the spatial arrangement of the apparatus, temperature points, and the positioning of flies during the assay. The drawing should also be accompanied by specific details about the setup (dimensions, material, etc). ii) It would be beneficial to include a visual representation of the distribution of flies within the temperature gradient on the apparatus. A graphical representation, such as a heatmaps or histograms, showing the percentage of flies within each one-degree temperature bin, would offer insights into the preferences and behaviors of the flies during the assay. In addition to the detailed description of the assay and data analysis, the inclusion of actual data plots, especially for key findings or representative trials, would provide readers with a more direct visualization of the experimental outcomes. These additions will not only enhance the clarity of the presented information but also provide the reader with a more comprehensive understanding of the experimental setup and results. I appreciate the authors' attention to these points and look forward to the potential inclusion of these elements in the revised manuscript.

Reviewer #1 (Public Review):

Xie and Colleagues propose here to investigate the mechanism by which exercise inhibits bone metastasis progression. The authors describe that osteocyte, sensing mechanical stimulation generated by exercise, inhibit NSCLC cell proliferation and sustain the dormancy thereof by releasing sEVs with tumor suppressor microRNAs. Furthermore, mechanical loading of the tibia inhibited the bone metastasis progression of NSCLC. Interestingly, exercise preconditioning effectively suppressed bone metastasis progression.

Reviewer #2 (Public Review):

In this manuscript, Xie and colleagues investigate the contribution of osteocytes to bone metastasis of non-small cell lung carcinoma (NSCLC) using a combination of clinical samples and in vitro and in vivo data. They find that metastatic NSCLC cells exhibit lower levels of the proliferation markers Ki-67 and CCND3 when located in areas adjacent to the bone surface in both NSCLC patients and an intraosseous animal model of NSCLC. Using in vitro approaches, they show that osteocyte-like cells inhibit the proliferation of NSCLC cells through the secretion of small extracellular vesicles (sEVs). They identify miR-99b-3p as a component of sEVs and demonstrate that miR-99b3p inhibits the proliferation of NSCLC cells by targeting the transcription factor MDM2. Interestingly, the data also shows that mechanical stimulation of osteocytes enhances the inhibitory effect of osteocytes on NSCLC cell proliferation via increasing sEVs release. By performing different in vivo studies, the authors show that tibial loading and moderate exercise (treadmill running), before and after tumor cell inoculation, suppress tumor progression in bone and protect bone mass. Intriguingly, the moderate exercise regime shows additive/synergistic effects with the co-administration of anti-resorptive therapy. These data add to the growing evidence pointing towards osteocytes as important cells of the tumor microenvironment capable of influencing the progression of tumors in bone.

The conclusions of the paper, however, are not well supported by the data, and some critical aspects of image analysis and data analysis need to be clarified and extended.

(1) In Figure 1, the authors rely on KI-67 as a marker of proliferation. Yet, it is intriguing that some osteocytes, non-proliferating cells by definition, are often positive for this marker, which questions the specificity of the staining. The data displayed in supplementary figures showing CCND3 as a marker of proliferation ,and GFP as a marker of cancer cells, is much more robust and should be moved to the main figures.

(2) Adding control groups to fully assess the impact of the in vivo interventions (tibial loading, moderate exercise, anti-resorptive therapy) on bone mass would be needed. The authors should have used naive mice or analyzed the bones from the non-injected contralateral legs.

(3) The data on miRNA99b-3p on NSCLC in Supplementary figure 3 is not convincing. The positive cells are difficult to see and most of the osteocyte lack nuclei. Better data, in humans and the mouse model, would have helped to confirm that osteocytes produce miRNA99b-3p.

(4) Some conclusions of the paper are not entirely supported by the data provided. Osteocytes, as well as other bone cells, can respond to mechanical stimulation and thus could virtually be responsible for the protective effects of mechanical loading or moderate exercise. While blocking miR-99b3p with antagomiRs rescued the decreases in proliferation, it is unclear whether this effect is mediated by osteocytes or other cells that express this miRNA. In vivo experiments demonstrating a direct role of osteocytes are needed to support the notion that osteocytes maintain tumor dormancy in NSCLC bone metastasis. In vivo, studies assessing tumor dormancy directly would be needed to confirm osteocytes promote cancer cell dormancy.

Reviewer #1 (Public Review):

Summary:<br /> TRIP13/Pch2 is a conserved essential regulator of meiotic recombination from yeast to humans. In this manuscript, the authors generated TRIP13 null mice and Flag-tagged TRIP13 knock-in mice to study its role in meiosis. They demonstrate that TRIP13 regulates MORMA domain proteins and is essential for meiotic completion and fertility. The main impact of this manuscript is its clarification of the in vivo function of TRIP13 during mouse meiosis and previously unrecognized role as a dose-sensitive regulator of meiosis.

Strengths:<br /> Two previously reported Trip13 mutations in mice are both hypomorphic alleles with distinct phenotypes, precluding a conclusion on its function. This study for the first time generated the TRIP13 null mice, definitively revealed the function of TRIP13 in meiosis. The authors also show novel localization of TRIP13 at SC and its independence from the axial element components. The finding of dose-sensitive regulation of meiosis by TRIP13 has implication in understanding human meiosis and disease phenotypes.

The results support the main conclusions and advance the understand of meiosis in the germline.

Reviewer #2 (Public Review):

Summary and Strengths:<br /> In this manuscript, Chotiner and colleagues demonstrated the localization of TRIP13 and clarified the phenotypes of Trip13-null mice in mouse meiosis. The meiotic phenotypes of Trip13 have been well characterized using the hypomorph alleles in the literature. However, the null phenotypes have not been examined, and the localization of TRIP13 was not clearly demonstrated. The study fills these important knowledge gaps in the field. The demonstration of TRIP13 localization to SC in mice provides an explanation of how HOMRA domain proteins are evicted from SC in diverse organisms. This conclusion was confirmed in both IF and TRIP13-tagged Tg mice. Further, the phenotypes of Trip13-null mice are very clear. The manuscript is well crafted, and the discussion section is well organized and comprehends the topic in the field. All in all, the manuscript will provide important knowledge in the field of meiosis.

Weaknesses:<br /> The heterozygous phenotypes demonstrate that TRIP13 is a dosage-sensitive regulator of meiosis. In relation to this conclusion, as summarized in the discussion section, other mutants defective in meiotic recombination showed dosage-sensitive phenotypes. However, the authors did not examine meiotic recombination in the Trip13-null mice.

Reviewer #1 (Public Review):

Summary:<br /> The authors employed a combinatorial CRISPR-Cas9 knockout screen to uncover synthetically lethal kinase genes that could play a role in drug resistance to kinase inhibitors in triple-negative breast cancer. The study successfully reveals FYN as a mediator of resistance to depletion and inhibition of various tyrosine kinases, notably EGFR, IGF-1R, and ABL, in triple-negative breast cancer cells and xenografts. Mechanistically, they demonstrate that KDM4 contributes to the upregulation of FYN and thereby is an important mediator of drug resistance. All together, these findings suggest FYN and KDM4A as potential targets for combination therapy with kinase inhibitors in triple-negative breast cancer. Moreover, the study may also have important implications for other cancer types and other inhibitors, as the authors suggest that FYN could be a general feature of drug-tolerant persister cells.

Strengths:<br /> (1) The authors used a large combination matrix of druggable tyrosine kinase gene knockouts, enabling studying of co-dependence of kinase genes. This approach mitigates off-target effects typically associated with kinase inhibitors, enhancing the precision of the findings.

(2) The authors demonstrate the importance of FYN in drug resistance in multiple ways. They demonstrate synergistic interactions using both knockouts and inhibitors, while also revealing its transcriptional upregulation upon treatment, strengthening the conclusion that FYN plays a role in the resistance.

(3) The study extends its impact by demonstrating the potent in vivo efficacy of certain combination treatments, underscoring the clinical relevance of the identified strategies.

Weaknesses:<br /> (1) The methods and figure legends are incomplete, posing a barrier to the reproducibility of the study and hindering a comprehensive understanding and accurate interpretation of the results.

(2) The authors make use of a large quantity of public data (Fig. 2D/E, Fig. 3F/L/M, Fig 4C, Fig 5B/H/I), whereas it would have strengthened the paper to perform these experiments themselves. While some of this data would be hard to generate (e.g. patient data) other data could have been generated by the authors. The disadvantage of the use of public data is that it merely comprises associations, but does not have causal/functional results (e.g. FYN inhibition in the different cancer models with various drugs). Moreover, by cherry-picking the data from public sources, the context of these sources is not clear to the reader, and thus harder to interpret correctly. For example, it is not directly clear whether the upregulation of FYN in these models is a very selective event or whether it is part of a very large epigenetic re-programming, where other genes may be more critical. While some of the used data are from well-known curated databases, others are from individual papers that the reader should assess critically in order to interpret the data. Sometimes the public data was redundant, as the authors did do the experiments themselves (e.g. lung cancer drug-tolerant persisters), in this case, the public data could also be left out.

More importantly, the original sources are not properly cited. While the GEO accession numbers are shown in a supplementary table, the articles corresponding to this data should be cited in the main text, and preferably also in the figure legend, to clarify that this data is from public sources, which is now not always the case (e.g. line 224-226). If these original papers do already mention the upregulation of FYN, and the findings from the authors are thus not original, these findings should be discussed in the Discussion section instead of shown in the Results.

(3) The claim in the abstract (and discussion) that the study "highlights FYN as broadly applicable mediator of therapy resistance and persistence", is not sufficiently supported by the results. The current study only shows functional evidence for this for an EGFR, IGF1R, and Abl inhibitor in TNBC cells. Further, it demonstrates (to a limited extent) the role of FYN in gefitinib and osimertinib resistance (also EGFR inhibitors) in lung cancer cells. Thus, the causal evidence provided is only limited to a select subset of tyrosine kinase inhibitors in two cancer types. While the authors show associations between FYN and drug resistance in other cancer types and after other treatments, these associations are not solid evidence for a causal connection as mentioned in this statement. Epigenetic reprogramming causing drug resistance can be accompanied by altered gene expression of many genes, and the upregulation of FYN may be a consequence, but not a cause of the drug resistance. Therefore, the authors should be more cautious in making such statements about the broad applicability of FYN as a mediator of therapy resistance.

(4) The rationale for picking and validating FYN as the main candidate gene over other genes such as FGFR2, FRK2, and TEK is not clear.<br /> a. While gene pairs containing FGFR2 knockouts seemed to be equally effective as FYN gene pairs in the primary screening, these could not be validated in the validation experiment. It is unclear whether multiple individual or a pool of gRNAs were used for this validation, or whether only 1 gRNA sequence was picked per gene for this validation. If only 1 gRNA per gene was used, this likely would have resulted in variable knockout efficiencies. Moreover, the T7 endonuclease assay may not have been the best method to check knockout efficiency, as it only implies endonuclease activity around a gene (but not to the extent of indels that can cause frameshifts, such as by TIDE analysis, or extent of reduction in protein levels by western blot).<br /> b. Moreover, FRK2 and TEK, also demonstrated many synergistic gene pairs in the primary screen. However, many of these gene pairs were not included in the validation screening. The selection criteria of candidate gene pairs for validation screening is not clear. Still, TEK-ABL2 was also validated as a strong hit in the validation screen. The authors should better explain the choice of FYN over other hits, and/or mention that TEK and FRK2 may also be important targets for combination treatment that can be further elucidated.

(5) On several occasions, the right controls (individual treatments, performed in parallel) are not included in the figures. The authors should include the responses to each of the single treatments, and/or better explain the normalization that might explain why the controls are not shown.<br /> a. Figure 2G: The effect of PP2 treatment, without combined treatment, is not shown.<br /> b. Figure 2H/3G: The effect of the knockouts on growth alone, compared to sgGFP, is not demonstrated. It is unclear whether the viability of knockouts is normalized to sgGFP, or to each untreated knockout.<br /> c. Figure 2L: The effect of SB203580 as a single treatment is not shown.

(6) The study examines the effects at a single, relatively late time point after treatment with inhibitors, without confirming the sequential impact on KDM4A and FYN. The proposed sequence of transcriptional upregulation of KDM4A followed by epigenetic modifications leading to FYN upregulation would be more compellingly supported by demonstrating a consecutive, rather than simultaneous, occurrence of these events. Furthermore, the protein level assessment at 48 hours (for RNA levels not clearly described), raises concerns about potential confounding factors. At this late time point, reduced cell viability due to the combination treatment could contribute to observed effects such as altered FYN expression and P38 MAPK phosphorylation, making it challenging to attribute these changes solely to the specific and selective reduction of FYN expression by KDM4A.

(7) The cut-off for considering interactions "synergistic" is quite low. The manual of the used "SynergyFinder" tool itself recommends values above >10 as synergistic and between -10 and 10 as additive (https://synergyfinder.fimm.fi/synergy/synfin_docs/). Here, values between 5-10 are also considered synergistic. Caution should be taken when discussing those results. Showing the actual dose response (including responses to each single treatment) may be required to enable the reader to critically assess the synergy, along with its standard deviation.

(8) As the effect size on Western blots is quite limited and sometimes accompanied by differences in loading control, these data should be further supported by quantifications of signal intensities of at least 3 biological replicates (e.g. especially Figure 3A/5A). The figure legends should also state how many independent experiments the blots are representative of.

(9) While the article provides mechanistic insights into the likely upregulation of FYN by KDM4A, this constitutes only a fragment of the broader mechanism underlying drug resistance associated with FYN. The study falls short in investigating the causes of KDM4A upregulation and fails to explore the downstream effects (except for p38 MAPK phosphorylation, which may not be complete) of FYN upregulation that could potentially drive sustained cell proliferation and survival. These omissions limit the comprehensive understanding of the complete molecular pathway, and the discussion section does not address potential implications or pathways beyond the identified KDM4A-FYN axis. A more thorough exploration of these aspects would enhance the study's contribution to the field.

(10) FYN has been implied in drug resistance previously, and other mechanisms of its upregulation, as well as downstream consequences, have been described previously. These were not evaluated in this paper, and are also not discussed in the discussion section. Moreover, the authors did not investigate whether any of the many other mechanisms of drug resistance to EGFR, IGF1R, and Abl inhibitors that have been described, could be related to FYN as well. A more comprehensive examination of existing literature and consideration of alternative or parallel mechanisms in the discussion would enhance the paper's contribution to understanding FYN's involvement in drug resistance.

Reviewer #2 (Public Review):

Summary:<br /> Kim et al. conducted a study in which they selected 76 tyrosine kinases and performed CRISPR/Cas9 combinatorial screening to target 3003 genes in Triple-negative breast cancer (TNBC) cells. Their investigation revealed a significant correlation between the FYN gene and the proliferation and death of breast cancer cells. The authors demonstrated that depleting FYN and using FYN inhibitors, in combination with TKIs, synergistically suppressed the growth of breast cancer tumor cells. They observed that TKIs upregulate the levels of FYN and the histone demethylase family, particularly KDM4, promoting FYN expression. The authors further showed that KDM4 weakens the H3K9me3 mark in the FYN enhancer region, and the inhibitor QC6352 effectively inhibits this process, leading to a synergistic induction of apoptosis in breast cancer cells along with TKIs. Additionally, the authors discovered that FYN is upregulated in various drug-resistant cancer cells, and inhibitors targeting FYN, such as PP2, sensitize drug-resistant cells to EGFR inhibitors.

Strengths:<br /> This study provides new insights into the roles and mechanisms of FYN and KDM4 in tumor cell resistance.

Weaknesses:<br /> It is important to note that previous studies have also implicated FYN as a potential key factor in drug resistance of tumor cells, including breast cancer cells. While the current study is comprehensive and provides a rich dataset, certain experiments could be refined, and the logical structure could be more rigorous. For instance, the rationale behind selecting FYN, KDM4, and KDM4A as the focus of the study could be more thoroughly justified.

Reviewer #1 (Public Review):

In this study, Li et al., report that FBXO24 contributes to sperm development by modulating alternative mRNA splicing and MIWI degradation during spermiogenesis. The authors demonstrated that FBXO24 deficiency impairs sperm head formation, midpiece compartmentalization, and axonemal/peri-axonemal organization in mature sperm, which causes sperm motility defects and male infertility. In addition, FBXO24 interacts with various mRNA splicing factors, which causes altered splicing events in Fbxo24-null round spermatids. Interestingly, FBXO24 also modulates MIWI levels via its polyubiquitination in round spermatids. Thus, the authors address that FBXO24 modulates global mRNA levels by regulating piRNA-mediated MIWI function and splicing events in testicular haploid germ cells.

This study is performed with various experimental approaches to explore and elucidate underlying molecular mechanisms for the FBXO24-mediated sperm defects during germ cell development. Overall, the experiments were designed properly and performed well to support the authors' observation in each part. In addition, the findings in this study are useful for understanding the physiological and developmental significance of FBXO24 in the male germ line, which can provide insight into impaired sperm development and male infertility.

In the revised manuscript, the authors address most of the concerns raised in the previous review. The following are representative remaining points.

• Quantification of the defective, vacuolar mitochondria (80%) and missing annulus (30%) was not shown in the figures or described in the results as well as in a few other figures.

Reviewer #2 (Public Review):

Spermatogenesis describes a complex sequence of differentiation events that lead to the development of genetically distinct male germ cells. The final part of spermatogenesis is called spermiogenesis, in which spermatids differentiate into mature sperm by developing an acrosome and a motile flagellum, which are required for reaching and successfully penetrating the oocyte. This process of spermatogenesis is based on a coordinated regulation of gene expressions in round spermatids. In the current study, FBXO24 was identified as a highly expressed protein in human and mouse testis. To define its biological role in vivo, the authors generated genetically engineered Fbxo24 knockout and Fbxo24-HA-labeled transgenic mouse models.

To elucidate the causes of the observed sterility in Fbxo24-KO males, the authors performed molecular and phenotypic analyses that revealed aberrant histone retention, incomplete axonemes, oversized chromatoid bodies (CB), and abnormal mitochondrial coiling along the sperm flagella. These results support the causal role of the FBXO24 gene in sperm motility.

Furthermore, the authors carefully characterized by SEM, TEM and western blot analyses that deletion of FBXO24 leads to incomplete histone-to-protamine exchange and defective chromatin interaction during spermiogenesis. In addition to increased MIWI expression, the authors show that FBXO24 interacts with SCF subunits and mediates the degradation of MIWI via K48-linked polyubiquitination.

This is a solid work demonstrating the role of FBXO24 in modulating alternative mRNA splicing, MIWI degradation and normal spermiogenesis.

Reviewer #3 (Public Review):

This work is carried out by the research group led by Shuiqiao Yuan, who has a long interest and significant contribution in the field of male germ cell development. The authors study a protein for which limited information existed prior to this work, a component of the E3 ubiquitin ligase complex, FBXO24. The authors generated the first FBXO24 KO mouse model reported in the literature using CRISPR, which they complement with HA-tagged FBXO24 transgenic model in the KO background. The authors begin their study with a very careful examination of the expression pattern of the FBXO24 gene at the level of mRNA and the HA-tagged transgene, and they provide conclusive evidence that the protein is expressed exclusively in the mouse testis and specifically in post-meiotic spermatids of stages VI to IX, which include early stages of spermatid elongation and nuclear condensation. The authors report a fully sterile phenotype for male mice, while female mice are normal. Interestingly, the testis size and the populations of spermatogenic cells in the KO mutant mice show small (but significant) reduction compared to the WT testis. Importantly, the mature sperm from KO animals show a series of defects that were very thoroughly documented in this work by scanning and transmission electron microscopy; this data constitutes a very strong point in this paper. FBXO24 KO sperm have severe defects in the mitochondrial sheath with missing mitochondria near the annulus, and missing outer dense fibers. Collectively these defects cause abnormal bending of the flagellum and severely reduced sperm motility. Moreover, defects in nuclear condensation are observed with faint nuclear staining of elongating and elongated spermatids, and reduction of protein levels of protamine 2 combined with increased levels of histones and transition protein 1. All the above are in line with the observed male sterility phenotype.

The authors also performed RNASeq in the KO animal, and found profound changes in the abundance of thousands of mRNAs; changes in mRNA splicing patterns were noted as well. This data reveals deeply affected gene expression patterns in the FBXO24 KO testis, which further supports the essential role that this factor serves in spermiogenesis. Unfortunately, a molecular explanation of what causes these changes is missing; it is still possible that they are an indirect consequence of the absence of FBXO24 and not directly caused by it.

The finding that Miwi protein levels are increased in the FBXO24 KO testis is an important point in this work, and it is in agreement with the observed increased size of the chromatoid body, where most of Miwi protein is accumulated in round spermatids. This finding is well supported with experiments performed in 293T cells showing that Miwi ubiquitination is FBXO24 dependent in this ectopic system. Moreover, the authors detect reduced ubiquitination of endogenous Miwi protein immunoprecipitated from FBXO24 KO testis. Consistent with an increase in Miwi protein levels, Miwi-sized piRNAs show increased abundance in total RNA from FBXO24 KO testis. It has been documented that Piwi proteins stabilize their piRNA cargo, so the increase in piRNA levels in 29-32 nt sizes is most likely not a result of altered biogenesis, but increased half-life of the piRNAs as a result of Miwi upregulation. piRNAs have been involved in the regulation of mRNAs in the post-meiotic spermatid, but it is unclear how increased Miwi protein and its piRNA cargo at the levels observed in this study contribute to the complete infertility phenotype of the FBXO24 KO male mice.

Therefore, a well-reasoned narrative on if and how the absence of FBXO24 as an E3 ubiquitin ligase is responsible for the observed mRNA and protein differential expression is largely absent. If FBXO24-mediated ubiquitination is required for normal protein degradation during spermiogenesis, protein level increase should be the direct consequence of genuine FBXO24 targets in the KO testis. Apart from Miwi, the possible involvement of ubiquitination was not shown for any other proteins that the authors found interact with FBXO24 such as splicing factors SRSF2, SRSF3, SRSF9, or any of the other proteins whose levels were found to be changed (reduced, thus the change in the KO is less likely due to absence of ubiquitination) such as ODF2, AKAP3, TSSK4, PHF7, TSSK6 and RNF8. Interestingly, the authors do observe increased amounts of histones and transition proteins, but reduced amounts of protamines, which directly shows that histone to protamine transition is indeed affected in the FBXO24 KO testis, consistent with the observed less condensed nuclei of spermatozoa. Could histones and transition proteins be targets of the proposed ubiquitin ligase activity of FBXO24, and in its absence, histone replacement is abrogated? Providing experimental evidence to address this possibility would greatly expand our understanding on why FBXO24 is essential during spermiogenesis.

Reviewer #1 (Public Review):

The authors assess the effectiveness of electroporating mRNA into male germ cells to rescue the expression of proteins required for spermatogenesis progression in individuals where these proteins are mutated or depleted. To set up the methodology, they first evaluated the expression of reporter proteins in wild-type mice, which showed expression in germ cells for over two weeks. Then, they attempted to recover fertility in a model of late spermatogenesis arrest that produces immotile sperm. By electroporating the mutated protein, the authors recovered the motility of ~5% of the sperm, although the sperm regenerated was not able to produce offspring using IVF.

This is a comprehensive evaluation of the mRNA methodology with multiple strengths. First, the authors show that naked synthetic RNA, purchased from a commercial source or generated in the laboratory with simple methods, is enough to express exogenous proteins in testicular germ cells. The authors compared RNA to DNA electroporation and found that germ cells are efficiently electroporated with RNA, but not DNA. The differences between these constructs were evaluated using in vivo imaging to track the reporter signal in individual animals through time. To understand how the reporter proteins affect the results of the experiments, the authors used different reporters: two fluorescent (eGFP and mCherry) and one bioluminescent (Luciferase). Although they observed differences among reporters, in every case expression lasted for at least two weeks.

The authors used a relevant system to study the therapeutic potential of RNA electroporation. The ARMC2-deficient animals have impaired sperm motility phenotype that affects only the later stages of spermatogenesis. The authors showed that sperm motility was recovered to ~5%, which is remarkable due to the small fraction of germ cells electroporated with RNA with the current protocol. The 3D reconstruction of an electroporated testis using state-of-the-art methods to show the electroporated regions is compelling.

The main weakness of the manuscript is that although the authors manage to recover motility in a small fraction of the sperm population, it is unclear whether the increased sperm quality is substantial to improve assisted reproduction outcomes. The quality of the sperm was not systematically evaluated in the manuscript, with the endpoints being sperm morphology and sperm mobility.

Some key results, such as the 3D reconstruction of the testis and the recovery of sperm motility, are qualitative given the low replicate numbers or the small magnitude of the effects. The presentation of the sperm motility data could have been clearer as well. For example, on day 21 after Armc2-mRNA electroporation, only one animal out of the three tested showed increased sperm motility. However, it is unclear from Figure 11A what the percentage of sperm motility for this animal is since the graph shows a value of >5% and the reported aggregate motility is 4.5%. It would have been helpful to show all individual data points in Figure 11A.

The expression of the reporter genes is unambiguous; however, better figures could have been presented to show cell type specificity. The DAPI staining is diffused, and it is challenging to understand where the basement membranes of the tubules are. For example, in Figures 7B3 and 7E3, the spermatogonia seems to be in the middle of the seminiferous tubule. The imaging was better for Figure 8. Suboptimal staining appears to lead to mislabeling of some germ cell populations. For example, in Supplementary Figure 4A3, the round spermatid label appears to be labeling spermatocytes. Also, in some instances, the authors seem to be confusing, elongating spermatids with spermatozoa, such as in the case of Supplementary Figures 4D3 and D4.

The characterization of Armc2 expression could have been improved as well. The authors show a convincing expression of ARMC2 in a few spermatids/sperm using a combination of an anti-ARMC2 antibody and tubules derived from ARMC2 KO animals. At the minimum, one would have liked to see at least one whole tubule of a relevant stage.

Overall, the authors show that electroporating mRNA can improve spermatogenesis as demonstrated by the generation of motile sperm in the ARMC2 KO mouse model.

Reviewer #2 (Public Review):

Summary:

Here, the authors inject naked mRNAs and plasmids into the rete testes of mice to express exogenous proteins - GFP and later ARMC2. This approach has been taken before, as noted in the Discussion to rescue Dmc1 KO infertility. While the concept is exciting, multiple concerns reduce reviewer enthusiasm.

Strengths:

The approach, while not necessarily novel, is timely and interesting.

Weaknesses:

Overall, the writing and text can be improved and standardized - as an example, in some places in vivo is italicized, in others it's not; gene names are italicized in some places, others not; some places have spaces between a number and the units, others not. This lack of attention to detail in the preparation of the manuscript is a significant concern to this reviewer - the presentation of the experimental details does cast some reasonable concern with how the experiments might have been done. While this may be unfair, it is all the reviewers have to judge. Multiple typographical and grammatical errors are present, and vague or misleading statements.

Reviewer #3 (Public Review):

Summary:

The authors used a novel technique to treat male infertility. In a proof-of-concept study, the authors were able to rescue the phenotype of a knockout mouse model with immotile sperm using this technique. This could also be a promising treatment option for infertile men.

Strengths:

In their proof-of-concept study, the authors were able to show that the novel technique rescues the infertility phenotype in vivo.

Weaknesses:

Some minor weaknesses, especially in the discussion section, could be addressed to further improve the quality of the manuscript.

It is very convincing that the phenotype of Armc2 KO mice could (at least in part) be rescued by injection of Armc2 RNA. However, a central question remains about which testicular cell types have been targeted by the constructs. From the pictures presented in Figures 7 and 8, this issue is hard to assess. Given the more punctate staining of the DNA construct a targeting of Sertoli cells is more likely, whereas the more broader staining of seminiferous tubules using RNA constructs is talking toward germ cells.

Further, the staining for up to 119 days (Figure 5) would point toward an integration of the DNA construct into the genome of early germ cells such as spermatogonia and/or possibly to Sertoli cells. Given the expression after RNA transfection for up to 21 days (Figure 4) and the detection of motile sperm after 21 days (Figure 11), this would point to either round spermatids or spermatocytes.

These aspects need to be discussed more carefully (discussion section: lines 549-574).

It would also be very interesting to know in which testicular cell type Armc2 is endogenously expressed (lines 575-591).